Identification of transcription regulatory mechanisms mediating host responses to the microbiota in the intestinal epithelium by Davison, James
IDENTIFICATION OF TRANSCRIPTIONAL REGULATORY MECHANISMS MEDIATING 
HOST RESPONSES TO MICROBIOTA IN THE INTESTINAL EPITHELIUM 
James M Davison 
A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in 
partial fulfillment of the requirements for the degree of Doctor of Philosophy in the curriculum 
of Cell Biology and Physiology in the School of Medicine 
Chapel Hill 
2017 
Approved by: 
John F. Rawls 
Patrick Brennwald 
Douglas M. Cyr 
Michael B. Major 
Praveen Sethupathy 
 
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2017 
James M Davison 
ALL RIGHTS RESEVERED
iii 
 
ABSTRACT
 
James M Davison: Identification of transcription regulatory mechanisms mediating host 
responses to the microbiota in the intestinal epithelium 
(Under the Direction of John F. Rawls) 
 
All organisms must detect and respond to environmental pressures or else risk 
death. For animals, these pressures include maintaining symbiosis with the microorganisms 
that dominate their world. Over the course of evolution, these intimate microbial 
relationships have influenced animal tissue function and cellular identities. Microbial impact 
on animal cellular identity is most salient in the intestinal epithelia which interfaces with the 
largest concentration of microorganisms on any animal surface. In this dissertation, I explore 
the genomic and transcriptional regulatory mechanisms that mediate microbial tuning of 
intestinal epithelial identities. The collection of microorganisms that reside in the intestine 
(the intestinal microbiota), contribute to host physiology by facilitating energy harvest, tuning 
metabolic programs, promoting epithelial barrier function, promoting epithelial renewal and 
promoting immune system development. In addition to these important roles in health, 
intestinal microbiota have been implicated in a growing number of human diseases 
associated with loss of intestinal epithelial identity and function like Inflammatory Bowel 
Diseases. The microbiota impact intestinal epithelial function in part by regulating the 
expression of hundreds of genes in intestinal epithelial cells. Extensive research has 
identified the downstream physiological consequences of this transcriptional control. 
However, there remains a significant gap in our understanding of the upstream molecular 
mechanisms that mediate these host transcriptional responses. I identified that zebrafish 
transcription factor Hepatocyte nuclear factor 4 alpha (Hnf4a) specifically binds and 
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activates a microbiota-suppressed intestinal epithelial transcriptional enhancer. Deletion of 
this transcription factor in zebrafish revealed that it activates nearly half of the genes that are 
also suppressed by the microbiota, suggesting that its activity is negatively regulated upon 
microbiota colonization. Experiments from intestinal epithelial cells from gnotobiotic mice 
revealed that microbiota colonization is associated with genome wide reductions in HNF4A 
DNA occupancy. Similarly, HNF4A binding sites were associated with hundreds of 
microbiota-activated or microbiota-inactivated enhancers. These data indicate HNF4A may 
be an important regulator in the host response to the microbiota. Together, these data 
provide a novel genomic mechanism for understanding how the microbiota tune intestinal 
epithelial transcription programs and may contribute to Inflammatory Bowel Diseases.  
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CHAPTER 1: INTRODUCTION
 
 All animals maintain intimate relationships with the microbial communities that reside 
on their surfaces. The largest of these microbial communities occupies the animal intestine 
and are named the gut microbiota. This microbial assembly of viruses, fungi, and bacteria 
interface with the intestinal epithelium. The intestinal epithelium is comprised of a single 
layer of columnar epithelial cells that harvest dietary nutrients from the lumen to maintain 
energy homeostasis for the animal. Furthermore, this single layer of cells also contains 
several specialized cell types that detect fluctuations in the environment of the intestinal 
lumen, including changes to the microbiota. These cells all contribute to maintaining an 
effective barrier against the microbiota residing in the lumen. Improper epithelial response to 
these fluctuations have the capacity to disrupt homeostasis with the microbiota or impair 
energy homeostasis. Therefore, the intestinal epithelia must be poised with a variety of 
mechanisms that restrict aberrant responses yet maintain sensitivities to the environment 
while preserving vital absorptive and barrier functions. Most of the known sensory and 
response mechanisms impact transcriptional regulation that facilitate appropriate handling of 
the environment and the microbiota.  
 There remains intense interest in understanding how the intestinal microbiota impact 
human health. The microbiota can reprogram metabolic homeostasis, edify the innate and 
adaptive immune systems, and fortify skeletal bone. However, the microbiota are also 
associated with several human diseases including Inflammatory Bowel Diseases (Ulcerative 
Colitis and Crohn’s Disease) and Metabolic Syndrome. We understand how the microbiota 
contribute to these processes through the help of gnotobiotic animal models. Gnotobiotics is 
a controlled experimental system that enables scientists to account for all organisms within 
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an environment. Using gnotobiotics, scientists have the capacity to add a controlled 
community of microbes to an animal model and observe how the microbes impact animal 
physiology. By using gnotobiotic systems, scientists now understand the profound rewiring 
of transcriptional programs that occurs in animal tissues (especially the intestinal epithelia) 
upon the introduction and establishment of a microbiota.   
Recent advances in the microbiome field have utilized whole genome analysis in 
conjunction with gnotobiotic animal models to test how the microbiota impact host 
epigenetics. By performing these types of experiments, scientists hope to understand the 
genomic mechanisms that mediate the host response. By identifying specific genomic and 
transcriptional regulatory mechanisms, scientists can begin to identify the broader host 
signaling pathways and microbial factors that control the host response and human health. 
Throughout the dissertation, I use the term “transcription program”. to refer to the network of 
regulatory mechanisms that control the expression of genes. These mechanisms include but 
are not limited to nucleosome location, histone modification, transcription factor binding, 
cofactor interactions, RNA polymerase binding, microRNA and long-non-coding RNA 
activities. Together these mechanisms function to activate and/or deactivate transcription of 
genes that can help determine cellular function and identity. However, I bias the discussion 
toward the transcription factors that mediate these “transcription programs”. 
A central question that I maintain as a theme in this dissertation is “How does the 
intestinal epithelia remain sensitive to the luminal environment without losing its identity?” In 
other words, if the microbiota are capable of modifying epithelial cell fate and cell decisions, 
how does the intestinal epithelia balance sensitivity and responses to the environment while 
maintaining epithelial function and intestinal homeostasis? This question is introduced and 
expanded in chapter 2 of this dissertation. I also discuss what we currently know about 
transcriptional programs and the transcription factors that control these programs in the 
intestinal epithelia. I then highlight the transcriptional regulatory mechanisms that tune 
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inflammatory, metabolic, cell fate, and circadian rhythm networks in response to the 
environment. In chapter 3 of this dissertation, I discuss the use of a yeast-1-hybrid assay to 
identify transcription factors that mediate epithelial response to the microbiota. I then use 
both gnotobiotic zebrafish and mice to validate the discoveries made using the yeast-1-
hybrid as well as make new observations about the role of a transcription factor, called 
Hepatocyte Nuclear Factor 4 (HNF4A), in the epithelium’s response to the microbiota. I 
conclude chapter 3 with multi-species meta-analysis to determine new links between the 
microbiota and HNF4A and their contributions to human diseases. In chapter 4 of this 
dissertation, I discuss the possible mechanisms that mediate microbial suppression of 
HNF4A. I explore the possible evolutionary advantages for both the host and the microbiota. 
I speculate that rather than a commensal relationship that drives this microbial suppression 
of HNF4A, it’s an antagonist relationship prompted by the host to secure an advantage in 
the warfare for resources in the intestinal lumen. I discuss how the HNF4A-microbiota 
interaction may be linked to human diseases and expand upon findings in chapter 3 
regarding human IBD. I conclude the dissertation with a discussion about the expansion of 
the nuclear receptor and their role in metazoan evolution. Together this dissertation provides 
a framework for how the luminal environment impacts intestinal epithelial transcriptional 
regulatory mechanisms.   
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CHAPTER 2: THE PARADOX OF MAINTAINING CELL IDENTITY WHILE REMAINING 
SENSITIVE TO A STOCAHSTIC AND COMPLEX ENVIRONMENT
 
2.1 Overview 
All animal tissues and cells must maintain a set of transcriptional programs that 
define their function (identity). Dysregulation of these transcriptional programs can result in 
human diseases such as cancers or Inflammatory Bowel Diseases (IBDs). However, animal 
cells must also remain responsive to changes in their environment to proceed through 
development or maintain physiological homeostasis. Therefore, cells must balance between 
“rigid” and “flexible” transcription programs to maintain both cellular identity and sensitivity to 
the environment. No cellular environment may be more stochastic or challenging to respond 
to than the intestinal lumen that interfaces with the intestinal epithelia. The intestinal 
epithelia maintain identity despite its exposure to a battery of growth factors, organic 
molecules, electrolytes, minerals, and microorganisms that have the capacity to modulate its 
transcription programs. The epithelium is comprised of several different specialized 
absorptive and secretory cell types that maintain epithelial function and each have their own 
unique set of transcription programs that define their identities. Each of these cell types 
similarly, must respond appropriately to the luminal environment to maintain intestinal 
homeostasis. These responses include tuning of their transcriptional programs which can 
impact their development, inflammatory response and energy harvest. Gross dysregulation 
of these same transcriptional responses can lead to human diseases such as IBDs where 
cellular identities are modified and the epithelia fails to appropriately respond the luminal 
environment. Paradoxically, a highly plastic transcriptional regulation is paramount to 
epithelial function and maintaining intestinal homeostasis and identity.
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2.2 Introduction 
The intestinal epithelium is a rapidly renewing and remarkably resilient tissue that 
interfaces with a complex luminal environment. At this interface, specialized cells that 
comprise the epithelium establish defensive barriers between itself and the intestinal 
microbiota. Most epithelial cell types absorb dietary nutrients while other cells communicate 
nutritional conditions to extra-intestinal tissues. The identity of each of these cell types is 
determined by a set of transcription factors that coordinate activities to establish and 
maintain cellular function. However, the transcriptomes for individual cell types varies along 
the length of the intestine, demonstrating a plasticity of these transcriptional programs (or 
regulatory transcriptional networks). Indeed, these malleable transcription programs permit 
the different cellular functions along the length of the intestine required to maintain animal 
health. However, aberrant dysregulation of these transcription programs can lead to the 
onset of human diseases such as cancer [1] and are associated with inflammatory bowel 
diseases [2]. 
The common function of all intestinal tracts is to harvest usable energy necessary for 
animal growth and survival from exogenous dietary nutrients (food) while maintaining a 
barrier between the microbiota and the animal. Along the length of the intestine, both host 
and microbiota catabolize and solubilize complex macromolecules to usable energy sources 
such as peptides and fatty acids (Figure 2.1A-C). The intestinal epithelium absorbs these 
dietary nutrients to achieve energy homeostasis for the whole organism. Both the microbiota 
and the host secrete digestive enzymes and small molecules into the lumen, which assist in 
nutrient harvest. Together with the dietary nutrients, these secreted factors contribute to an 
already complex luminal environment that interface with and direct intestinal epithelial 
differentiation and processes (Figure 2.2A) [3-5].The relative concentrations of these dietary 
factors change along the length of the intestine and these correlate with epithelial function. 
For examples, the most proximal segments of the mammalian intestine, the duodenum and  
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Figure 2.1: Macroscopic and microscopic morphology of the mouse and zebrafish intestine. 
(A) A schematic of the mouse gastrointestinal tract which is comprised of an esophagus, stomach, 
small intestine (duodenum, jejunum, and ileum), the cecum, and the colon. (B) A schematic of the 
larval zebrafish digestive tract. (C) A schematic of the adult zebrafish digestive tract. The coloration of 
the zebrafish intestines in the schematic represents the conserved regional specification shared 
between the zebrafish and mouse. The zebrafish lacks a stomach and the intestinal segments are 
classically broken up into three parts: Segment one, which based on gene expression resembles the 
mouse duodenum and jejunum segments; Parts of Segment 2 resembles the ileum in that a small 
section (highlighted in blue) expresses an ileum specific gene, fabp6, involved in bile acid absorption 
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(Lickwar et al; in revision)[6]. Segment 2 is also highly enriched in goblet cells [7]. Further the 
epithelial cells contain large vacuoles that are associated with lysosomal membrane proteins cells [7, 
8]. Based on gene expression and the larger concentration of bacterial load in the intestinal lumen [9], 
Segment 3 resembles the mammalian colon. (D) Schematic of the mouse small intestinal epithelia 
showing the villus-crypt axis. Most epithelial cells are represented in the schematic; however, Tuft 
cells, mention briefly in this chapter are not depicted. Programmed cell “death”, termed anoikis, 
occurs most frequently at the villus apex [10]. (E) Schematic of the zebrafish intestinal epithelia. 
Zebrafish do not have crypts or villi. Instead, their intestinal morphology resembles the mammalian 
stomach with epithelial folds termed rugae. The zebrafish have many of the same cell types including 
enterocytes, enteroendocrine cells and goblet cells. There is no evidence for Paneth cells. There is 
recent evidence for fish having a proliferative cell compartment and perhaps also stem cells near the 
base of the rugae [6, 11, 12]. 
 
jejunum, function as the primary location for protein, fatty acid and simple carbohydrate 
absorption (Figure 2.1A and Figure 2.2B). Bile acids enter the intestinal lumen through the 
common bile duct in the duodenum and facilitate fatty acid digestion by breaking down large 
dietary fat droplets into micelles that are digestible by secreted lipases. This process 
primarily occurs in the duodenum and jejunum where these fatty acids are absorbed and 
then transported to other tissues in the body for energy or storage. Bile acids are 
reabsorbed in the subsequent segment of the small intestine, the ileum, distal to the site of 
fatty acid absorption (Figure 2.2B). These bile acids are transported back to the liver and 
again stored in the gall bladder until they are again secreted into the duodenal lumen 
following a meal [13]. This enterohepatic bile acid circuit represents the logical layout of the 
intestinal tract, where molecules are absorbed after they facilitate nutrient harvest in 
previous segments. Water and electrolytes are similarly absorbed in the most distal part of 
the intestine [14]. The zebrafish and mouse intestinal epithelia demonstrate conserved 
regional and cellular specification that each participate in key aspects of energy harvest and 
digestive physiology (Lickwar et al, in revision)[6, 12] (Figure 2.1). 
The cellular specification and luminal environment not only changes along the 
proximal-distal axis of the intestine, but a gradient of mucus and antimicrobial peptides that 
protects the intestinal epithelia from the microbiota contributes to distinct microenvironments 
within the invaginations of the epithelia called the intestinal crypts. The multipotent intestinal 
stem cells (ISCs) reside at the base of these intestinal crypts (Figure 2.1D). As ISCs rapidly 
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and asymmetrically divide, they give rise to undifferentiated progenitor cells that migrate 
away from the base of the crypts staying along the epithelial layer. These progenitor cells 
migrate through the transient amplifying region where rapid cell division and the initiation of 
specific transcription programs begin to determine their cellular function (Figure 2.1D). The 
luminal environment is known to direct these transcription programs and control aspects of 
epithelial identity. 
 
 
 
Figure 2.2: The intestinal luminal environment changes along the length of the intestine. (A) A 
diagram illustrating the interaction between the microbiota, the diet and other molecules within the 
intestine and the intestinal epithelia. (B) A diagram depicting the functional specification along the 
intestine and the major processes that occurs along each segment in the mouse intestine. 
 
Loss of cellular identity promotes the onset of human diseases like cancers [15]. 
Each animal tissue maintains cellular identity using a variety of different strategies. Some 
cells progress slowly, if at all, through the cell cycle which reduces the rates of mutations 
generated during DNA replication [16]. Interestingly, most genetic mutations that manifest in 
human disease are in non-coding regions of the genome, indicating that non-coding 
transcriptional regulatory mechanisms like transcription factor binding or non-coding RNAs 
are critical aspects of disease etiology [17, 18]. Activating or repressing transcription factors 
recognize and bind specific DNA sequences within Cis-regulatory regions (CRRs), which 
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can be located proximal to the transcription start sites (TSS), within gene bodies, as well as 
in intergenic regions [19]. CRRs are generally depleted of nucleosomes (“accessible 
chromatin”), which can be experimentally captured by hypersensitivity to DNase I cleavage 
[20] (Figure 2.3). CRRs are also generally associated with specific post-translational 
modification of histone proteins within adjacent nucleosomes. For example, mono-
methylation of lysine 4 (H3K4me1) and acetylation of lysine 27 of histone H3 (H3K27ac) 
distinguishes between CRRs that act as poised and active enhancers respectively [21]. 
CRRs associated with H3K27ac marks are “permissive chromatin”, meaning the chromatin 
arrangement promotes transcription factor binding and induces transcription of the regulated 
genes. Genome wide binding locations of transcription factors and locations of H3K27ac 
modifications can be captured using ChIP-seq (Figure 2.3). Specific types of transcription 
factors, termed pioneer factors or master transcription factors, orchestrate the accessible 
and permissive chromatin landscape by initially displacing nucleosomes and recruiting 
histone modifying enzymes to regulatory sites [22-25]. These processes enable the 
recruitment of other transcription factors to the sites of open and permissive chromatin and 
promote transcription of the regulated gene. Similarly, competing transcription factors may 
bind to the same site and repress transcription of the regulated gene [26].  
The intestine-specific master transcription factor, Caudal type homeobox 2 (CDX2), 
functions as a pioneer factor that imprints and retains accessible chromatin in ISC and 
progenitor cell types within the intestinal epithelium [27-31]. Aberrant activity of CDX2 in 
esophageal epithelia is an early marker in Barrett’s disease where esophageal epithelial 
cells take on a small intestine epithelial identity [32, 33]. Similarly, loss of CDX2 activity is 
associated with the development of a specific type of colorectal cancer [1, 34]. Interestingly, 
changes in CDX2 activity is also associated with molecules in the luminal environment. 
Increased bile acid concentrations in the esophagus induces CDX2 expression through 
activity of another transcription factor, NF-κB [35]. This aberrant CDX2 expression imprints a 
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chromatin architecture in esophageal epithelia that promotes small intestinal epithelial 
transcription programs and loss of esophageal identity. Similarly, the short chain fatty acid, 
butyrate, stimulates CDX2 expression in colon cancer cell lines which may protect against 
oncogenesis and thus preserve epithelial identity [36]. To suppress disease onset, it may be 
beneficial for the intestinal epithelia to adopt a rigid transcription program that would be less 
sensitive to environmental stimuli. However, the primary role of the intestine is to harvest 
nutrients for the organism to maintain energy homeostasis. To accomplish this goal, the 
epithelia may need to detect and respond to the millions of molecules in the intestinal lumen. 
How does the intestinal epithelium maintain cellular identity while remaining sensitive to its 
environment? What are the transcriptional mechanisms that permit both sensitivity and 
retain cell identity in the intestine? In this chapter, I will explore the transcription programs 
that control cellular identity followed by the programs that permit cellular sensitivity. I then 
explore the overlap of these transcription programs and how dysregulation may lead to the 
onset of inflammatory bowel diseases.  
 
 
Figure 2.3: Genome wide sequencing techniques used to identify mechanisms of 
transcriptional regulation. Illustrated in this figure is a gene locus, three genome browser tracts 
each depicting different types of chromatin architecture, and a cartoon that summarizes what those 
genome tracts indicate.  
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2.3 The basic architecture of the transcription programs that maintain intestinal 
epithelial identity 
To maintain homeostasis with the microbiota and the luminal environment, the 
mammalian intestine has evolved several different cell types that maintain a barrier between 
the exogenous environment and the host. These cells are programmed by transcription 
networks that determines their specific cellular function and identity. These cell types include 
enterocytes, enteroendocrine cells (EECs), cup cells, tuft cells, Paneth cells and goblet cells 
(Figure 2.1D). Each one of these cells types differentiates from the ISCs residing in the base 
of the intestinal crypts [37]. In the next subsections, I will explore the transcriptional 
programs that control cell identity for the majority of intestinal epithelial cell types and during 
their “lifespan” on the epithelial layer. 
Throughout this chapter, I concentrate on the transcription factors that mediate 
intestinal epithelial cell function. These transcription factors activate or deactivate 
transcription of coding genes as well as non-coding RNAs like microRNAs and long-non-
coding RNAs that have been shown to similarly control cellular identity. Recent studies have 
shown microRNAs in particular play an important role in tuning the host transcriptional 
response to the microbiota in multiple cell types [38-41]; however, for the following sections, 
I primarily discuss the transcription factors that control the transcription programs.  
 
2.3.1 The intestinal stem cell and the journey toward anoikis 
The intestinal epithelia have an underlying transcriptional program that maintains 
their identity despite rapid cell turnover. These transcription programs are defined during 
differentiation as cells migrate out of the intestinal crypts along the epithelial barrier. Most of 
the intestinal epithelia self-renews every 4 – 7 days and this process is driven by the rapidly 
dividing multipotent intestinal stem cells residing in the base of these crypts [42]. Unlike 
other mammalian stem cell types which are thought to remain in mainly quiescent states to 
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preserve their long-term proliferation and guard against DNA replication errors that can be 
passed onto daughter and progenitor cells [43, 44], the intestinal stem cell rapidly self-
renews, producing daughter cells and progenitor cells that eventually differentiate into a 
specialized intestinal epithelial cell type [44]. Furthermore, unlike other stem cells, the 
intestinal stem cell is exposed to a potentially harsh external environment, and therefore the 
risk of injury and DNA damage is potentially greater [37]. As such, the intestinal stem cells 
are protected in specialized niches that maintain the proliferative potential while minimizing 
cellular and DNA damage. In both the large and small intestine, the ISCs are protected by a 
thick layer of mucus, primarily secreted by goblet cells, that blocks the invasion of potentially 
dangerous molecular signals or pathogens [45]. These niches are also composed of a 
subepithelial stromal microenvironment, and an epithelial/luminal microenvironment which is 
mainly supported by the adjacent cells [37]. In the small intestine, these adjacent cells 
include the specialized Paneth cells that sense and suppress microbiota infiltration and they 
nurse stem cells with pro-proliferative growth factors and signals to maintain the ISC 
proliferative potential [46, 47]. In the small intestine, Paneth cells are immediately apposed 
to these stem cells and as such are thought to be the primary cell type that sustains stem 
cell multipotency and maintain the stem cell niche in the luminal microenvironment. Colonic 
crypts lack Paneth cells. However colonic ISC are protected by sentinel goblet cells that 
never migrate out of the colon and secrete mucus upon the detection of harmful molecules 
[48]. In the small intestine, both the stromal microenvironment and Paneth cells are 
individually sufficient to maintain a functional stem cell niche and are further discussed in 
these reviews [37, 49, 50]. Wnt signaling plays a critical role in the maintenance of intestinal 
stem cells and crypts compartments. Mice lacking Tcf4, a transcription factor that becomes 
active after forming a complex with beta-catenin downstream of Wnt signaling, lack actively 
dividing cells in the base of their crypts. [51]. 
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Progenitor cells differentiate into the specialized cell types that both survey the 
microenvironment and absorb exogenous and endogenously derived molecules as well as 
maintain homeostasis between the host and microbiota. These cells types fall into two major 
lineages: secretory cell lineages (Paneth cells, tuft cells, goblet cells, and enteroendocrine 
cells) and absorptive cell lineages (enterocytes). Following asymmetric stem cell division, 
progenitor cells begin a journey of further differentiation that proceeds along the villus-crypt 
axis through the transit amplifying compartment (Figure 2.2D) [37, 42]. During this process 
of differentiation, progenitor cells maintain an accessible and permissive chromatin 
architecture that resembles the intestinal stem cell [31, 52]. These studies indicate that 
distinct differentiation programs are not predefined by nucleosome location. Instead, cell 
type specific transcription factors likely bind to the accessible chromatin and direct 
differentiation. Conversely, mouse intestinal epithelial cells (IECs) exhibit distinct accessible 
chromatin profiles across segments of the intestine [53]. However, we do not know if these 
differences in chromatin accessibility are inherent to the stem cell populations from which 
they are derived or if the chromatin accessibility is modified during terminal differentiation to 
achieve a cellular identity that permits appropriate regional activity.  
Fully differentiated enterocytes and goblet cells diverge from this ISC-like chromatin 
landscape [31, 52]. These data indicate that these cells express transcription factors that 
have the capacity to function as pioneer factors and govern terminal differentiation [54]. 
During intestinal epithelial differentiation, cell-type specific transcription factors, like HNF4A 
or RBPJ, bind to the open chromatin as determined by pioneer factors or other nucleosome 
displacement factors and initiate different transcription programs that drive lineage 
differentiation [23]. The transcription factor ATOH1 activates the transcription of genes that 
are involved in secretory cell differentiation [55, 56]. HES1 drives absorptive cell 
differentiation by suppressing ATOH1 and consequently suppressing secretory lineage 
differentiation [55]. Once fully differentiated, epithelial cells (with the exception of Paneth 
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cells and sentinel goblet cells) continue to migrate up the crypt (and along the villus in the 
small intestine) and end their journey in the zone of extrusion where mature 4 – 7 day old 
epithelial cells undergo apoptosis and leave the epithelium through a process called anoikis 
[10]. Anoikis is an important function in the repertoire of small and large intestinal epithelial 
cell identity. Aberrant repression of E-cadherin transcription in colon epithelial cells reduces 
anoikis and promotes tumor growth [57, 58]. Thus, the intestinal epithelia must maintain tight 
transcriptional control during cellular migration toward the zone of extrusion to maintain 
epithelial identity and homeostasis. 
 
2.3.2 Secretory cell lineages 
The transcription factor ATOH1 mediates differentiation of all secretory cell lineages 
[56]. Its activity and binding to different promoters in mouse colonic crypts is associated with 
the induction of other transcription factors including Neurog3, Gfi1, Sox9, Creb3l142 and 
Spedf [59]. The activities of these transcription factors support differentiation into goblet 
cells, enteroendocrine cells, and Paneth cells. The roles of these transcription factors in 
secretory cell differentiation are each discussed in more detail below. Interestingly, ATOH1 
also binds directly to the genes of the Notch signaling ligands Dll1 and Dll4. Previous reports 
have indicated that ATOH1 expression induces lateral inhibition of secretory cell 
differentiation by inducing Notch signaling in neighboring cells and directing neighboring 
cells toward absorptive cell differentiation [31] (discussed in more detail below in 2.3.3). 
These studies demonstrate how ATOH1 activity helps determine secretory cell identity while 
also directing the absorptive cell identity in neighboring cells. 
Enteroendocrine cells (EECs) comprise the largest population of chemosensory cells 
in the intestine although represent only a small fraction of total epithelial cells [42]. These 
cells detect dietary molecules within the intestinal lumen including amino acids, free fatty 
acids, bile acids and many more. During fasting and upon nutrient detection, EECs release 
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hormones like PYY and somatostatin that fine-tune both intestinal and systemic responses 
to the nutrient status [60]. Activity of the transcription factor NEUROG3 is necessary for 
differentiation of the EEC fate [61, 62]. Following expression of the Neurog3 gene, EECs 
express transcription factors like NEUROD1, ISL1 and PDX1 which promote its endocrine 
signaling activities. For example, transcription factor PDX1 binds and activates the promoter 
of Glucose-dependent-insulintrophic polypeptide (GIP) [63], a signaling peptide that is 
secreted by EECs upon sensing dietary fat or carbohydrates and induces insulin release 
from pancreatic beta cells [64, 65]. This group of transcription factors also regulates 
transcription programs involved in pancreatic islet development which highlights the 
similarities between these hormone producing cell types [66]. The nuclear receptor 
transcription factor HNF4G similarly participates in glucose tolerance through regulating 
Glucose-like peptide (GLP) expression and secretion by EECs. [67] The transcription factors 
FOXA1 and FOXA2 have also been shown to regulate the transcription of several EEC-
secreted hormones. These factors function downstream of NEUROG3 activity, but it is 
unknown if NEUROG3 regulates their transcription directly [68].  
Goblet cells are professional mucus producing cells that maintain a thick mucus layer 
between the microbiota in the luminal environment and the intestinal epithelia [69]. These 
cells produce a highly glycosylated secretory mucin called MUC2 which is tightly folded, 
packaged and processed in the endoplasmic reticulum and Golgi networks and stored in 
secretory granulae at the cell membrane. Following secretion, mucus expands ~1,000 fold 
[70], forming large nets that in the colon have been shown to attenuate Brownian motion of 
molecules like microbe-associated molecular patterns (MAMPs) and blocks the invasion of 
the majority of the microbiota [71]. Like other secretory cell lineages, Goblet cell identity is 
primed by ATOH1 activity. ATOH1 induces expression of SPDEF and GFI1. GFI1 suppress 
Neurog3 expression, thereby blocking differentiation toward an EEC identity [72]. Knockout 
mouse models indicate both SPDEF and GFI promote goblet cell differentiation [72, 73]. 
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Similarly, both FOXA1 and FOXA2 knockout animals have reduced goblet cell differentiation 
[74]. The transcription factors FOXA1, FOXA2 and CDX2 have been shown to bind the 
promoter of Muc2 and activate its transcription [68, 74, 75]. In gastric and lung epithelial 
tissues, the pioneer factor SOX2 promotes goblet cell differentiation [76, 77]; however, 
aberrant activity of SOX2 activity in the small intestine reprograms the epithelial identity into 
gastric-like epithelia [78].  
Deletion of the Sox9 transcription factor gene in the mouse intestinal epithelia results 
in attenuated differentiation of goblet cells, and complete ablation of the Paneth cell lineage, 
indicating a requirement for Sox9 in Paneth cell fate determination [79, 80]. In cell culture, 
SOX9 suppresses WNT signaling by physically interacting with beta-catenin which results in 
degradation of both proteins [81]. Furthermore, in the intestine, SOX9 trans-activates the 
expression of Groucho-related inhibitors of the beta-catenin-TCF pathways and 
transcriptionally suppresses proliferation markers like Cyclin-D1 and c-Myc [79]. 
Suppression of these pathways may indicate why secretory cells make up a small proportion 
of epithelial cells. Terminally differentiated Paneth cells do not express Sox9, indicating 
SOX9 activity is only required for fate determination and not function following differentiation 
[82]. Paneth cells differentiate amongst other progenitor cells and migrate down toward the 
stem cell niche where they reside in the crypt for 2 – 3 months [83, 84]. They contain large 
cytoplasmic secretory granulae that contain antimicrobial peptides and proteins like 
lysozyme [47, 85-87]. Paneth cells secrete these granulae into the crypt lumen to protect the 
precious stem cells and progenitor cells from certain microbiota that may threaten intestinal 
homeostasis. These cells also maintain stem cell longevity and promote progenitor 
differentiation by producing EGF, Notch, and WNT ligands [37]. Furthermore, the gradient of 
these ligands in the epithelial microenvironment control transcription programs in progenitor 
cells that ultimately influence cellular identity [46, 88]. The nuclear receptor transcription 
factor HNF4A may regulate Paneth cell function, following differentiation. The intestine 
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specific HNF4A knockout mouse has equivalent numbers of Paneth cells compared to 
control mice; however, the granulae within the Paneth cells of the knockout mouse fail to 
stain for lysozyme. This study indicates HNF4A may play important roles in maintaining 
Paneth cell function [89].  
Tuft cells represent a minor percentage of secretory cells and seem to function as 
chemosensory cells [62]. Tuft cells differentiation requires ATOH1 activity, suggesting it 
belongs to the secretory cell lineages [62]. These cells detect pathogens in the luminal 
environment and respond by signaling to neighboring epithelial cells and cells residing in the 
lamina propria. These signals launch a type 2 immune response and induce tuft cell 
expansion [90]. Tuft cell biology remains relatively unstudied compared to other intestinal 
epithelial cell lineages. Only recently have researchers identified novel transcriptional 
programs that mediate Tuft cell differentiation. Indeed, deletion of the transcription factor 
POU2F3 in mouse results in failed Tuft cell differentiation and a deficiency to initiate the type 
2 immune response to intestinal parasites [91, 92]. Each of these secretory cell identities are 
programed and maintained by unique transcription factor networks.  
 
2.3.4 Absorptive cell lineages 
Several of these transcription factors that participate in secretory cell function also 
participate in absorptive cell lineages. However, a master transcription factor, HES1, 
controls the initial “decision” to become either a secretory cell or an absorptive cell during 
early progenitor differentiation. HES1 expression is upregulated by active Notch signaling. 
The ligands Dll1 and Dll4 bind and activate the Notch transmembrane receptor which results 
in proteolytic cleavage of the intracellular-domain (NICD). The NICD translocates to the 
nucleus and forms a transcriptional complex with RBPJ and activates transcription of the 
Hes1 gene [93]. Notch signaling along with enhanced beta-catenin signaling promotes rapid 
proliferation of these progenitor-absorptive cells [94, 95]. The transcription factor HES1 
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represses ATOH1 expression and promotes absorptive cell (enterocyte) differentiation [55]. 
In the small intestine, GATA transcription factors function in tandem to tune Notch signaling 
and promote enterocyte differentiation [96]. For example, GATA4 binds near the 
transcription start site of the Notch ligand Dll1 [97]; And, GATA4 knockout mice have 
reduced progenitor proliferation and reduced Dll1 expression, suggesting GATA4 directly 
activates Dll1 transcription and promotes Notch signaling. Similarly, GATA6 promotes 
progenitor proliferation and GATA4 and GATA5 promote enterocyte identity by upregulating 
terminal differentiation genes in the intestinal villi [96]. Deletion of GATA4 and GATA6 in the 
mouse intestine results in decreased proliferation, reduced enterocyte enteroendocrine cell 
numbers and increased Goblet cell numbers [97, 98]. As mentioned early, ATOH1 binds 
directly to the genes of the Notch signaling ligands Dll1 and Dll4, supporting its role in lateral 
inhibition of secretory cell differentiation of neighboring cells [59]. 
Enterocytes comprise the largest cell population in the small intestinal epithelia [99]. 
These cells are professional absorptive cells that transport dietary molecules across their 
plasma membrane. Amino acids and monosaccharides are transported across the plasma 
membrane by sodium dependent transporters [100]. However, the majority of water 
absorption in the colon is facilitated by electrochemical gradients generated by transport 
activity of short chain fatty acids generated by the microbiota [101]. Uptake of dietary fats 
occur only after triglycerides are cleaved to form free fatty acids and 2-monoglycerides 
which can enter the enterocyte by simple diffusion or through the help of long chain fatty 
acid transporters [102]. Once in the enterocyte, fatty acids can be reassembled into 
triglycerides and packaged in the endoplasmic reticulum to form lipid droplets for temporary 
storage or packaged in chylomicrons and trafficked into the body through the basolateral 
membrane [102]. Chylomicrons are large lipoproteins particles. The apolipoproteins APOA4 
and APOC2 are highly expressed by enterocytes and secreted as surface competents on 
newly synthesized chylomicrons. APOA4 and APOC2 stimulate lipoprotein lipase activity 
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[103], an enzyme that is tethered to endothelial cells at sites throughout the body and 
cleaves triglycerides into free fatty acids permitting their absorption into the nearby cells for 
storage or energy consumption. Thus, these apolipoproteins promote serum triglyceride 
clearance. The transcription factor CREBH/CREB3l3 activates transcription of APOA4 and 
APOC2 in mice and supports serum triglyceride clearance [104]. Similarly, overexpression 
of Crebh/Creb3l3 represses transactivation by binding directly to promoters of genes that 
mediate intestinal cholesterol absorption like Npc1l1 [105]. Overexpression of Crebh also 
represses Srebp2 expression, a transcription factor that has previously been shown to 
activate transcription of genes involved in lipogenesis and may mediate cholesterol 
homeostasis by binding the promoter and activating transcription of Npc1l1 [106, 107]. In 
zebrafish, the nuclear receptor transcription factor LXRa was shown to regulate the delivery 
of ingested lipid to circulation, perhaps through its transactivation of a gene involved in 
biogenesis and growth of lipid droplets [108]. The transcription factor HES1 directs 
absorptive cell differentiation, however, once differentiated, several other transcription 
factors tune its absorptive function. Many of the enterocyte transcription factors have been 
shown to be regulated by the influx of nutrients into the lumen and these will be discussed in 
section 2.4. 
 
2.3.5 Regional specification 
Aside from cellular specialization along the villus-crypt axis, transcription networks 
generate distinct differences in cellular function along the proximodistal axis of the small 
intestinal tract. For instance, GATA4 suppresses ileal transcription programs and promotes 
the transcription of the fatty acid metabolism and absorption genes in the jejunum [97, 109]. 
Likewise, the nuclear receptor FXR is most highly expressed in the ileum and selectively 
regulates genes involved in bile acid absorption [110, 111]. Furthermore, FXR binds bile 
acids directly and activates transcription of Fgf19 [112]. FGF19 (FGF15 in mouse) is an ileal 
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secreted hormone that regulates bile acid synthesis in the liver hepatocyte by inhibiting the 
enzyme that controls the rate limiting step of bile acid synthesis, CYP7A1 [112, 113]. 
Regionalization also impacts cell identity as well as gross morphology of the intestine. 
Indeed, the distal end of the small intestine has greater number of goblet cells compared to 
the proximal end, perhaps to protect the epithelia from the larger concentration of microbes 
in the posterior intestine [114, 115]. The primary secreted hormones by enteroendocrine 
cells changes along the length of the small intestine [60]. The duodenum harbors the 
highest concentration of EECs that produce hormones like secretin and motilin which 
mediate water homeostasis and peristalsis, respectively. Although EECs in the distal part of 
the small intestine have the capacity to secrete these hormones, they primarily secrete 
hormones that regulate the dopamine pathway (neurotensin) and glucogaon- and insulin-like 
peptides (GLP-1, GLP-2, and INSL5) [60]. Furthermore, the duodenal and jejunal segments 
have longer villi compared to the ileal segment [115, 116], perhaps because these regions 
are both exposed to a higher concentration of dietary nutrients and are responsible for the 
majority of the nutrient uptake including fatty acid absorption [114]. The longer villi in the 
anterior intestine optimizes surface area and exposure to the environment which increases 
the capacity of nutrient absorption. Intestine-specific deletion of the nuclear receptor 
transcription factor HNF4A reduces villus size and impairs fatty acid absorption in the 
jejunum and impaired colonocyte differentiation [89, 117, 118]. Since HNF4A is most highly 
expressed in the duodenum and jejunum and given the intestine specific knockout 
phenotype, transcription programs controlled by HNF4A may help define regional 
specification [28, 119]. Lastly, chromatin accessibility likely contributes to regional 
specification since accessible chromatin marginally differs in epithelial cells from anterior 
versus posterior segments of the small intestine [53]. Collectively, these insights into the 
transcriptional programs that contribute to intestinal identity provide an essential frame of 
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reference for how the epithelia tune these programs to effectively handle its changing 
environment. 
 
2.4 The transcription programs that permit intestinal epithelial sensitivity 
Microbiota colonization of germ free animals is associated with robust changes to 
intestinal transcription programs, resulting in differential regulation of hundreds of genes 
(see Chapter 3 and [119-121]). Similarly, the diet has also been shown to drastically change 
intestinal transcriptional programs [122]. Host dietary habits control the nutritional content 
within the lumen and it has direct effects on the microbial communities and the taxa present 
in the lumen [123-128]. Similarly, microbes in the intestine have the capacity to modify the 
dietary contents. Indeed, some bacterial taxa like Rosburia intestinalis encode genes that 
generate isomers of poly-unsaturated fatty acids which have been shown to affect host 
physiology [129] and the large cohort of anaerobic bacteria in the colon have the capacity to 
catabolize dietary fibers that generate short-chain fatty acids [130]. Diet and microbiota 
mediate activity of transcription programs that fall into four categories: 1) developmental 
programs, 2) metabolic programs, and 3) immune/inflammatory programs 4) circadian 
rhythm programs  [120, 121]. This categorization of transcription is not entirely accurate 
since the activation of one of these programs may result in activation or suppression of the 
others [131-135] and therefore they are not truly distinct transcriptional programs. Instead, 
their regulatory mechanisms often interact to define cellular function (Figure 2.4). 
Furthermore, activation of these transcription programs are selectively modified by the 
presence of specific bacterial taxa and the factors these bacteria produce [136-139], 
indicating IECs respond to specific cues in the environment. Interestingly, mouse and 
zebrafish intestinal epithelial cells share a conserved transcriptional response to microbiota 
colonization indicating the same regulatory pathways may be mediating these responses 
[137, 140].  
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Only recently have studies identified the epigenetic and genomic changes that 
underlie some of these transcriptional and downstream responses. Surprisingly, microbiota 
colonization does not significantly impact chromatin accessibility in the intestinal epithelia, 
suggesting that microbiota modulate epithelial transcription by modifying the activity of 
specific transcription factors [53]. However, recent studies suggest histone modifying and 
DNA-methylation enzymes play key roles in the epithelial response to diet, the microbiota, 
and antibiotic treatment [141-144]. We still lack an understanding if microbiota regulate 
transcription factor binding genome wide. 
Identifying the transcription factors that mediate epithelial response has become an 
intense field of study due the microbiome’s relationship with human diseases such as 
metabolic syndrome and inflammatory bowel diseases. The transcription factors involved in 
these pathways may represent novel therapeutic targets. Strategies for identifying these 
transcription factors have included identifying microbiota-responsive cis-regulatory regions 
proximal to differentially regulated genes [53, 145]. The cis-regulatory regions contain 
Figure 2.4: IEC identity is 
determined by the blend of 
environmental factors and 
transcriptional programs. The 
microbiota and nutrition within the 
intestinal lumen influence each 
other’s molecular makeup. This 
blend of environmental factors 
influences transcription programs 
that similarly blend together to 
modify the environment and 
establish an IEC identity. 
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specific sequences that transcription factors recognize and bind to activate or repress a 
gene. Other transcription factors have been identified simply by their association with 
differentially regulated genes. Similarly, genetic analysis and CRR reporter constructs in in 
vivo systems have also provided important insight into transcription factors that mediate the 
epithelial response [146]. 
 
2.4.1 Metabolic programs 
Microbiota colonization elicits a strong response in transcription of genes involved in 
metabolic processes in the epithelia. Following microbiota colonization, the transcriptional 
programs in the jejunum shift over a 4 day period from oxidative phosphorylation to an 
anabolic metabolism [120]. Fatty acid mobilization genes, like Apoc3 and Cd36, and genes 
involved in the processing of fatty acids for energy, like Cpt1b and Pdk4, remained 
suppressed by the microbiota even after 30 days post colonization [120]. The microbiota 
similarly suppress the expression of the transcription factors that regulate these metabolic 
pathways [53, 119, 120]. These transcription factors include the GATA motif binding 
transcription factors GATA4 and GATA5 and nuclear receptors transcription factors like 
PPARA, CAR, LXR, and MCR.  
Enterocytes detect nutrient availability through metabolite sensors that activate and 
deactivate transcription networks that impact cellular and systemic processes. Nuclear 
receptors represent a key set of transcription factors that are expressed in the enterocytes 
and serve as elegant detection and response modules. Several nuclear receptors bind 
metabolites and metabolic intermediates and initiate or suppress transcription programs 
[147]. Nuclear receptors are animal innovations, first emerging in sponges [148]. This 
superfamily of transcription factors includes ~50 members. The most studied of these 
transcription factors are the steroid-binding receptors; however, the metabolite-binding 
receptors have recently received much more attention [147]. Bile acids serve as an 
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activating ligand for some nuclear receptors, including FXR [149]. Microbiota regulate FXR 
activity in the ileum, the site of bile acid uptake in the small intestine and as a consequence 
regulates systemic metabolic processes like fat storage [113, 150-153]. Furthermore, the 
microbiota modify primary bile acids, adding different chemical groups to the structure of 
these molecules to generate secondary bile acids [113, 154]. Different bile acid species bind 
and activate FXR at varying capacities [149]. These data permit the hypothesis that the 
microbiota may selectively tune FXR activity by modulating the levels of bile acid species. 
This mechanism of transcriptional regulation represents an attractive model for how the 
microbiota mediate epithelial gene transcription programs. The microbiota also modify or 
produce other ligands for nuclear receptors. PPARG transcriptional activity is enhanced by 
SCFAs, which are generated by the microbiota in the colon [155]. Similarly, the microbiota 
express enzymes that modify long-chain fatty acids which might serve as ligands for other 
nuclear receptors like HNF4A [129].  
One of the best studied genes suppressed by the microbiota in small intestine is 
Angptl4, which inhibits lipoprotein lipase activity and blocks serum triglyceride clearance 
[119, 120, 156]. Microbial suppression of intestinal Angptl4 leads to decreased serum 
triglyceride levels and increased epidydimal fat pads in murine models. Interestingly, the 
probiotic bacterium Lactobacillus paracasei induces expression of Angptl4 in colon cell lines 
and reduces fat storage, indicating this bacterium may have the capacity to directly regulate 
the transcription of this hormone peptide [157]. This gene is regulated by the nuclear 
receptors PPARG in IECs of the colon [158], and Glucocorticoid receptor in hepatocytes and 
adipocytes [159, 160]. Perhaps microbial regulation of these transcription factors or another 
nuclear receptor in the small intestine mediates microbial control of Angptl4. 
The primary location of SCFA production occurs in the lumen of the mammalian 
colon that harbors anaerobic bacteria that thrive in this low O2 concentration environment 
[161]. These SCFA are the primary source of energy for colonic epithelia. Consumption of 
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these SCFA by the epithelia decreases O2 concentrations within the cell which promotes 
stable activation of the transcription factor Hypoxia induced factor (HIF) [162]. HIF activity 
results in transcriptional activation of defensing-b, an antimicrobial peptide, MUC3 and ITF, 
which all help maintain epithelial barrier function [163-165]. HIF similarly induces 
transcription of the antimicrobial peptide LL77 which protects the host the opportunistic 
pathogen Candida albicans . However, it remains unknown if hypoxic environment induces 
HIF transactivation of LL77 [166]. 
Colonization of GF animals with a microbiota leads to increased energy harvest [167, 
168] and changes in metabolic homeostasis including decreased AMPK activity in skeletal 
muscle and liver [169]. Low-dose penicillin treatment similarly rewires metabolic 
transcriptional programs and persists long after microbiota communities recover from 
penicillin treatment [170, 171]. Together, these data indicate reorganization of the luminal 
environment through microbial colonization or antibiotic treatment alter metabolic 
transcriptional programs indirectly through induced alterations in energy homeostasis. In 
Drosophila, reorientation of the metabolic processes in the intestinal epithelia in response to 
microbiota colonization may be in part mediated by NF-κB signaling, a transcription factor 
that regulates immune/inflammation programs [172]. Maintaining an adaptive transcriptional 
program provides the flexibility the epithelia need in order to respond to fluctuations in the 
nutrition in the intestinal lumen and maintain energy homeostasis. 
 
2.4.2 Immune/inflammation programs 
Epithelial cells are equipped with a variety of signaling receptors called Pattern 
Recognition Receptors (PRRs) which detect Pathogen-associated molecular patterns 
(PAMPs), Damage-associated molecular patterns (DAMPs), or Microbial-associated 
molecular patterns (MAMPs); These three classes of molecules are derived from microbes 
in the environment (MAMPs or PAMPs) or damaged host cells (DAMPs) [173]. Upon 
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detection of these molecular patterns, PRRs induce innate immune responses which protect 
the host from infection. Two commonly studied PRRs expressed in the small intestinal 
epithelia are Tol-like receptors (TLRs) and NOD-like receptors (NLRs). TLRs reside on the 
cell surface (both basolateral and apical membranes) and promote homeostasis with the 
microbiota [174]. NOD2 polymorphisms are associated with impaired innate immunity, 
reduced expression of antimicrobial peptides and deregulation of immune tolerance to the 
microbiota [175-179]. Loss of TLR signaling can result in impaired response to infection and 
closer epithelial association with microbiota [180, 181]. Conversely, aberrant activation of 
these PRRs can similarly result in inflammatory bowel diseases, representing the important 
balance of inflammation that must be maintained to prevent disease [177, 182]. TLRs bind a 
specific type of molecular pattern; for instance, TLR4 bind lipopolysaccharide (LPS), TLR5 
binds flagellin, and TLR1, TLR2 and TLR5 bind lipopeptides [183]. TLR signaling includes 
two types of signaling cascades: those that require the adapter protein MyD88, and those 
that require the adaptor protein TRIF [184-187]. Mouse models of infection have 
demonstrated Myd88 is required for protective innate immune responses [188]. Signal 
transduction through these surface receptors results in activation of the transcription factors 
NF-κB and JUN which regulate transcription of genes involved innate immunity and 
proinflammatory cytokines [173, 189-191].  
Signaling through MyD88 dependent pathways induces transcription of “early-phase” 
activation of the transcription factor complex NF-κB which promotes transcription of the 
innate immune response and proinflammatory cytokines [190]. The MyD88 independent 
pathway induces “late-phase” activation of NF-κB which promotes transcription of interferon 
genes which may induce caspase activation and apoptosis [192]. NF-κB represents a 
central factor that maintains the appropriate balance of pro- and anti-inflammatory programs 
in the intestinal epithelia. In macrophages, NF-κB has been shown to regulate the 
transcription of IL-1b and TNF-alpha, two proinflammatory cytokines that can induce 
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apoptosis [193]. NF-κB activity promotes transcription of serum amyloid a (saa) and 
stimulates neutrophil migration to the intestine in the zebrafish [194]. NF-κB activity similarly 
regulates beta-defensin transcription, a primary antimicrobial peptide used as a defense 
mechanism to maintain mucosal homeostasis with the microbiota. Some bacterial species 
suppress NF-κB trans-activity and thereby evade these antimicrobial defense mechanisms 
[195]. In the Drosophila intestine, the transcription factor caudal directs NF-κB activity 
toward just a subset of NF-κB targets including antimicrobial peptides [196]. Suppression of 
caudal activity in the presence of a Drosophila pathogen results in intestinal epithelial 
apoptosis, impaired epithelial barrier function and an epithelium that resembles inflammatory 
bowel disease due to reduced antimicrobial peptide transcription [196]. Similarly, inhibition 
of NF-κB activity by deletion of its activating kinase NEMO in mouse IECs results in chronic 
inflammatory response in intestinal epithelia [197]. Loss of NF-κB activity in IECs resulted in 
increased apoptosis, reduced expression of antimicrobial peptides and increased bacterial 
infiltration into the mucosa. In macrophages, NF-κB suppresses inflammation by activating 
transcription of the antiapoptotic proteins PAI-2 and Bcl-XL which inhibit activity of 
caspases. NF-κB also down regulates itself by participating in an inflammation negative 
feedback loop where it activates transcription of its own suppressor, IkBa and the anti-
inflammatory protein Tnfiap3 [193, 198]. 
Microbial stimulation may result in MAP kinase signal transduction and the activation 
of the transcription factor ATF2. ATF2 forms homodimers or heterodimers with c-JUN [199] 
and binds to the promoter and activates transcription of DUOX [200]. In the Drosophila 
intestine, this transcriptional activity has been shown to induce cell proliferation (see below 
in Developmental programs). Transcription of reactive-oxygen species (ROS) generating 
enzymes, like DUOX or NOS2, represents another innate immune response [201]. The 
transmembrane proteins DUOX1 and DUOX2 generate ROS in the intestinal lumen which 
promotes mucosal defense against microbes [202]. A c-JUN/ATF2/IRF3 complex has been 
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captured on an enhancer that regulates IFN-beta, an important cytokine in viral defense 
[199]. 
Janus Kinase-Signal Transduction And Transcription (JAK-STAT) signaling also 
plays important roles in the response to the microbiota. Activation of the JAK-STAT signaling 
pathway in the intestine by a cytokine results in phosphorylation of STAT transcription 
factors by JAKs. Once phosphorylated, STATs homo or heterodimer with other STAT family 
members and translocate to the nucleus to bind to CRRs and activate transcription of innate 
immune genes like NOS2 [203]. Upon microbiota colonization and infection of pathogenic 
bacteria, Paneth cells become filled with granulae that are filled with lysozyme and 
antimicrobial peptides [121]. These antimicrobial peptides include alpha-defensins and the 
C-type lectins, like RegIIIg, both of which may disrupt microbial membrane integrity as a 
mechanism to kill bacteria [204]. Symbiotic bacteria induce expression of RegIIIg in Paneth 
cells [205], but the transcription factors that mediate its activity in this cell type remains 
unknown. In the lung and gastric epithelia, STAT3 binds the promoter of RegIIIg and drives 
transcription of the gene [204, 206]. Microbiota colonization similarly induces Stat3 
expression, so perhaps the same transcriptional mechanisms are shared between these 
other epithelial cell types and the intestinal epithelia. The transcription factor TCF-4 
mediates transcription of the alpha-defensins in Paneth cells, indicating the microbiota may 
impact TCF-4 activity. Indeed, microbiota mediate beta-catenin/Wnt signaling (see below in 
Developmental programs) and cellular gradients of these pathways are linked to TCF-4 
activity [207].  
 
2.4.4 Developmental programs 
Following microbial colonization, an intense restructuring of the small intestinal 
mucosa occurs that results in decreases in villus length and increases in crypt depth [120, 
121]. Microbiota colonization results in transient repression of transcripts involved in Notch 
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signaling and a rapid expansion of goblet cells [120, 121]. Microbiota colonization also 
results in sustained suppression of Neurog3 transcription [120], the transcription factor that 
drives the enteroendocrine cell differentiation. Indeed, microbiota colonization results in 
reduced EEC populations as determined by Sox9:GFPhigh transgenic mice [38]. Similarly, 
microbiota colonization also induces an expansion of mature goblet cells in rats [208]. 
Microbiota colonization similarly promotes goblet cell differentiation in zebrafish [209]. Since 
microbiota colonization results in changes to host metabolic homeostasis [156, 210], 
perhaps microbiota influence goblet cell differentiation through the activation of the 
transcription factor NFAT5 which suppresses the metabolic regulator mTORC1 and 
suppresses Notch signaling, which results in an expansion of goblet cells and MUC2 
expression [211, 212]. 
Experiments using larval zebrafish have demonstrated that a dominant member of 
the zebrafish microbial community secretes a factor that promotes proliferation through 
activation of the beta-catenin/Tcf4 transcription complex. Furthermore, these experiments 
demonstrated that the innate immune response, but not inflammation, mediated the 
microbial induction of IEC proliferation [136]. In drosophila, JAK-STAT signal transduction 
mediate an oxidative burst that drives epithelial renewal in response to the microbiota and 
infection [213]. Similarly, In cell culture studies, STAT3 regulates progression through the 
cell cycle through upregulation of cyclins D2, D3 and A, as well as Cdc25a and down 
regulates cell cycle regulators p21 and p27 [214]. Conversely, antibiotic treatment results in 
cell cycle arrest in colon epithelial cells [215], suggesting that the loss of microbial 
communities impairs epithelial proliferation.  
Several proinflammatory cytokines and interferons are capable of inducing apoptosis 
including TGFb, TNFa, and IL-1b [193, 216]. Microbial induction of the proinflammatory 
cytokines and chemoattractant TNFa results in epithelial apoptosis and increased cell 
shedding [217]. ETS-factor transcription factors can bind the promoter of this gene and 
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activate its transcription [218]. ETS-factors represent a novel set of transcription factors that 
have been implicated in mediating epithelial response to the microbiota [53]. However, little 
is known about either genomic or molecular mechanisms that mediate its response to 
microbial stimuli. 
 
2.4.5 Circadian rhythms 
Feeding and the circadian rhythms in the intestinal epithelia are tightly connected 
[133]. Circadian rhythms coordinate several intestinal epithelial functions including nutrient 
absorption, nutrient trafficking and cell proliferation [219]. Microbiota colonization results in 
transcriptional suppression of several key circadian rhythm transcription factors including 
Arntl2, Per1, Per2 and Cry1 in the jejunum.  This suppression persists over several weeks 
and does not appear to recover after the epithelial immune response reaches homeostasis 
[120]. Since this expression pattern resembles the metabolic reorientation, perhaps the 
fluctuations in energy homeostasis upon colonization regulate transcription of these 
circadian rhythm genes [120].  
Surprisingly, antiphasic and oscillating expressions of the nuclear receptors RORa 
and ReverbA coordinate a rhythmic pattern of TLR expression. This rhythmic pattern of TLR 
expression translates an arrhythmic signal from the microbiota to oscillating signal resulting 
in a circadian rhythm output of AP-1 and NFkB signaling [131]. The diurnal oscillations of 
TLR signaling may direct the microbiota rhythmic oscillations which undergo phasic changes 
to community composition and metabolic function [141, 220]. These diurnal oscillations 
impact histone modifications at oscillating genes and maintain intestinal homeostasis [141, 
220]. 
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2.5 Loss of intestinal identity and inflammatory bowel diseases 
Prolonged loss of the homeostasis between the intestinal epithelia and the luminal 
environment can result in inflammatory bowel diseases [221]. Interactions between human 
genetics the microbiota and the diet have been implicated in Crohn’s disease (CD) and 
ulcerative colitis (UC) [221-224]. Indeed, dietary interventions are early steps used to treat 
IBDs [225-227] and fecal (microbiota) transplantations can ameliorate IBD symptoms [228, 
229]. However, a variety of genetic and genomic factors within the human intestinal epithelia 
also control disease pathology and progression [2, 230-234]. Indeed, dysregulation of the 
acetylome by Hdac1 and Hdac2 disrupts epithelial homeostasis [235]. Furthermore, the 
intestinal epithelia require Hdac3 for maintenance in the presence of the microbiota [236]. 
Interestingly, the transcriptional pathways that respond to microbiota colonization overlap 
the transcriptional pathways that are dysregulated in IBDs [40, 237, 238]. Another 
fascinating aspect of inflammatory bowel diseases is the aberrant loss of epithelial identity. 
Previous transcriptome analysis from patients with ileal Crohn’s disease and colonic Crohn’s 
diseases indicate a subset of these patients have tissue identities that correspond to the 
wrong intestinal segment [2]. That is, some transcriptomes from colonic Crohn’s disease 
biopsies identified more with healthy ileal transcription programs than colonic programs. 
Similarly, ileal transcriptomes from ileal Crohn’s disease biopsies identified more with 
healthy colonic programs. However, the tissue complexities in human biopsy samples limit 
the conclusions about the role of how specific cell types contribute to disease progression.  
Transcriptome analysis of patients with UC, ileal CD (iCD) and colonic CD (cCD) 
revealed genes that are differentially regulated in IBD compared to healthy patients. 
Analysis of these transcriptomes identified 5 transcription factors that serve as central 
regulators of the genes differentially expressed in all three types of IBD. Two of these 
transcription factors, NFkB and STAT1, activate transcription of genes differentially 
upregulated in IBD. These TFs in the context of IBD have been discussed extensively in 
32 
 
other reviews [239-241]. The three transcription factors that mediate expression of genes 
commonly downregulated in IBD are excitingly nuclear receptors: HNF4A, PPARG, and 
NR3C1 (GR). Despite all three TFs being implicated in IBD pathology, their roles in disease 
progression remains unknown. Furthermore, the genes consistently downregulated in IBD 
are genes involved in metabolic pathways (ex. oxidative reduction, fatty acid trafficking, 
intestinal absorption) and how suppression of these pathways impacts impact chronic 
inflammation remains relatively unstudied. Furthermore, other studies have indicated that 
inflammatory programs and metabolic transcription programs are mutually exclusive [132]; 
however, underlying causes remain unclear.  
The three transcription factors that regulate genes that are suppressed in all three 
types of IBD are all Nuclear receptors. Aside from these three nuclear receptors, several 
other nuclear receptors have been implicated in UC or CD or both [242], indicating the 
importance these direct-environment-sensing transcription factors play in intestinal 
homeostasis. Several nuclear receptors have been shown to suppress inflammation in 
multiple tissues: Estrogen Receptor [243], Glucocorticoid Receptor , Vitamin D Receptor 
[244], PPARs [245, 246], LXR [247], HNF4A [248-251]. GR, PPAR, and LXR work 
synergistically to suppress TLR signaling in macrophages [252]. Perhaps these nuclear 
receptors and others function similarly in intestinal epithelia to suppress inflammation. To 
support this hypothesis, loss of FXR function in mice increases susceptibility to DSS and 
TNBS induced colitis [253] Indeed, FXR has been shown to modulate proinflammatory 
responses by forming a repressor complex with NCOR on the NF-κB response element on 
the IL-1B promoter [254].  Similarly, LXR activation suppressed the expression of the pro-
inflammatory marker TNFa in the colon following DSS treatment. LXR deletion resulted in 
enhanced migration of immune cells to a DSS damaged colon [255]. 
Three independent GWAS studies have identified variants of the HNF4A risk loci for 
CD and UC [232, 233, 256] and another study indicated HNF4G may also be a risk locus for 
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UC [257]. Importantly, differentially activate enhancers in IBD have predicted HNF4A 
binding sites [230, 231]. Furthermore, HNF4A expression is reduced in biopsies from UC 
and IBD patients [258]. IEC-specific knockout of mouse Hnf4a results in spontaneous 
intestinal inflammation, resembling human IBD [251, 259]. The IEC-specific knockout mice 
of Hnf4a have reduced lysozyme staining in the granulae of Paneth cells, but unaltered 
Paneth cell number compared to WT [89]. These data indicate Paneth cells in the mutant 
animals produce fewer antimicrobial peptides. Therefore, one possible reason for 
spontaneous colitis in IEC-specific mutants could be an overgrowth of pathogenic bacteria. 
Similarly, DSS-induced colitis and inflammation suppresses HNF4A nuclear localization and 
expression [260]. In the liver, knockdown of HNF4A expression induces a proinflammatory 
feedback circuit that continues to repress HNF4A expression and upregulate 
proinflammatory genes [250]. Indeed, HNF4A activates the transcription of miR-124 in liver 
cells [250]. mir-124 has reduced expression in biopsies from pediatric CD patients compared 
to healthy patients and may protect from CD by silencing STAT3 [261]. Together, these 
studies suggest HNF4A protects against inflammation and IBDs. Therefore, HNF4A target 
genes may also protect from IBD. If HNF4A regulates mir-124 in the intestine like it does in 
the liver, then this scheme provides one possible way HNF4A protects from IBD. Similarly, 
biopsies from IBD patients demonstrate decreased APOA1 expression, a target of HNF4A. 
Furthermore, injection of APOA1 mimetic peptide rescues experimental colitis [262] and 
induces tissue repair in endothelial cells through the Akt/AMPK/eNOS pathways [263].  
Genetic variants at human PPARG are associated with increased risk for both UC 
and CD [242, 264, 265]. UC is associated with decreased PPARG expression [266]. 
Although the exact mechanism in IBDs remains unknown, PPARG has been shown to 
suppress TLR signaling by exporting a subunit of NF-κB, RelA, out of the nucleus and 
inhibiting transcription of proinflammatory genes [267]. Induction of PPARG activity by 
chemical ligands, rosiglitazone and troglitazne, suppresses colonic inflammation associated 
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with DSS administration in mice [268, 269]. These studies provide insight into how dietary 
interventions may help alleviate IBD symptoms. Both PPARG and HNF4A bind nutrients like 
long chain fatty acids and short chain fatty acids and these dietary molecules have been 
used to relieve IBD-associated inflammation [270]. For example, conjugated linoleic acid 
supplementation suppresses the immune response of patients with Crohn’s disease [271]. 
Chemical models of inflammation in zebrafish indicate linoleic acid, a poly-unsaturated fatty 
acid and the endogenous ligand of HNF4A, is protective of inflammation. This result 
contrasts with treatment with two other fatty acids, palmitoleic acid and palmitic acid, which 
exacerbated the inflammatory response [272].  
Nuclear receptors represent an attractive class of transcription factors for therapeutic 
design. Activation of glucocorticoid receptor (GR, NRC31) suppresses inflammation by 
activating transcription of anti-inflammatory genes like IL-10 [273]. GR also inhibits 
transcription of the proinflammatory cytokine IL-11 [274]. In may perform these anti-
inflammatory roles by suppressing AP-1 and NF-κB transcriptional activity. Indeed, 
glucocorticoids suppress NF-κB and AP-1 activity and increased GR expression is 
associated with decreased NF-ΚB activity [275, 276]. Genetic variants at human NR3C1 are 
associated with risk for CD [277],but genetic variation may have more important role in 
choice of therapy. Glucocorticoid treatment represents a cornerstone therapy for 
inflammatory conditions [278]. As such, it remains an obvious choice for inflammatory bowel 
disease treatment. However, Genetic variants at NR3C1 are associated with hormone 
resistant therapies in UC and CD [279, 280]. Indeed, augmented expression of GR-beta, a 
ligand binding isoform of GR and a putative dominant negative regulator of GR activity, is 
associated with unresponsive UC to glucocorticoid treatment [281]. Both villus and crypt 
epithelial cells express GR, however, aside from maintaining ionic gradients across the 
epithelia [282, 283], its role in maintaining the intestinal epithelia remains relatively 
unstudied.  
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2.6 Chapter Conclusion: 
Cells must balance between “flexible” and “rigid” transcription programs to maintain 
both cellular identity and sensitivity to the environment. No cellular environment may be 
more challenging to maintain this balance than the intestinal lumen that interfaces with the 
intestinal epithelia. The epithelia tune its transcription programs to maintain homeostasis 
with the microbiota. Dysregulation of these transcription programs can promote the onset of 
human diseases, like cancers and inflammatory bowel diseases [221, 284]. However, these 
diseases represent extreme circumstances and do not reflect the normal symbiotic 
relationships that have been maintained between animals and their microorganisms for over 
650 million years. Above, I have provided individual stories of how particular transcription 
factors mediate the expression of a handful of genes and how these transcription factors 
function to maintain epithelial identity. However, microbiota colonization is associated with 
the induction and suppression of hundreds of genes in the epithelia. And to date, no study 
has identified how the microbiota tune entire regulatory networks. Therefore, there remains 
a significant gap in understanding how the host normally perceives and responds to the 
microbiota. We do not have a strong understanding of how the “rigid” transcriptional 
programs overlap with these “flexible” transcription programs that permit sensitivities to the 
intestinal environment. In the next chapter, I will provide the first genome wide evidence of 
how microbiota colonization impacts histone modifications and transcription factor binding to 
regulate host gene expression.
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CHAPTER 3: MICROBIOTA REGULATE INTESTINAL EPITHELAIL GENE EXPRESSION 
BY SUPPRESSING THE TRANSCRIPTION FACTOR HEPATOCYTE NUCLEAR FACTOR 
4 ALPHA 
 
3.1 Overview 
Microbiota influence diverse aspects of intestinal physiology and disease in part by 
controlling tissue-specific transcription of host genes. However, host genomic mechanisms 
mediating microbial control of intestinal gene expression are poorly understood. Hepatocyte 
nuclear factor 4 (Hnf4) is the most ancient family of nuclear receptor transcription factors 
with important roles in human metabolic and inflammatory bowel diseases, but a role in host 
response to microbes is unknown. Using an unbiased screening strategy, we found that 
zebrafish Hnf4a specifically binds and activates a microbiota-suppressed intestinal epithelial 
transcriptional enhancer. Genetic analysis revealed that zebrafish hnf4a activates nearly half 
of the genes that are suppressed by microbiota, suggesting microbiota negatively regulate 
Hnf4a. In support, analysis of genomic architecture in mouse intestinal epithelial cells 
disclosed that microbiota colonization leads to activation or inactivation of hundreds of 
enhancers along with drastic genome-wide reduction of HNF4A and HNF4G occupancy. 
Interspecies meta-analysis suggested interactions between HNF4A and microbiota promote 
gene expression patterns associated with human inflammatory bowel diseases. These 
results indicate a critical and conserved role for HNF4A in maintaining intestinal 
homeostasis in response to microbiota. 
 
3.2 Introduction 
All animals face the fundamental challenge of building and maintaining diverse 
tissues while remaining sensitive and responsive to their environment. This is most salient in 
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the intestinal epithelium which performs important roles in nutrient absorption and barrier 
function while being constantly exposed to complex microbial communities (microbiota) and 
nutrients within the intestinal lumen. The presence and composition of microbiota in the 
intestinal lumen influence diverse aspects of intestinal development and physiology 
including dietary nutrient metabolism and absorption, intestinal epithelial renewal, and 
edification of the host immune system. Abnormal host-microbiota interactions are strongly 
implicated in the pathogenesis of inflammatory bowel diseases (IBD), including Crohn’s 
disease (CD) and ulcerative colitis (UC) [221]. Studies in mouse and zebrafish models of 
IBD have established that impaired intestinal epithelial cell (IEC) responses to microbiota 
are a key aspect of disease progression [223, 285, 286]. Improved understanding of the 
molecular mechanisms by which microbiota evoke host responses in the intestinal 
epithelium can be expected to lead to new strategies for preventing or treating IBD and 
other microbiota-associated diseases.  
The ability of IEC to maintain their physiologic functions and respond appropriately to 
microbial stimuli is facilitated through regulation of gene transcription. Genome-wide 
comparison of transcript levels in intestinal tissue or isolated IEC from mice reared in the 
absence of microbes (germ-free or GF) to those colonized with a microbiota 
(conventionalized or CV) have revealed hundreds of genes that have significantly increased 
or decreased mRNA levels following microbiota colonization [53]. Interestingly, many mouse 
genes that are transcriptionally regulated by microbiota have zebrafish homologs that are 
similarly responsive, suggesting the existence of evolutionarily-conserved regulatory 
mechanisms [137]. For example, the protein hormone Angiopoetin-like 4 (ANGPTL4, also 
called FIAF) is encoded by a single ortholog in the mouse and zebrafish genomes, and 
microbiota colonization results in significant reductions in transcript levels in the small 
intestinal epithelium of both host species [145, 156]. Whereas these impacts of microbiota 
on host IEC transcriptomes and their downstream consequences have been extensively 
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documented, the upstream transcriptional regulatory mechanisms remain poorly 
understood.  
Specification and tuning of gene transcription proceeds in part through interactions 
between transcription factors (TFs) and their sequence-specific binding to cis-regulatory 
DNA. Cis-regulatory regions (CRRs) harbor binding sites for multiple activating or repressing 
TFs and are generally associated with nucleosome depletion and specific post-translational 
modifications of histone proteins within adjacent nucleosomes when acting as poised 
(H3K4me1) or active (H3K27ac) enhancers [21]. Antibiotic administration can impact 
transcript levels and histone modifications in IECs [141], however it’s unclear if these 
changes are indirect effects caused by alterations to microbiota composition, direct effects 
of the antibiotic on host cells, or by the effects of remaining antibiotic-resistant microbiota 
[287].  Previous studies have shown that histone deacetylase 3 is required in IECs to 
maintain intestinal homeostasis in the presence of microbiota [236], and that overall histone 
acetylation and methylation in the intestine is altered by microbiota colonization [142]. 
However, the direct and specific effects of the microbiota on host CRRs and subsequent 
transcriptional responses in IECs remain unknown.   
Our previous studies predicted key roles for one or more nuclear receptor TFs in 
microbial down regulation of IEC gene expression [53], but the specific TF(s) were not 
identified. Nuclear receptors are ideal candidate TFs for integrating microbe-derived signals, 
since for many their transcriptional activity can be positively or negatively regulated by the 
binding of metabolic or hormonal ligands [288]. However, the roles of nuclear receptors in 
host responses remain poorly understood, and no previous study has defined the impact of 
microbiota on nuclear receptor DNA binding. Nuclear receptors are a metazoan innovation. 
The earliest animals encoded a single nuclear receptor orthologous to Hepatocyte nuclear 
factor 4 (HNF4; nuclear receptor subfamily NR2A) [148]. Despite subsequent duplication 
and diversification, distinct HNF4 TFs remain encoded in extant animals including mammals 
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(HNF4A, HNF4G) and fishes (Hnf4a, Hnf4b, Hnf4g) (Supplemental Figure 3.S1G). HNF4A 
serves particularly important roles in IECs, where it binds CRRs and activates expression of 
genes involved in IEC maturation and function [289]. IEC-specific knockout of mouse Hnf4a 
results in spontaneous intestinal inflammation similar to human IBD [251]. In accord, genetic 
variants at human HNF4A are associated with risk for both UC and CD as well as colon 
cancer [232, 233, 256, 290].  HNF4A is predicted to bind a majority of IBD-linked CRRs and 
to regulate IBD-linked genes [231, 237]. Similarly, genetic variants near human HNF4G 
have been associated with obesity and CD [257, 291]. Importantly, these diverse roles for 
HNF4 TFs in host physiology have only been studied in animals colonized with microbiota. 
Therefore, the role of Hnf4 in host-microbiota interactions and the implications for human 
IBD remain unknown.  
 
3.3 Results 
3.3.1 hnf4a is essential for transcriptional activity from a microbiota-suppressed cis-
regulatory DNA region 
To identify transcriptional regulatory mechanisms underlying microbial control of host 
gene expression, we took advantage of a previously identified microbiota-responsive CRR 
termed in3.4 located within the third intron of zebrafish angptl4 (Figure 3.1A). A GFP 
reporter construct under control of in3.4 termed in3.4:cfos:gfp drives tissue specific 
expression of GFP in zebrafish IEC and is suppressed by microbiota colonization, 
recapitulating the microbial suppression of zebrafish angptl4 [145]. However, the factor(s) 
that mediate microbial suppression of in3.4 were unknown. Using a yeast one-hybrid (Y1H) 
assay, we tested the capacity of 150 TFs expressed in the zebrafish digestive system to 
bind in3.4 (Supplemental Figure 3.S1A,B) and detected an interaction only with hnf4a, 
hnf4b, and hnf4g (Figure 3.1B). When either of two predicted Hnf4 motifs in in3.4 are 
mutated, the Hnf4-in3.4 interaction in the Y1H assay and intestinal GFP expression in 
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in3.4:cfos:gfp zebrafish is strongly reduced (Supplemental Figure 3.S1C-F). Interestingly, 
while gata4, gata5, and gata6 have predicted motifs in in3.4 [145] these TFs did not interact 
in the Y1H assay. This suggests that HNF4 TFs are capable of binding in3.4 directly and 
HNF4 binding sites are necessary for directing in3.4-based transcription in vitro and in the 
intestine.  
 
Figure 3.1: Zebrafish hnf4a is required for robust in3.4:cfos:gfp activity (A) Schematic of the 
microbiota-suppressed zebrafish enhancer, in3.4, highlighting the regions required for intestinal 
activity (purple) which both contain putative HNF4 binding sites (Site 1 and Site 2) [145]. (B) Image of 
4 plates from the Y1H assay showing the hnf4 family of transcription factors capable of binding in3.4 
and driving expression of the antibiotic resistance reporter gene. (C) Hnf4a+/+ and Hnf4a-/- protein 
cartoons showing the DNA binding domain (DBD) and hinge domain (HD). We characterized the two 
with the largest lesions, a -43 deletion in the hinge domain and a +25 insertion in the hinge domain 
which both result in frame-shift early-stop codons and significantly reduced transcript. (D) 
Stereofluorescence GFP and bright field microscopy showing representative hnf4a+/+ (top 3) and 
hnf4a-/- (bottom 3) 6dpf in3.4:cfos:gfp zebrafish. Genotype was blinded and samples were arranged 
by intensity of GFP fluorescence. (E) GFP fluorescence (mean ± sem) in hnf4a+/+ (n = 8), hnf4a+/- (n 
= 8) and hnf4a-/- (n = 8) 6dpf in3.4:cfos:gfp zebrafish (Two-tailed t-test: t = 17.84, 16.51, respectively, 
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df = 14, and **** p < 0.0001). (F) Confocal microscopy showing representative axial cross sections in 
6dpf hnf4a+/+ (n = 4) and hnf4a-43/-43 (n = 4) larval zebrafish. 4e8 antibody (yellow) labels the 
intestinal brush border, DAPI (blue) and phalloidin (red), and nephros (n). (G) Bright field microscopy 
(top) and stereofluorescence GFP (bottom) for representative hnf4a+/+ (n = 3) (left) and hnf4a-/- (n = 
3) (right) dissected intestinal folds from adult in3.4:cfos:gfp zebrafish. (H) Relative mRNA levels 
(mean ± sem) in hnf4a+/+ (n = 3) and hnf4a-/- (n = 3) adult zebrafish intestinal epithelial cell as 
measured by qRT-PCR. Two-tailed t-test: t = 0.93, 5.22, 6.56, 10.65, 0.75, 0.94 respectively, df = 4, 
and * p <0.05, *** p < 0.001). See also Supplemental Figures 3.S1 and 3.S2. 
 
We hypothesized that the hnf4 transcription factor family is required to mediate 
microbial suppression of in3.4 activity. Although the Y1H assay demonstrated all 3 zebrafish 
Hnf4 members are capable of binding in3.4, we concentrated our efforts on understanding 
the function of hnf4a because it is the most highly conserved Hnf4 family member 
(Supplemental Figure 3.S1G) and has well-documented roles in intestinal physiology [292]. 
To that end, we generated hnf4a mutant zebrafish using the CRISPR/Cas9 system (Figure 
3.1C; Supplemental Figure 3.S2A-C,E). Whole-animal Hnf4a knockout mice die during early 
embryogenesis due to failure to develop visceral endoderm [293], but zebrafish and other 
fishes do not develop that extra-embryonic tissue. We found that zebrafish homozygous for 
a non-sense mutation in hnf4a are viable and survive to sexual maturity (Supplemental 
Figure 3.S2D) providing new opportunities to study the roles of HNF4A in host-microbiota 
interactions.   
To determine if hnf4a is essential for in3.4 activity, we crossed mutant hnf4a alleles 
to the in3.4:cfos:gfp transgenic reporter line. GFP expression was significantly reduced in 
the absence of hnf4a suggesting that hnf4a activates in3.4 (Figure 3.1D,E,G,H). This loss of 
GFP expression in hnf4a-/- mutants was not associated with overt defects in brush border 
development or epithelial polarity in larval stages (Figure 3.1F), nor in the establishment of 
intestinal folds during adult stages (Figure 3.1G). However, intestinal lumen of mutant larvae 
was reduced in size at 6 days post fertilization (dpf) compared to WT siblings (Figure 3.1F; 
Supplemental Figure 3.S2F). Together, these data indicate hnf4a is essential for robust 
activity of a microbiota-suppressed CRR. Unlike in3.4:cfos:gfp, angptl4 is expressed in 
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multiple tissues and cell types [145]. To determine if intestinal angptl4 expression is 
dependent on hnf4a function, we isolated RNA from IECs from hnf4a+/+ and hnf4-/- adult 
in3.4:cfos:gfp zebrafish and performed qRT-PCR. Adult IECs (AIECs) from hnf4a-/- have 
significant reductions in mRNA for gfp, fabp2 (a known HNF4A target in human cell lines) 
[294], and hnf4a compared to hnf4a+/+ controls. However, angptl4 expression remained 
unchanged in hnf4-/- AIECs compared to WT, suggesting angptl4 transcript levels in the 
adult intestine are regulated by additional mechanisms and not solely from in3.4 or Hnf4a 
(Figure 3.1H). Transcript levels for hnf4g and hnf4b in hnf4a-/-AIEC were also unchanged. 
Together, these results establish that Hnf4a is required for in3.4 activity in IECs and raises 
the possibility that Hnf4a may have broader roles in mediating host transcriptional and 
physiological responses to microbiota.  
 
3.3.2 Hnf4a activates transcription of genes that are suppressed upon microbiota 
colonization  
To better define the roles of hnf4a in microbiota response and other aspects of 
digestive physiology, we used RNA-seq to compare mRNA levels from digestive tracts 
isolated from hnf4a+/+ and hnf4a-/- zebrafish larvae in the presence (CV) or absence of a 
microbiota (GF; Figure 3.2A). Consistent with our previous studies [137, 146], comparison of 
wildtype zebrafish reared under CV vs GF conditions revealed differential expression of 598 
genes that were enriched for processes such as DNA replication, oxidation reduction, and 
response to bacterium (Figure 3.2B,D; Supplemental Figure 3.S3D). Strikingly, disruption of 
the hnf4a gene caused gross dysregulation of the transcriptional response to microbiota 
colonization, with the total number of microbiota responsive genes (CV vs GF) increasing to 
2,217. Furthermore, comparison of the hnf4a mutant (Mut) vs wild type (WT) genotypes 
revealed differential expression of many genes in the CV condition (2,741 genes) and GF 
condition (1,441 genes) that inform a general role for Hnf4a in regulating genes in the 
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intestinal tract (Figure 3.2D,E). Principal components analysis (Supplemental Figure 3.S3A) 
and hierarchical clustering (Figure 3.2B) of FPKM values indicated that hnf4a genotype had 
a complex contribution to regulating genes involved in both responses to the microbiota and 
digestive physiology. 
Figure 3.2: Hnf4a activates the majority of coregulated genes that are suppressed by the 
microbiota. (A) Schematic showing the experimental timeline for zebrafish digestive tract GF and CV 
hnf4a+/+ and hnf4a-/- RNA-seq experiment (n = 3 for WTCV and WTGF and n = 2 for MutCV and 
MutGF). (B) Hierarchical relatedness tree and heatmap of differentially regulated genes in mutant and 
gnotobiotic zebrafish digestive tracts. Gene averaged log10 FPKMs for the biological replicates are 
represented for each of the 4,007 differentially regulated genes. (C) Representative RNA-seq signal 
tracks at fatty acid-desaturase 2 (fads2), serum amyloid a (saa) loci. (D) Summary of the total number 
of differentially expressed genes between indicated conditions (GF and CV) and genotype (WT and 
hnf4a-/- (Mut)). (E) 4-way Venn diagram showing overlaps between all 4,007 differentially regulated 
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genes. (F) The 295 coregulated genes were plotted using the log2 (FC) calculated in the 
WTGF/WTCV comparison (X-axis) and WTCV/MutCV (Y-axis). The 88 out of 98 genes that are 
activated by hnf4a but suppressed by the microbiota are highlighted (red) and (G) their GO term, 
KEGG pathway and disease associations are listed. See also Supplemental Figure 3.S3. 
 
Because we found that hnf4a activates the microbiota-suppressed intestinal CRR, 
in3.4, we hypothesized that this may represent a general regulatory paradigm for other 
microbiota-influenced CRRs and genes across the genome. When we compared the 598 
genes that were microbiota responsive in wildtype digestive tracts with the 2,741 genes that 
hnf4a regulates in CV digestive tracts we found these lists shared 295 genes that included 
fads2 and saa, both of which have human orthologs that are either implicated (FADS1/2) or 
markers (SAA) of IBD [224, 295] (Figure 3.2C-F). While loss of Hnf4a could be pleiotropic, 
strikingly, the overlap between these subsets reveals that a disproportionate 88 of the 98 
(~90%) microbiota-suppressed genes are activated by hnf4a (Figure 3.2F). These 88 genes 
represent almost half of all 185 genes suppressed by the microbiota.  These data suggest, 
like its role at in3.4, hnf4a plays a critical role in directly activating a large percentage of 
genes that are suppressed by microbial colonization. This set of hnf4a-activated microbiota-
suppressed genes is enriched for ontologies and pathways involved in lipid and 
carbohydrate metabolism, suggesting microbiota might regulate these processes through 
suppression of Hnf4a (Figure 3.2G). Interestingly, the top 2 diseases associated with this 
gene set were obesity-related traits and IBD (Figure 3.2G). Based on these results, we 
hypothesized that Hnf4a DNA binding is lost upon microbial colonization within CRRs 
associated with microbiota-suppressed genes.  
 
3.3.3 HNF4A binding sites are enriched in promoters near genes associated with 
microbiota-regulated H3K27ac marks 
Previous attempts to identify microbial responsive enhancers genome-wide were 
complicated by the lack of significant changes in chromatin DNase accessibility between GF 
and CV IECs from mouse colon and ileum [53]. These previous findings suggested other 
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chromatin dynamics may be involved in regulating the IEC response to microbiota. We 
therefore sought to provide a genomic context for understanding how the microbiota alter 
HNF4A activity and chromatin modifications in IECs by performing RNA-seq, DNase-seq, 
and ChIP-seq for the enhancer histone modifications H3K4me1 and H3K27ac, and the Hnf4 
TF family members HNF4G and HNF4A in CV and GF conditions totaling 35 datasets. We 
conducted these experiments in jejunal IEC from gnotobiotic mice because: (1) ChIP-grade 
antibodies for mouse HNF4A and HNF4G are available, (2) the larger organ size in mice 
provided sufficient numbers of IECs for ChIP-seq experiments, and (3) we speculated that 
the roles of HNF4A in host response to microbiota may be conserved to mammals. We first 
performed DNase-seq in jejunal IEC from mice reared GF or colonized for two weeks with a 
conventional mouse microbiota (CV) to determine the impact of microbiota colonization on 
chromatin accessibility (Figure 3.3A). In accord with previous studies that that tested for 
chromatin accessibility in ileal or colonic IECs from GF or CV mice [53], we similarly found 
no differential DNase hypersensitivity sites (DHSs) in GF or CV jejunum (data not shown, 
but see Supplemental Figure 3.S4A). These data indicate that gross accessibility changes in 
chromatin do not underlie the transcription of microbiota-responsive genes in IECs. 
To test if other metrics of chromatin utilization were dynamically regulated by 
microbiota, we performed ChIP-seq from GF and CV mouse jejunal IECs for histone marks 
H3K4me1 and H3K27ac that are enriched at poised enhancers and active enhancers, 
respectively (Figure 3.3B). By determining the single-nearest gene TSS within 10kb of the 
differential histone marks and overlaying these data with our new RNA-seq datasets, we 
found that regions that gain poised (H3K4me1) and activated (H3K27ac) enhancers upon 
colonization are associated with genes that have increased transcript levels upon 
colonization (Figure 3.3C,H-K; Supplemental Figure 3.S4I). Similarly, regions that lose 
poised and active enhancers upon colonization are associated with microbiota-suppressed 
genes (Figure 3.3C,G,I,J,L; Supplemental Figure 3.4J). A two-sided Kolmogorov-Smirnov  
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Figure 3.3: Microbiota selectively induce enhancer activity near genes that are upregulated 
upon microbiota colonization. (A) Schematic showing the gnotobiotic experimental timeline for 
testing mRNA levels and chromatin architecture in GF and CV. (B) MA plots from DESeq2 analysis 
(FDR < 0.01) of H3K4me1 (n = 3 per condition) (left) and H3K27ac (n = 2 per condition) (right) ChIP-
seq from GF and CV mouse jejunal IECs. Colored dots signify regions significantly enriched for a 
histone mark in GF (blue) or CV (orange). We found 4,579 unique H3K4me1 and 1,354 unique 
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H3K27ac peaks in GF and 5,155 unique H3K4me1 and 893 unique H3K27ac peaks in CV. (C) 
Volcano plots showing pairwise comparison of RNA expression between GF (n = 2) and CV (n = 2) 
jejunal IECs. Blue and orange dots represent genes associated with a region enriched for H3K4me1 
(left) or H3K27ac (right) signal in GF or CV. (D) Two-sided Kolmogorov-Smirnov goodness-of-fit test 
shows a positive relationship on average between the presence of a region enriched for 
H3K4me1/H3K27ac signal in a specific colonization state and increased transcript abundance of a 
neighboring gene in that same colonization state. (E) Top de novo binding site motifs found in DHSs 
that are flanked by regions enriched with H3K27ac signal in GF (E) or CV (F). Representative ChIP-
seq tracks highlighting a microbiota-regulated gene associated with differential histone marks in GF 
(G) (Akr1c19, Aldo-keto reductase 1c19) or CV (H) (Ubd, Ubiquitin D). Heatmaps showing the 
average GF and CV H3K4me1 (I) or H3K27ac (J) signal at the 1000 bp flanking differential sites. (K-
L) GO terms and KEGG pathways enriched in genes associated with differential H3K27ac sites 
shown in J. See also Supplemental Figure 3.S4. 
 
goodness-of-fit test shows a positive relationship between differential H3K4me1/H3K27ac 
region and increased transcript abundance of nearby genes in the same colonization state 
(Figure 3.3D). Collectively, we identified for the first time a genome-wide map of hundreds of 
newly identified microbial regulated CRRs, suggesting that microbiota regulation of host 
genes is mechanistically linked to histone modifications changes more than gross chromatin 
accessibility changes [53]. 
We leveraged this novel atlas of microbiota-regulated enhancers and accessible 
chromatin to determine which TFs are predicted to bind to these regions. An unbiased 
analysis found that three HNF4A binding site motifs were significantly (p < 1e-45, p < 1e-28, 
and p < 1e-13) enriched in promoters of genes associated with microbiota-suppressed 
enhancers (Supplemental Figure 3.S4E), and STAT1 binding site motifs were significantly (p 
< 1e-16) enriched in promoters of genes associated with microbiota-activated enhancers 
(Supplemental Figure 3.S4F). Interestingly, DHS sites associated with differentially active 
enhancers were enriched for two different sets of TF binding sites. DHSs flanked by 
microbiota-inactivated enhancers were enriched for nuclear receptor DR1 sites, which can 
be recognized by HNF4A [296], and GATA binding sites (p = 2.3e-12 and 1.1e-6 
respectively) (Figure 3.3E). DHS sites associated with microbiota-activated enhancers were 
similarly enriched for the nuclear receptor DR1 binding sites but also for STAT/IRF-like and 
ETS binding sites (p = 6.5e-15 and 1.3e-17 respectively) (Figure 3.3F). These data suggest 
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that nuclear receptors like HNF4A may play a central role in IEC responses to microbial 
colonization. 
 
3.3.4 Microbiota colonization is associated with a reduction in HNF4A and HNF4G 
cistrome occupancy 
To directly evaluate the impact of microbiota on HNF4A activity, we tested the plasticity of 
the genome wide distribution of HNF4s in response to microbial colonization. HNF4A bound 
28,901 and HNF4G bound 21,875 across the genome in GF conditions in jejunal IECs with 
~80% of these sites being bound by both TFs. In striking contrast, the number of sites bound 
by HNF4A and HNF4G in CV conditions was ~10 fold less (Figure 3.4A,B; Supplemental 
Figure 3.S5A-D). Of the 3,964 HNF4A binding sites detected in CV there were only 267 
HNF4A sites that were specific to the CV condition (Supplemental Figure 3.S6A,C). Yet, the 
genes associated with these HNF4A sites that are retained in CV are enriched for ontologies 
and pathways fundamental to intestinal epithelial biology (Supplemental Figure 3.S6B). 
Surprisingly, we found HNF4A sites are equally distributed between genes that are 
upregulated in both GF and CV conditions (Supplemental Figure 3.S5E). However, we did 
find that the average CV HNF4A signal strength was significantly increased at HNF4A sites 
associated with microbiota-induced genes relative to those HNF4A sites associated with 
microbiota-suppressed genes, suggesting HNF4A may play a limited role in genes 
upregulated by colonization (Supplemental Figure 3.S6F). In contrast, GF HNF4A ChIP 
signal was equivalent at HNF4A sites associated with microbiota-suppressed and induced 
genes (Supplemental Figure 3.S6F). Interestingly, we found that HNF4A sites were 
significantly correlated with increased H3K27ac, H3K4me1 and DHS signal in GF compared 
to these same chromatin marks in CV (Supplemental Figure 3.S6G). We do not believe that 
the reduction of HNF4A binding is the result of chromatin quality in a particular condition 
since there are genomic locations where GF and CV HNF4A sites appeared to have  
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Figure 3.4: Microbiota colonization results in extensive loss of HNF4A DNA binding in IEC 
(A) Heatmaps showing the average GF and CV ChIP-seq or DNase-seq signal at the 1000 bp 
flanking HNF4A sites found in GF.(B) Line plots showing the average GF (light-colored line) and CV 
(dark-colored line) ChIP-seq and DNase-seq RPKM-normalized signal for the indicated TF, histone 
mark or DHS at the 1000 bp flanking HNF4A sites found in GF (HNF4A: n = 3 per condition; HNF4G: 
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n = 4 per condition; H3K27ac n = 2 per condition; H3K4me1: n = 3 per condition; DNase: n = 3 for 
CV, n = 2 for GF) . (C) Representative signal tracks highlighting a microbiota-induced gene (Pigr, 
Polymeric immunoglobulin receptor) that is associated with an HNF4A peak with similar signal in both 
GF and CV jejunal IECs. (D) Heatmap showing the enrichment of TFBS motifs within 50 bp of the 
DHS or HNF4A peak maxima. (E) Representative signal track at Angptl4 highlighting two GATA4 
sites within an HNF4A bound region. (F) Bar graph showing HNF4A ChIP-PCR results at Angptl4, 
Apoa1 and Pck1 loci from jejunal IECs from mice colonized for 0 (n = 2), 6 (n = 3), 15 (n = 2) and 45 
(n = 3) days. Data are relative to the GF condition and normalized against a negative control locus 
(Neurog1) * p < 0.5, ** p < 0.005, *** p  < 0.0005. See also Supplemental Figures 3.S5 and 3.S6. 
 
equivalent signal (Figure 3.4C). Furthermore, ChIP enrichment in these IEC preparations for 
another zinc finger TF, CTCF, was unaffected by microbiota colonization (Supplemental 
Figure 3.S6D). This indicates that the observed reduction of Hnf4 ChIP signal in CV IECs is 
a result of microbiota on HNF4 binding, and is not the result of altered ChIP efficiency or 
sample quality in the different conditions. To test if microbial suppression of HNF4A 
occupancy is persistent, we performed ChIP-PCR from ex-GF mice that were colonized with 
microbiota for 6, 15 or 45 days. We found that even after 45 days post-colonization, HNF4A 
occupancy at binding sites was significantly reduced compared to GF (Figure 3.4F). The 
dramatic loss of HNF4A and HNF4G DNA binding upon colonization is consistent with 
HNF4A acting as a potent activator of microbiota-suppressed genes. 
We further speculated that certain coregulatory sequence-specific transcription 
factors may also contribute to regulating transcription with HNF4 at these sites.  To explore 
this possibility, we searched for TF motifs associated with HNF4A ChIP sites and found an 
enrichment of putative binding sites for TFs known to be involved in small intestinal 
physiology (GATA and HOXC9) as well as nutrient metabolism (PDX1) at both HNF4A 
bound regions associated with genes and enhancers suppressed by microbes (Figure 
3.4D). We similarly found GATA sites located within an HNF4A-bound CRR near murine 
Angptl4 (Figure 3.4E), similar to the coincident HNF4 and GATA motifs in in3.4 [145]. 
Furthermore, binding sites for TFs known to be involved in cell proliferation and cell death 
(ETS transcription factor family) are enriched near HNF4A bound regions that intersect 
microbiota-induced enhancers (Figure 3.4D). Collectively our integrative analyses of these 
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novel ChIP-seq, DNase-seq, and RNA-seq datasets identifies a core set of putative 
microbiota-responsive TFs that may interact with HNF4A to mediate microbial control of IEC 
gene expression. These results suggest HNF4A plays a major role in integrating microbial 
signals to regulate gene expression, and raise the possibility that this novel microbiota-
HNF4A axis might contribute to human disease. 
 
3.3.5 Microbiota-mediated suppression of HNF4A may contribute to gene expression 
profiles associated with human IBD 
Both HNF4A and the intestinal microbiota have been separately implicated in the 
pathogenesis of the human IBDs Crohn’s disease (CD) and ulcerative colitis (UC) [221, 
258]. However, a mechanistic link between microbiota and HNF4A in the context of IBD 
pathogenesis has not been established. Previous transcriptomic studies have identified 
genes differentially expressed in ileal (iCD) and colonic CD (cCD) and UC [237, 238] 
biopsies. We queried these human gene lists to identify one-to-one orthologs in mice, and 
referenced them against our new gnotobiotic mouse jejunal HNF4A ChIP-seq data (Figure 
3.5A). Strikingly, the majority of human genes downregulated in each of these IBD datasets 
have mouse orthologs that are associated with an HNF4A-bound region (Figure 3.5B,C) 
Focusing on the iCD dataset from the largest of these previous studies [237], we found 
differential iCD genes associated with HNF4A sites are enriched for distinct ontologies and 
pathways that are dysregulated in IBD (Figure 3.5H-K). In contrast to IBD, analysis of 
intestinal transcriptomic datasets from human subjects with necrotizing enterocolitis (NEC) 
[297] or insulin-resistance (IR) [298] did not reveal strong enrichment of HNF4A-bound 
regions near downregulated genes (Figure 3.5C). Notably, in each of these CD, UC, NEC, 
and IR datasets, a greater percentage of downregulated genes were linked to HNFA-bound 
regions compared to upregulated genes (Figure 3.5B). These data suggest microbiota-
dependent and microbiota-independent suppression of HNF4A activity in the intestine might  
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Figure 3.5. Microbiota suppression of HNF4A activity is highly correlated with genes and 
intestinal processes suppressed in human IBD and conserved in zebrafish. (A) Flow chart 
showing the experimental design and filters used to identify IBD or NEC gene orthologs associated 
with mouse HNF4A ChIP sites. (B) Bar chart showing the proportion of HNF4A associations in GF 
and CV mouse jejunal IECs near human-to-mouse one-to-one gene orthologs differentially regulated 
in human pediatric ileal Crohn’s Disease (iCD-1), adult iCD (iCD-2), adult colonic Crohn’s Disease 
(cCD), adult ulcerative colitis (UC), neonatal necrotizing enterocolitis (NEC) or insulin-resistance (IR). 
(C) Heatmap representing the -Log10 (pValue) of the enrichment of GF or CV HNF4A associated 
genes that are differentially regulated genes in the indicated IBD datasets.  Log10 p-values were 
calculated using a hypergeometric enrichment analysis and converting all HNF4A ChIP associated 
mouse genes to human orthologs (GF = 5863 genes and CV = 2119 genes). (D) Flow chart showing 
the experimental design and filters used to identify correlations between gnotobiotic WT or mutant 
zebrafish gene expression and gene orthologs differentially expressed in human IBD or NEC. 
Because loss of hnf4a function in zebrafish appeared to more closely resemble iCD signature than 
cCD or UC, we performed pairwise comparisons of gene orthologs that are (1) differentially regulated 
in human iCD and (2) have a mouse HNF4A ChIP association. Example of Deming linear regression 
analysis showing the correlation of Log2 (FC) between WTCV/WTGF (E) or MutCV/WTCV (F) 
zebrafish and pediatric iCD or NEC. m = slope of the line. (G) Heatmap representing slopes of 
Deming linear regression lines showing positive correlative relationships between the log2 gene 
expression fold changes of one-to-one orthologs from human diseases compared to log2 fold 
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changes in zebrafish WTCV/WTGF, MutCV/MutGF, MutCV/WTCV, and MutGF/WTGF. Hash signs 
indicate slope of Deming linear regression lines is significantly greater than WTCV/WTGF comparison 
(#, p < 0.05; ##, p < 0.0001). Asterisks indicate slope of Deming linear regression line is significantly 
greater than MutGF/WTGF (*, p <0.05; **, p <0.001). Solid boxes correspond to slope of lines in 
panel 5D, and dashed boxes correspond to slope of lines in panel 5E. (H-K) The top 5 GO terms and 
the top 5 KEGG pathways for indicated gene lists. 
 
play an important role in IBD pathologies. To assess if microbiota suppression of HNF4A 
activity regulates genes differentially expressed in IBD, we queried the published human 
IBD and NEC gene expression datasets to identify human-mouse-zebrafish one-to-one-to-
one orthologs that were differentially expressed in our RNA-seq analysis of gnotobiotic 
zebrafish hnf4a mutants (Figure 3.5D). We found ortholog expression fold changes in 
human IBD/healthy comparisons most closely resembled the expression fold changes of 
MutCV/MutGF and MutCV/WTCV (Figure 3.5E-G). Neither the WTCV/WTGF nor the 
MutGF/WTGF comparisons faithfully recapitulate the expression profiles of IBD/healthy 
comparisons. This indicates that both the microbiota and loss of hnf4a function in zebrafish 
are necessary to induce a gene expression profile that resembles human IBD. Strikingly, the 
positive correlation and significant resemblance to the iCD-like gene signatures in the 
colonized hnf4a-/- compared to colonized hnf4a+/+ zebrafish digestive tracts become even 
stronger when we limited our analysis to one-to-one orthologs that have an association with 
an HNF4A bound region in mouse IECs (Figure 3.5G). Together, these results indicate that 
intestinal suppression of HNF4A target genes is a prevalent feature of human CD and UC, 
and suggests a model wherein HNF4A maintains transcriptional homeostasis in the 
presence of a microbiota and protects against an evolutionarily-conserved IBD-like gene 
expression signature. 
 
3.4 Discussion 
Over the course of animal evolution, the intestinal epithelium has served as the 
primary barrier between animal hosts and the complex microbial communities they harbor. 
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IECs maintain this barrier and perform their physiological roles in nutrient transport and 
metabolism through dynamic transcriptional programs. The regulatory mechanisms that 
orchestrate these transcriptional programs represent potential therapeutic targets for a 
variety of human intestinal diseases including IBD. Here we discovered that HNF4A activity 
and its transcriptional network are suppressed by microbiota. HNF4A is the oldest member 
of the nuclear receptor TF family [148], and our findings in fish and mammals suggest that 
microbial suppression of HNF4A may be a conserved feature of IEC transcriptional 
programs present in the common ancestor.  
We discovered HNF4A as a microbiota-suppressed transcription factor by 
demonstrating it specifically binds to a microbiota-suppressed cis-regulatory element, in3.4, 
which is located at the zebrafish gene angptl4.  This finding combined with our zebrafish 
RNA-seq data (Fig. 2FG) revealed a broad role for HNF4A in activation of microbially-
suppressed transcripts. Though hnf4a mutant zebrafish have reduced in3.4 activity in the 
intestinal epithelium based on transgenic reporter assays, the transcript levels of the 
endogenous zebrafish angptl4 gene appears unaffected in both larval digestive tracts and 
adult IECs. The zebrafish genome encodes two additional HNF4 family members (hnf4b, 
hnf4g), and previous studies in mammals have shown Angptl4 can be regulated by other 
metabolically-activated nuclear receptors [158, 299]. We hypothesize that loss of HNF4A 
function may lead to a metabolic imbalance leading to atypical or compensatory activation of 
other trans- and cis-factors that control expression of angptl4 and other genes in the 
intestine.    
Our results suggest new links between HNF4A and microbiota in the context of 
human IBD. IBD patients, particularly those suffering from Crohn’s disease, often present 
with decreased serum low-density lipoprotein levels and reduced total cholesterol levels 
compared to healthy individuals [300, 301]. These serum levels are consistent with reduced 
transcript levels for genes involved in intestinal absorption and transport of lipid and 
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cholesterol in ileal and colonic biopsies from UC and CD patients [237, 238]. Transcription 
factors, including nuclear receptors like HNF4A and FXR, are known to regulate bile acid 
production, lipid and cholesterol absorption and have already been implicated in IBD [258, 
302]. Previous studies have shown that some IBD-associated H3K27ac activated regions 
that also overlap with an IBD-associated SNP contain HNF4A binding sites [230]. This is 
consistent with our findings and supports a role for HNF4A in regulating gene expression 
and inflammation in the context of IBD. However, our work is the first to demonstrate a role 
for microbiota in suppressing HNF4A, and to implicate microbiota-HNF4A interactions in 
driving an IBD-like gene expression signature (Fig. 5).  In addition to IBD, human HNF4A 
variants are associated with metabolic syndrome [303] and type 2 diabetes [304]. 
Interestingly, microbiota have also been implicated in both of these diseases [305, 306] 
raising the possibility that microbiota suppression of HNF4A trans activity could play a role in 
these diseases as well. Indeed, we find that genes down regulated in intestinal tissue from 
IR obese patients have increased HNF4A binding associations compared to up-regulated 
genes [298], similar to the enrichment of HNF4A associations at down-regulated genes in 
IBD (Fig. 5B,C). Interestingly, up-regulated genes in these IR-obese patients were enriched 
for pro-inflammatory markers. This underscores the relationship between metabolic 
impairments and inflammation in the intestine, and prompts further investigation of how 
HNF4A might contribute. HNF4A has been shown to play key roles in anti-oxidative and 
anti-inflammatory defense mechanisms [307] so aberrant microbial suppression could 
promote an inflammatory state. HNF4A target genes are downregulated in human IBD [237, 
238] and mouse experimental colitis [260], and the HNF4A target APOA1 has been shown 
to be protective against intestinal inflammation in mice [262]. We speculate that the genes 
governed by this novel microbiota-HNF4A axis may include additional anti- and pro-
inflammatory factors that could provide new targets for IBD therapy. 
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Our results reveal similar effects of microbiota colonization and experimental colitis 
on HNF4A cistrome occupancy in the intestine, but the underlying molecular mechanisms 
are unresolved. DSS induced colitis results in reduced HNF4A protein levels and altered 
cellular localization [260], however our results indicate the microbiota neither reduce HNF4A 
protein levels nor impact its nuclear localization in jejunal IECs two weeks after colonization 
(Supplemental Fig. 65H,I). Colonization of GF mice with microbiota initiates a transcriptional 
adaptation in the intestine that progresses for several weeks before reaching homeostasis 
[121]. However, our data indicate HNF4A suppression is achieved within 15 days and 
persists through at least 45 days after colonization. These data collectively suggest that 
microbiota suppress HNF4A activity in the jejunum through mechanisms distinct from those 
utilized in DSS induced colitis. 
HNF4A has been characterized as a master metabolic regulator for its conserved roles in 
gluconeogenesis, glucose homeostasis, and fatty acid metabolism [118, 308, 309]. Despite 
its clear importance in metabolic health, relatively little insight into its regulation in a 
biological context has been reported. In vitro and cell culture studies have identified possible 
suppressors and activators of HNF4A including acetylation by CREB-binding protein (CBP), 
which has been shown to induce HNF4A activity [310, 311]. The nuclear receptor cofactor 
and master regulator of mitochondrial biogenesis PGC-1A binds HNF4A and promotes 
activation of HNF4A target genes [312]. Colonization of GF animals with a microbiota leads 
to increased energy harvest [167, 168] and changes in metabolic homeostasis including 
decreased AMPK activity in skeletal muscle and liver [169]. AMPK activates PGC-1A [313], 
therefore, microbiota might suppress HNF4A activity indirectly through induced alterations in 
metabolic homeostasis. Other studies have shown that HNF4A activity is controlled through 
use of alternative promoters which generate different isoforms [314]. However, we did not 
detect differential Hnf4a exon usage by DEXseq [315] in our RNA-seq data from GF and CV 
IECs (data not shown). Another facet of HNF4A biology that remains unresolved is the 
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identity of its endogenous ligand(s). Although historically considered an orphan nuclear 
receptor, several fatty acids, including linoleic acid, have been identified as ligands for 
HNF4A [308, 316, 317]. Fatty acids are an attractive class of putative regulators of HNF4A 
since the microbiota are known to regulate FA absorption in zebrafish IECs [168].  Further, 
specific bacterial taxa are known to modify the structure of polyunsaturated FAs (PUFAs) 
and these native and modified PUFAs have distinct impacts on animal health [318] and may 
serve as therapeutics for IBD [319]. 
In our attempt to understand how the microbiota regulate HNF4A activity and host 
gene transcription, we were motivated to investigate if microbiota impact histone 
modification and chromatin accessibility in the mouse jejunum. Our findings support the 
model that microbiota alter IEC gene expression by affecting TF binding and histone 
modification at tissue-defined open chromatin sites [53]. We provide the genomic addresses 
of hundreds of microbiota-regulated enhancers as well as the genes associated with these 
enhancers and HNF4A binding sites. Similar to other findings in intraepithelial lymphocytes 
[320], our work demonstrates a clear microbial contribution to the modification of the histone 
landscape in IECs and provides another important layer of regulation that orchestrate 
microbiota regulation of host genes involved in intestinal physiology and human disease. We 
were also able to establish a link between microbiota-regulated genes and enhancers and 
NR binding sites. These NR binding sites are coincident with a core set of TFs that are 
enriched near microbiota-suppressed enhancers/genes (GATA) or induced 
enhancers/genes (ETS-factors and IRF) (Supplemental Fig. S7). GATA4 was previously 
shown to be a positive regulator of genes suppressed by microbiota in the mouse jejunum 
([132], supporting potential coregulatory interactions with HNF4A. Coregulation by other TFs 
represents one possible mode of HNF4A regulation by which the microbiota could suppress 
HNF4A activity without impacting the gene transcription of all HNF4A -associated genes.  
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3.5 Methods 
3.5.1 Zebrafish Husbandry: 
Tg(in3.4:cfos:gfp) (Camp et al., 2012) stable transgenic lines were maintained on a 
TL/Tü background using established protocols approved by the Animal Studies Committee 
at the University of North Carolina at Chapel Hill and Duke University School of Medicine. 
Conventionally raised zebrafish were reared and maintained as described [321]. Production, 
colonization, maintenance, and sterility testing of gnotobiotic zebrafish were performed as 
described [322]. 
 
3.5.2 Mouse Husbandry:  
All mouse husbandry was performed as described in [53] using established protocols 
approved by the Animal Studies Committee at the University of North Carolina at Chapel Hill 
and Duke University School of Medicine with the following exceptions. All mice used in this 
study were 10 – 12 week old male C57BL/6J, housed on Alpha-dri bedding (Shepherd) and 
fed 2020SX diet (Envigo) ad libitum.  To generate conventionalized mice, germ-free mice 
were colonized with a conventional microbiota from by receiving a 200 uL oral gavage 
of 20% glycerol stock containing 1:1 w/v fecal sample collected from adult SPF C57BL/6J 
mice collected over 2 weeks and homogenized in reduced PBS.   
 
3.5.3 Yeast 1-Hybrid ORFeome Screen:   
The yeast 1-hybrid ORFeome screen was performed using the Clontech 
MatchmakerTM Gold Yeast One-hybrid Library Screening System (cat. 630491) protocol 
with the following exceptions: The Y1HGold yeast strain was transformed using standard 
yeast transformation procedures with BstBI digested pBait-AbAi containing either the WT or 
a SDM in3.4 or the p53 binding site sequence, and positive transformants were selected on 
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SD/-URA media. In addition, a ORFeome library consisting of 148 zebrafish transcription 
factors cloned from adult zebrafish liver into pDEST22 prey vectors containing an N-terminal 
GAL4-activation domain was utilized [323]. Each plasmid was individually transformed in the 
yeast strains Y1HGold[in3.4/AbAi] or Y1HGold[p53/AbAi] and positive transformants were 
selected on SD -URA -TRP.  The primary screen to test for positive interactions between the 
prey transcription factor and the bait sequence was tested twice in the laboratory by 
pipetting 10 uL of transformed yeast onto SD/-URA/-TRP with AbA (125ng/ml) agarose 
plates.  The secondary screen to test for positive interactions was performed by streaking 
individual colonies from the primary screen onto SD/-URA/-TRP with AbA (125ng/ml) 
agarose plates.  Zebrafish hnf4a and hnf4g cDNAs (see Supplemental Table 1 for primers 
used for amplification) were cloned into a custom pENTR plasmid (termed pENTR-Ale1) 
using In Fusion (Takara Bio 638909) and inserted into pDEST22 using LR clonase 
(Invitrogen 12538120).  These newly cloned transcription factors were tested for a positive 
interaction with in3.4 using the same procedures as above.   
 
3.5.4 Site Directed Mutagenesis: 
Site directed mutagenesis was performed using the primers found in Supplemental 
Table 1.  A 40 cycle PCR reaction was performed using iProof HiFi Polymerase (Biorad 
1725301).  Newly synthesized plasmids were digested with DpnI (New England Biolabs 
R0176L) overnight to digest template DNA and transformed into DH5a E. coli.  SDM Vectors 
were confirmed by Sanger sequencing.  
 
3.5.5 Zebrafish Transgenesis and Imaging: 
Co-injections of Tol2 SDM or WT in3.4:cfos:gfp plasmid and transposase mRNA 
were performed as described (Camp et al., 2012) with the following exceptions: 50 – 100 
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zebrafish embryos were injected at the 1–2 cell stage with approximately 69 pg of plasmid 
DNA at a DNA:transposase ratio of 1:2. At least 9 - 18 fish/construct were imaged on a 
Leica M205 FA with a Leica DFC 365FX camera at the same magnification and exposure 
time and densitometric measures were quantified in 8-bit gray scale images using FIJI 
software. Three mosaic patches within a given tissue of an imaged fish were quantified for 
mean fluorescence intensity and averaged. Statistical significance was analyzed using 
Kruskal-Wallis one-way analysis of variance and Dunn’s multiple comparison test using 
GraphPad Prism software.  
 
3.5.6 Zebrafish Mutagenesis: 
Targeted gene deletion of the hnf4a gene was performed using CRISPR/Cas9 
nuclease RNA-guided genome editing targeting the fourth exon of hnf4a.  The guide RNA 
sequences were designed using “CRISPR Design Tool” (http://crispr.mit.edu/).  Guide RNAs 
(Supplemental Table 1) were generated from BamHI (New England Biolabs R0136L) 
digested pT7-gRNA plasmid (a gift from Wenbiao Chen and available from Addgene: 
http://www.addgene.org/46759/) and by performing an in vitro transcription reaction using 
MEGAshortscript T7 kit (Ambion/Invitrogen AM1354) [324].  Cas9 mRNA was generated 
from XbaI (New England Biolabs R0145S) digested pT3TS-nls-zCas9-nls plasmid (a gift 
from Wenbio Chen and available from Addgene: http://www.addgene.org/46757/) followed 
by an in vitro transcription reaction using mMESSAGE mMACHINE T3 kit 
(Ambion/Invitrogen AM1348) [324]. 150 ng/uL of nls-zCas9-nls and 34 ng/uL of each gRNA, 
0.05% phenol red, 120 mM KCl, and 20mM Hepes (pH 7.0) were injected directly into the 
cell(s) of one to two cell stage developing zebrafish embryos of Tü background.  
Mutagenesis was initially screened using Melt Doctor High Resolution Melting Assay 
(Thermo Fisher Scientific 4409535) and subsequent screening of the -43 and +25 alleles 
was performed using 2% agarose sodium borate gel electrophoresis. Protein and DNA 
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sequences were visualized using CLC Sequence Viewer 7(CLC Bio) HNF4A protein 
phylogeny tree was generated in CLC Sequence Viewer 7.  The majority of zebrafish 
experiments were performed using hnf4a-43/-43 genotype. However, the gnotobiotic zebrafish 
experiment was performed using larvae from an intercross between hnf4a-43/-43 and hnf4a-
43/+25 adults.  We have not observed significant gene expression or morphological 
differences between hnf4a-43/-43 and hnf4a+25/+25 genotypes.  
 
3.5.7 Zebrafish Immunohistochemistry: 
6 dpf zebrafish larvae were fixed in 4% PFA overnight at 4 C.  Fixed larvae were 
mounted in 4% low melting point agarose molds.  200 um axial cross sections of fixed larvae 
were generated using a Leica VT1000S.  Vibratome slices were washed once in ice cold 
PBS followed by 4 times with PBS containing 0.1% tween 20 and then incubated in blocking 
solution (PBS with 10% heat inactivated calf serum, 0.1% Tween-20 and 0.5% Triton X-100) 
for 4 hours.  Slices were incubated overnight with 4e8 antibody (Mouse anti-4e8, Abcam 
ab73643) diluted 1:200 in PBS with 5% heat inactivated calf serum, 0.1% Tween-20 and 
0.5% Triton X-100 at 4°C with agitation.  Samples were washed in PBST 3 times for 10 
minutes per wash and incubated with secondary antibody (1:1000) (Goat Anti-Mouse Alexa 
Fluor 568 Invitrogen, A11004) and Alexa Fluor 647 phalloidin (1:300) (Invitrogen, A22287) in 
PBS with 5% heat inactivated calf serum, 0.1% Tween-20 and 0.5% Triton X-100 for 3 
hours.  Slices were washed in PBS 3 times for ten minutes per wash, mounted onto slides 
with DAPI mounting media (Vector Laboratories, Inc, H-1200) and imaged on a Leica SP8 
confocal microscope.  Images shown in Figure 3.1F are representative of two experiments 
with 3 larvae per experiment per genotype. 
 
62 
 
3.5.8 Mouse IEC Isolation: 
Mice were euthanized under CO2 and cervical dislocation and placed on a chilled 
wax dissection pad.  The small intestine was removed from the mouse and the jejunum was 
excised from the duodenum and ileum. Duodenum was defined as the anterior 5 cm of the 
midgut and ileum was defined as posterior 6 cm of midgut as described (Camp, et al 2014).  
Adipose and vasculature were removed from the tissue.  The jejunum was opened 
longitudinally along the length of the tissue, exposing the lumen and epithelial cell layer.  
Luminal debris was washed away from the epithelia with ice cold sterile PBS.  The tissue 
was temporarily stored in 10 ml of ice cold sterile PBS with 1x Protease Inhibitor (Complete 
EDTA-Free, Roche 11873580001) and 10 uM Y-27632 (ROCK I inhibitor, Selleck Chemicals 
S1049) to inhibit spontaneous apoptosis.  The jejunum was moved into a 15 ml conical tube 
containing 3 mM EDTA in PBS with 1x protease inhibitor and 10 uM Y-27632.  The tissue 
was placed on a nutator in a cold room for 15 minutes.  The jejunum was removed from the 
3 mM EDTA and placed on an ice cold glass petri dish with PBS containing 1mM MgCl2 and 
2 mM CaCl2 with protease inhibitors and 10 uM Y-27632.  Villi were scraped off of the tissue 
using a sterile plastic micropipette and placed into a new 15 ml conical tube.  The isolated 
IECs were then pelleted at 250 x g at 4°C for 5 minutes, resuspended in 15 ml of ice cold 
PBS containting 10 uM Y-27632 and 1x protease inhibitors and pelleted again at 250 x g at 
4°C.  The cell pellet was used for chromatin immunoprecipitation or for nuclear extractions.   
 
3.5.9 Mouse Intestine Immunofluorescence and Western Blot: 
Mid-jejunal tissue was dissected and cleaned as in the IEC villi isolation above.  The 
whole, splayed open tissue was pinned to 3% agarose and fixed in 4% PFA overnight with 
gentle agitation at 4°C.  The fixed tissue was washed 4 times with PBS for 15 minutes.  The 
tissue was then permeabilized in PBS with 0.5% Tween 20 for 1.5 hours at room 
temperature.  Following permeabilization, the tissue was blocked in 5% donkey serum in 
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PBS with 0.1% Tween 20 for 2 hours at room temperature.  The tissue was moved into a 35 
mm dish and incubated with the primary antibody (Mouse anti- HNF4A, Abcam 41898 or 
Goat anti-HNF4G, Santa Cruz sc-6558X) diluted 1:200 overnight at 4°C with gentle 
agitation.  The tissue was washed 4 times in immunowash buffer (PBS, 0.1% Tween-20, 1% 
DMSO and 1% BSA) at room temperature and incubated in secondary antibody (Goat Anti-
Mouse Alexa Fluor 488 Invitrogen, A11001 or Donkey Anti-Goat Alex Fluor 568 Invitrogen, 
A11057) diluted 1:100 and Alexa Fluor 488 phalloidin or Alexa Fluor 568 phalloidin diluted 
1:250 (Invitrogen A12379 and A12380, respectively) in PBS with 0.1% Tween-20 for 4.5 
hours at room temperature.  The tissue was then washed 6x in Immunowash buffer, 
mounted on a microscope slide with DAPI mounting media (Vector Laboratories, Inc, H-
1200) and imaged on a Leica SP8 confocal microscope. 
Western blots were performed on non-crosslinked IEC lysates (see below) using standard 
chemoluminescence Western blot protocols, including ECL (Biorad 170-5061) and primary 
antibodies Goat anti-HNF4A (Santa Cruz sc-6556), Goat anti-HNF4G (Santa Cruz sc-
6558X) and Rabbit anti-ACTB (Cell Signaling 13E5), Donkey anti-Goat-HRP conjugate 
(Santa Cruz sc-2020), and Goat anti-Rabbit-HRP conjugate (Jackson ImmunoResearch 
111-035-003, a gift from Stacy Horner at Duke University).  The western blot shown in 
Supplemental Figure 3.S6H is a representative of two experiments.    
 
3.5.10 Cell Lysis and Chromatin Sonication for ChIP: 
Washed and pelleted IECs were resuspended in 10 ml of 1% EM grade 
formaldehyde (Electron Microscopy sciences, 15710) in ice cold PBS containing 10 uM Y-
27632 and 1x protease inhibitors.  The cells were fixed for 25 minutes at room temperature 
with agitation.  Formaldehyde fixation was quenched by adding glycine to a final 
concentration of 125 mM.  The cells were pelleted at 250 x g for 5 minutes at 4°C and 
resuspended in ice cold PBS with 1x protease inhibitors and 10 uM y-27632.  This wash 
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step was repeated twice.  Upon the third wash, the cell pellet was aliquoted into 3 equal 
volumes in 3 microfuge tubes.  The cells were pelleted in the microfuge tubes and 
resuspended in 300 uL of ChIP Lysis Buffer (1% IGEPAL, 0.5% sodium deoxycholate, 1% 
SDS in 1x PBS) containing 1x protease inhibitor (Roche).  The cells were stored on ice for 2 
hours and sonicated using a Bioruptor 4°C water bath sonicator.  Chromatin was sheared to 
mean size of 250 – 300 bp (10 minutes of 30 seconds on High, 30 seconds off, repeated 
once for a total of 20 minutes – total sonication time is 10 minutes on High, 10 minutes off).  
Sonicated material was spun at 14,000 x g for 20 minutes and the supernatant was 
transferred to a new microfuge tube.  ChIP was performed immediately on sonicated 
chromatin or it was snap frozen and stored at -80°C.  To check chromatin shearing 
efficiency and to prepare ChIP input samples, 20 uL of each sonicated sample was removed 
and added to a new tube.  180 uL of ChIP elution buffer and 8 uL of 5 M NaCl was added to 
the 20 uL input samples.  Chromatin shearing efficiency was visualized on a gel following 
reverse crosslinking by incubating the input sample at 65°C overnight. 
 
3.5.11 Chromatin Immunoprecipitation, Library Preparation and Next-Generation 
Sequencing: 
Frozen sonicated chromatin was thawed on ice.  Thawed and fresh chromatin 
samples were diluted in 1 mL of ChIP dilution buffer (1% Triton X-100, 2 mM EDTA, 20 mM 
Tris-Cl (pH 8.1), and 150 mM NaCl) containing 1x protease inhibitor and precleared with 
washed protein G Dynabeads for 3 hours at 4°C on a nutator.  Precleared chromatin was 
incubated with ChIP grade antibodies [4 ug H3K4me1 (Rabbit anti-H3K4me1, Abcam 
ab8895), 4 ug H3K27ac (Rabbit anti-H3K27ac, Abcam ab4729), 8 ug HNF4A (Mouse anti-
HNF4A, Abcam 41898), 8 ug HNF4G (Goat anti-HNF4G, Santa Cruz sc-6558X), 8 ug CTCF 
(Rabbit anti-CTCF, Active Motif, 61311)] overnight at 4°C on a nutator.  Antibody-chromatin 
complexes were pulled down with washed protein G dynabeads for 4 hours at 4°C on a 
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nutator.  The beads were washed 5x for 3 minutes with ice cold LiCl wash buffer (100 mM 
Tris-Cl (pH 7.5), 500 mM LiCl, 1% IGEPAL, 1% sodium deoxycholate)) and 1x with ice cold 
TE buffer at 4°C on a nutator.  Washed beads were resuspended in 100 uL of ChIP elution 
buffer (1% SDS and 0.1 M sodium bicarbonate)) and placed in a thermomixer heated to 
65°C and programed to vortex at 2000 RPM for 15 seconds, rest for 2 minutes for a total of 
30 minutes.  The beads were pelleted, placed on a magnet, and the supernatant was moved 
to a new tube.  This elution process was repeated once and corresponding elutions were 
combined for a total of 200 uL.  To reverse crosslink immunoprecipitated chromatin, 8 uL of 
5 M NaCl was added to each 200 uL ChIP elution and elutions were incubated at 65°C 
overnight.  Immunoprecipitated chromatin was isolated using a QIAquick PCR quick 
preparation kit (Qiagen 28104), quantified using a Qubit 2.0 flourometer and stored at -80°C 
until library preparations and amplification.  Libraries were always prepared within 3 days of 
the immunoprecipitation with the NEBNextUltra DNA Library Prep Kit for Illumina (New 
England Biolabs E7370S).  Prepared libraries were quantified using a Qubit 2.0 fluorometer 
and submitted to Hudson Alpha Genomic Services Laboratory for 50 bp single end 
sequencing on an Illumina HiSeq 2500 with 4 samples per lane in the flow cell.    
Germ free or conventionalized chromatin for input normalization was generated 
using the same protocol as above except no antibody was used during the overnight 
antibody incubation; instead, chromatin was incubated at 4°C with gentle agitation.  Bead 
incubation, reverse-crosslinking and library preparations for these samples were performed 
using the same protocol as the ChIPs.   
 
3.5.12 DNase Hypersensitivity on IECs: 
DNase hypersensitivity was performed as described [53] with the following modifications: 
IECs were isolated as above from jejunum and subjected to endogenous DNase activity to 
digest chromatin.  DNase-seq libraries were constructed as previously described, with “Oligo 
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1b” phosphorylated at the 5’-end to enhance ligation efficiency [325].  Libraries were 
sequenced by Illumina HiSeq 2000 with 50 bp single end reads with 3 samples per lane.   
 
3.5.13 RNA Isolation, qRT-PCR, RNA-seq: 
For RNA-seq, zebrafish digestive tracts (n = 13 – 20 per condition per genotype) 
were removed by microdissection and resuspended in 1 mL TRIzol 
(Ambion/Invitrogen/ThermoFisher Scientific 15596026).  Larval digestive tracts were lysed 
by being passing through a 25 G needle followed by a 27.5 G needle 5 times each.  Mouse 
jejunum intestinal epithelial cells were collected as mentioned above.  Prior to crosslinking, 
1/50 of the isolated IECs were suspended in 1 ml TRIzol and stored at -80°C.  For both 
zebrafish and mouse RNA samples, 200 uL of chloroform was added to the TRIzol and the 
sample was vortexed on high for 30 seconds at room temperature.  The samples were 
incubated at room temperature for 2 minutes and centrifuged at 12,000 x g for 15 minutes at 
4°C.  The top aqueous layer was removed and added to equal volume of isopropanol.  The 
nucleic acids were isolated using a column-based RNA-isolation kit (Ambion Cat 
12183018A) with an on column DNase I (RNase-free) treatment (New England Biolabs 
M0303L) to remove DNA contamination.  RNA was eluted off the column in nuclease-free 
water, quantified using a Qubit 2.0 and stored at -80°C until submission to the Duke 
Sequencing and Genomic Technologies Core.  RNA-seq libraries were prepared and 
sequenced by Duke Sequencing and Genomic Technologies Core on an Illumina HiSeq 
2500 with 4 samples per lane in the flow cell. 
For qRT-PCR, adult zebrafish IECs from one adult or 6 dpf larvae (n= 5 – 10) with 
the same genotype were suspended in 1 mL of TRIzol.  RNA was extracted using the same 
protocol as above with the following exceptions: following sample resuspension in 
isopropanol, samples were frozen at -20°C O/N and spun at 15,000 x g for 30 minutes.  
Pellets were washed twice with RNase-free 70% ethanol and left to air dry for 10 minutes.  
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Nucleic acids were resuspended in RNase-free water containing DNase (DNA-free DNA 
Removal Kit, ThermoFisher Scientific AM1906) and incubated for 30 minutes at 37°C.  
DNase was inhibited and purified RNA was quantified using a Nanodrop spectrophotometer 
and stored at -80°C.  cDNA was generated using iScript cDNA synthesis kit (Biorad 
1708891) and qRT-PCR was performed using Quanta’s PerfeCTa Sybr-green (Quanta 
101414-154) in an Applied Biosystems StepOnePlus Real-Time PCR Systems machine 
(Supplemental Table 1). 
For ChIP-PCR, Immunoprecipitated chromatin was isolated using a QIAquick PCR quick 
preparation kit (Qiagen 28104), and stored at -20°C.  Immunoprecipitated chromatin was 
used as template in a qRT-PCR reaction using Quanta’s PerfeCTa Sybr-green (Quanta 
101414-154) in an Applied Biosystems StepOnePlus Real-Time PCR Systems machine 
(Supplemental Table 1). 
 
3.5.14 RNA-seq Bioinformatics: 
Zebrafish RNA-seq reads were aligned to the zebrafish genome (danRer7) using 
TopHat2 v0.6 using de novo splice junction mapping (default TopHat settings). FPKM 
expression values were obtained for transcripts via Cufflinks, and pairwise differential gene 
expression tests were carried out with Cuffdiff v0.0.6 (Trapnell et al. 2012) using a minimum 
alignment count of 100 and using multi-read correct and read group datasets.  The default 
significance threshold of FDR < 5% was used for each comparison.  Hierarchical clustering 
of replicates and gene expression heatmap of RNA-seq data were generated using 
complete linkage clustering and averaging the log10 (FPKM) of each gene with Cluster v3.0.  
Subsequent heatmaps in Supplemental Figure 3.S3 were generated using complete 
hierarchical gene clustering of the log2 (fold change) between compared conditions with 
Cluster v3.0.  Principle components analysis was performed with a wide estimation method 
with JMP13.  Discriminant analysis was performed with a wide linear method with JMP13. 
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GO enrichments were performed with DAVID 6.7 [326, 327].  The relatedness heatmap was 
generated with principle components in R (ggplot2 package). A 4-way Venn diagram was 
generated using the 4,007 genes that were differentially regulated in any comparisons with 
online software: http://bioinformatics.psb.ugent.be/webtools/Venn/.  Disease associations 
were performed using DRSC Disease Gene Query Tool [328] (http://www.flyrnai.org/diopt-
dist).  The number of genes associated with various diseases were added together and 
ranked by total number of associated genes.  Unique genes associated with “Inflammatory 
Bowel Disease”, “Crohn’s Disease”, and “Ulcerative Colitis” were combined into one IBD list.  
If a zebrafish gene was orthologus to many human gene associated with the same gene, the 
zebrafish gene was counted only once for a given disease.  For example, fads2 has 3 
human othologs: FADS1, FADS2, and FADS3.  FADS1 and FADS2 are both associated 
with IBD but the gene family was only counted once.  
Mouse RNA-seq reads were aligned to the mouse genome (mm9) using TopHat 
v2.1.0 using de novo splice junction mapping with default settings).  Normalized fragments 
per kilobase of transcript per million mapped reads (FPKM) expression values were 
obtained for genes via Cufflinks, and pairwise differential gene expression tests were carried 
out with Cuffdiff v2.2.1.3 (Trapnell et al. 2012) using multi-read correct, bias correction and 
read group datasets.  The default significance threshold of FDR < 5% was used for each 
comparison.  To assess the association of differential DHS, H3K4me1 and H3K27ac and 
nearby gene expression differences in the presence and absence of a microbiota, we linked 
chromatin marks found within 10kb upstream or downstream of the nearest expressed gene 
(as defined by RNA-seq; minimum alignment count of 100 reads was used to determine 
detectable expression) transcription start site with that gene using GREAT version 3.0.0 
(Single nearest gene definition) for putative regulation.  The distributions of fold-change 
FPKM values in the presence and absence of a microbiota were compared to the 
distributions of all 9,173 expressed genes by a two-sided Kolmogorov-Smirnov test.  GO 
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enrichments were performed using DAVID 6.7 [326, 327].  IBD and NEC gene expression 
summary tables were derived from the published studies [237, 238, 297]. 
 
3.5.15 ChIP-seq and DNase-seq Bioinformatics: 
Mouse ChIP-seq were aligned to the mouse genome (mm9) using Bowtie2 v2.2.6 
with default settings.  ChIP peaks were called using the appropriate aligned input reads as 
the control file with MACS2 callpeak Galaxy version 2.1.0.20151222.0 with FDR <5% as the 
peak detection threshold.  Sequencing depth normalization was performed in two ways: 
DESeq was used for sequencing depth normalization, variance fitting, and pairwise 
differential analysis (Anders and Huber 2010) and bamCoverage (Galaxy version 2.2.3.0) 
using RPKM normalization.   
To identify differential H3K27ac and H3K4me1 sites, H3K27ac and H3K4me1 ChIP-
seq peak calls were merged using the same parameters as in DNase-seq analysis except 
using a FDR < 1%.  Raw counts were pulled from BAM files and used for calling differential 
peaks using R packaged DESeq2 v1.10.1 [329].  Motif enrichment in promoters near 
differential H3K27ac regions were generated using the single nearest gene definition in 
GREAT v3.0.0 and limiting the regulatory domain to 10kb. Heatmaps and average signal 
graphs were generated by aligning the average signals around MACS2 peaks from 
differential H3K27ac regions (Supplemental Figure 3.S4F) or median number of MACS2 
called peaks of condition/ChIP: Supplemental Figure 3.S4G,H (CV DHS), Figure 3.4A,B (GF 
HNF4A-ChIP replicate), Supplemental Figure 3.S6A (CV HNF4A-ChIP replicate), 
Supplemental Figure 3.S6C (CV HNF4A-ChIP minus GF HNF4A-ChIP).  Peaks generated 
from sequencing noise were omitted from these analyses by MACS2 or manually.  Gene 
associations for GF and CV HNF4A peaks were generated using the replicate with the 
largest number of MACS2 called peaks using the single nearest gene definition in GREAT 
v3.0.0 and limiting the regulatory domain to 10kb.  Repeat masked FASTA sequences 
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extracted from the noted regions were submitted for de novo transcription factor binding site 
analysis using MEME-suite (Figure 3.3E,F).  Specific transcription factor binding site 
analysis (Figure 3.4D) was performed using HOMER2.  The hierarchal clustering and 
heatmap representation of PWM enrichment was generated with Cluster v3.0.  Deming 
linear regression analysis was used to determine significant increases in H3K27ac, 
H3K4me1, and DNase-seq signal around HNF4A binding sites.  Pairwise comparison of 
ChIP-seq signal (Supplemental Figure 3.S5) from individual replicates was performed by 
generating read counts as determined by HTSeq Galaxy Version 0.6.1.galaxy1 [330] using 
intersection (nonempty) and non-stranded parameters with a minimum alignment quality of 
10. Reads were counted at MACS2 peaks from the GF3 replicate (GFrep3) and GF4 
(GFrep4) replicate for HNF4A and HNF4G respectively.  
Mouse DNase-seq reads were aligned using Bowtie version 0.12.0, with 2 mismatches 
allowed and mapping up to 4 sites.  The output BAM files were transformed to bed files.  
Blacklist regions and PCR artifacts were then filtered from bed files.  DNase hypersensitivity 
sites narrow peak calls were generated from MACS2 (version 2.1.0.20140616, 
https://github.com/taoliu/MACS/), with FDR <1%.  To identify differential DHS sites, DHS 
peak calls for each condition were merged and windowed as described in ChIP-seq 
analysis. Raw sum counts for each base-pair’s DNase-seq signals within each 300 bp 
window from each replicates were input into R package DESeq2 v1.10.1[329] and 
differential peaks were identified using FDR <5% (no differential peak calls found) and p < 
1%.   
 
3.5.16 Bioinformatic and Statistical analysis: 
Sample sizes for zebrafish experiments (noted in figure legends) were selected 
based on genotype availability and transgenesis efficiency. All sample collection was 
performed two or more times on independent days. For sequencing experiments, statistical 
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calls for differential gene expression were made by Cuffdiff2 using parameters stated above 
[331]. For the zebrafish RNA-seq experiment Next-Gen sequencing was performed once 
and at the same time to avoid batch effects: WTGF and WTCV (n = 3); MutGF and MutCV 
(n = 2). We originally collected n = 3 MutGF and MutCV biological replicates, however, using 
pre-established criteria and to avoid RNA contamination, we excluded one biological 
replicate from all analysis from these groups because of sequencing reads that mapped 
within the deleted hnf4a exon in the hnf4a-/- genotype.  
GF mice were randomly chosen by gnotobiotic staff for microbiota colonization (CV) 
based on their availability and litter sizes. All sample collection was performed two or more 
times per condition on independent days. GF and CV mouse samples were collected on 
different days. For sequencing experiments, statistical calls for differential gene expression 
and differential peak calls were made by Cuffdiff, MACS2, and DSseq2 using parameters 
stated above [329, 331-333]. For the mouse RNA-seq experiment Next-Gen sequencing 
was performed once and at the same time to avoid batch effects: GF (n = 2) and CV (n = 2). 
Paired GF and CV ChIP and library amplification was performed simultaneously. Typically, 
biological ChIP replicates were sequenced on different days and were always paired with 
the other condition (i.e. CV and GF were always sequenced together). The number of 
biological ChIP replicates (noted in figure legends) was dependent on reproducibility 
between ChIP samples and/or our ability to determine statistical differential sites using 
DESeq2 (for H3K4me1 and H3K27ac).  
 All statistical metrics (except where otherwise noted) were performed in Graphpad 
Prism 7.01. Deming linear regression was used for Figure 3.5 because it is a stronger and 
more accurate assessment of correlation when both the x and y variables have experimental 
error. Details regarding the other statistical tests used in this study can be found in the figure 
legends or above. 
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3.6 Data Access 
Transcription factor ChIP-seq, Histone ChIP-seq, DNase-seq and RNA-seq datasets 
have been submitted to the NCBI Gene Expression Omnibus (GEO; 
http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE90462. More supplemental 
tables are accessible on the Genome Research website. 
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3.8 Supporting Information 
 
Figure 3.S1: The hnf4 family of transcription factors bind specifically to a microbiota 
suppressed zebrafish enhancer. (A) Schematic showing the molecular mechanism of the yeast-1-
hybrid assay.  A library of 148 zebrafish transcription factors was transformed into a yeast strain that 
contained a reporter construct that contained the zebrafish CRR in3.4.  If one of the zebrafish TFs 
bound to in3.4, the reporter gene will be transcribed and the yeast will grow on media containing the 
antibiotic Aureobasidin A (Aba). (B) Scanned plates from the primary yeast-1-hybrid (Y1H) screen 
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that identified hnf4b (red circle) as the only transcription factor that robustly rescued yeast growth on 
the selective media.  hnf4a and hnf4g were not included in the initial 148 TF library. After cloning 
these TFs into the prey vectors, we found that all three Hnf4 family members bound to the in3.4 bait 
sequence and drove expression of the reporter gene (Figure 3.1B).  Gata6 is used as a control since 
it is predicted to bind in3.4, but does not rescue yeast growth. However, this TF family failed to rescue 
yeast when in3.4 was replaced with a canonical p53 binding site control bait sequence, suggesting a 
sequence specific interaction (data not shown). (C) Single nucleotide site-directed mutations (SDM) 
within Site 1 and Site 2. The selected nucleotides were predicted to impact Hnf4 binding. The 
nucleotide mutation is highlighted in a color for each SDM. Using mammalian position weight 
matrices (PWMs), we found HNF4 is predicted to bind both regions previously shown to be essential 
for intestinal reporter expression (Figure 3.1A). To test if these putative binding sites are the location 
of Hnf4 binding and essential for reporter activity, we performed site-directed mutagenesis on 
individual nucleotides within the predicted Hnf4 binding sites (Figure 3.1C). (D) Images of plates from 
serial dilutions of a Y1H assay using WT and mutated in3.4 as bait and zebrafish hnf4 genes and 
gata6 as prey. Yeast were grown on media without the selective antibiotic to demonstrate equivalent 
CFUs were plated and on media containing AbA which inhibits yeast growth in the absence of an 
actively transcribed reporter gene.  Mutations in the first predicted binding site (Site 1) resulted in 
severe growth attenuation of yeast transformed with the hnf4g and hnf4b prey vectors.  However, 
yeast transformed with the hnf4a prey vector only had partial attenuated growth when harboring 
mutations in the Site 1 sequence. Strikingly, mutations in the second predicted binding site (Site 2) 
resulted in failed growth of yeast transformed with all three hnf4 prey vectors with the notable 
exception of Site 2.2, which only partially attenuated growth of yeast transformed with the hnf4a prey 
vector. (E) To test if the putative HNF4A site was essential for in3.4 enhancer activity, we generated 
new versions of the in3.4:cfos:gfp reporter which contained single nucleotide mutations in Site 1 or 2. 
These reporter constructs were injected into wild-type zebrafish to generate mosaic transgenics. 
Single nucleotide mutations in Site 1 or 2 of the in3.4:cfos:gfp reporter were sufficient to ablate in3.4 
intestinal activity in zebrafish. Data shown in panels D and E establish that one or more Hnf4 family 
members bind in3.4 in a sequence dependent manner and that mutation of the predicted Hnf4 
binding sites of this microbiota-suppressed CRR result in suppressed enhancer activity in the 
intestinal epithelium. (F) Chart showing the GFP fluorescence (mean ± sem) in 6dpf mosaic zebrafish 
injected with transposase and WT (n =10) and SDM in3.4:cfos:gfp Tol2 vectors (n =9 and n = 17). 
Mean fluorescence was measured within the intestine of mosaic animals using a constant region of 
interest (ROI) (Kruskal-Wallis, Kruskal Wallis statistic = 20.26 and **** p < 0.0001). (G) HNF4 protein 
phylogenetic tree showing the evolutionary relationship of the Hnf4s across species. Dm. – 
Drosophila melanogaster, Dr. – Danio rerio, Mm. – Mus musculus, Hs. – Homo sapiens. 
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Figure 3.S2: hnf4a-43/-43 mutants survive to adulthood and have reduced hnf4a transcript and 
reduced intestinal lumen size. (A) Schematic showing the zebrafish hnf4a gene locus (splice form 
hnf4a-201) and the region that was targeted by the guide RNAs.  Exons are highlighted in solid blue 
blocks, untranslated regions are indicated by white blocks with blue outlines, and the CRISPR 
targeted region is indicated by the orange line. (B) DNA sequence showing the genomic region that is 
mutated in the hnf4a+25 and hnf4a-43 allele. (C) Amino acid sequence of human, mouse, and WT and 
mutant zebrafish Hnf4a proteins showing sequence conservation in the DNA binding domain and 
hinge domain.  The hnf4a+25/+25 and hnf4a-43/-43 mutations are predicted to result in truncated proteins 
in this highly conserved domain.  (D) Bar graph showing genotypes at the expected Mendelian ratios 
of progeny from an hnf4a+/-43 heterozygous incross at both 6dpf and adult stages (mean ± sem). (E) 
Bar graph showing the hnf4a relative mRNA expression (mean ± sem) from whole hnf4a+/+ (n = 4), 
hnf4a+/-43 (n = 4) and hnf4a-43/-43 (n = 4) 6dpf larvae (Two-tailed t-test, t = 4.79, 6.734, respectively and 
df = 6). (F) Bar graph showing the diameter of the intestinal lumen (mean ± sem) along the first 
segment of hnf4a+/+ (n = 9) and hnf4a-43/-43 (n = 8) 6dpf larvae (Two-tailed t-test, t = 2.56, df = 15 and 
p = 0.0219). 
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Figure 3.S3: Hnf4a maintains transcriptional homeostasis in the presence of a microbiota in 
zebrafish digestive tracts. (A) Principle components analysis (PCA) using a wide estimation method 
showing the relative similarities of mRNA-seq transcript abundances in digestive tracts from WTGF 
(Blue), WTCV (purple), MutGF (red), and MutCV (orange) 6dpf zebrafish.  (B) Discriminant analysis 
using wide linear parameters plot showing the relative similarities and statistical groupings of mRNA-
seq transcript abundances in digestive tracts from WTGF (Blue), WTCV (purple), MutGF (red), and 
MutCV (orange) 6dpf zebrafish.  The inner ellipse of each group signifies the 95% confidence interval 
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to contain true mean of that group and the outer ellipse signifies 50% of the population within the 
group is contained within ellipse. (C) Heatmap showing the relative similarities of mRNA-seq 
transcript abundances in digestive tracts from WTGF (Blue), WTCV (purple), MutGF (red), and 
MutCV (orange) 6dpf zebrafish. (D) Heatmaps referred to in Figure 3.3B showing the log2 (FC) 
relative expression of sublists of differentially regulated genes.  The top 5 enriched GO terms and top 
5 enriched KEGG pathways for each sublist of genes is included to the left of each heatmap.  The 4 
columns are: WTCV/WTGF, MutCV/MutGF, MutCV/WTCV, and MutGF/WTCV, respectively. (E) 
Heatmap showing the Log2 (FC) relative expression of 86 genes that have an exacerbated microbiota 
induction in the hnf4a-/- digestive tracts.  The GO term enrichment for this set of genes is included to 
the left of the heatmap.   
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Figure 3.S4: HNF4A and STAT1 binding sites are enriched with within promoters of microbiota 
suppressed and induced genes, respectively. (A) MA plots from DESeq2 analysis of DNase 
hypersensitivity from GF and CV mouse jejunal IECs.  Colored dots signify regions enriched for a 
histone mark in GF (blue) or CV (orange) jejunal IECs. We detect 162 unique DHSs in GF and 1,424 
unique DHS in CV. These results were generated using a less stringent significance test (p < 0.01) 
rather than FDR < 0.01 utilized in our other comparisons in this study, therefore, we are less confident 
in these results.  Using a FDR cutoff of < 0.01, none of these regions are significantly different. (B) 
Volcano plots showing pairwise comparison of RNA expression between GF and CV jejunal IECs.  
Blue and orange dots represent genes associated with a region enriched for DNase signal in GF or 
CV, respectively.  (C) Two-sided Kolmogorov-Smirnov goodness-of-fit test shows a positive 
relationship between the presence of a DHS in a specific colonization state and increased transcript 
abundance in that same colonization state.  The y-axis shows the cumulative fraction of genes linked 
to microbiota induced DHSs.  Deviation from the null expectation that linked genes display a normal 
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distribution on a fold change of 1 (black line) suggests that microbiota induced DHSs are enriched 
near genes of higher expression upon microbiota colonization.  Though the Kolmogrov-Smirnov test 
may not be sufficient for such a small number of sites, these results suggest that IEC gene 
expression responses to microbiota are not explained by changes in chromatin accessibility. (D) 
Representative signal track highlighting a microbiota induced gene associated with a CV-specific 
DHS and regions enriched for H3K4me1 and H3K27ac CV (Ifi44, Interferon induced protein 44). Bar 
graphs showing the enrichment for specific TF bindings sites within promoters for genes associated 
with increased H3K27ac regions in GF (E) or CV (F). (G) Heat maps of the replicate average DNase 
signal, H3K27ac signal, and H3K4me1 signal at individual CV DHS sites. Despite the MA plots 
indicating an increase in DNase-seq signal in CV conditions (Fig.3A and Supplemental Figure 3.S4A), 
we find these heat maps do not show this trend. (H) Line plots showing the average GF (light-colored 
line) and CV (dark-colored line) -seq signal for the indicated TF, histone mark or DHS at the 1000 bp 
flanking DHS sites found in CV. The average DNase-signal at all DHS sites is significantly increased 
in GF compared CV. Similarly, the average H3K27ac signal at these DHS sites shows a significant 
increase in H3K27ac signal in GF compared to CV by the Whitney-Mann U test. We do not see this 
trend in H3K4me1.  The tentative discrepancies in results between the MA plots and average signal 
plots can be explained by inherent differences in DESeq2 and average signal analysis. DESeq2 
performs a powerful statistical test to determine differential signal and therefore is a more ideal type 
of analysis to identify enrichment of DHS or histone marks based on variation and average signal of 
replicates within a set window. We performed the second type of analysis which shows the average 
signal at a given base pair relative to the center of a ChIP peak because DESeq2 would be an 
inappropriate analysis for downstream applications in which the GF conditions had an overwhelming 
signal compared to CV (i.e., HNF4A and HNF4G ChIP-seq, Figure 3.4). Instead, we find this second 
type of analysis is only useful when comparing the signals or relative signals from the same condition 
at two different sets of genomic locations (see Supplemental Figure 3.5F,G). Furthermore, the 
average number and median number of DHS sites, H3K27ac peaks and H3K4me1 peaks as 
determined by MACS2 were similar between GF and CV conditions; this was not true for HNF4A or 
HNF4G peaks (Supplemental Table 2). Based on our stringent DESeq2 analysis (FDR < 0.01) and 
because of the similar number of MACS2 peaks, we do not believe the average H3K27ac and DHS 
signal differences at DHS sites between CV and GF conditions is biologically or technically relevant to 
our conclusions. (I-J) GO terms and KEGG pathways enriched in genes associated with differential 
H3K4me1 sites shown in Figure 3.3I. 
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Figure 3.S5 HNF4 GF ChIP-Seq replicates have reproducibly higher signal than HNF4 CV Chip-
seq replicates. (A) Grouped pairwise comparison of all HNF4A ChIP-seq signal at HNF4A binding 
sites compared to GFrep3 (third HNF4A GF replicate).  (B) Individual pairwise comparison of HNF4A 
ChIP-seq signal at binding sites compared to GFrep3 (third HNF4A GF replicate) or CVrep3 (third 
HNF4A CV replicate).  (C) Grouped pairwise comparison of all HNF4G ChIP-seq signal at HNF4G 
binding sites compared to GFrep4 (fourth HNF4G GF replicate).  (D) Individual pairwise comparison 
of HNF4G ChIP-seq signal at HNF4G binding sites compared to GFrep4 (fourth HNF4G GF replicate) 
or CVrep4 (fourth HNF4G CV replicate).  The correlation coefficient (r) is provided for each graph. We 
believe the HNF4G CV r value was substantially lower than the other reported HNF4A and HNF4G 
correlation coefficients because of the very low signal-to-noise ratio among these replicates.  
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Figure 3.S6: Microbiota suppress HNF4A and HNF4G activity without overtly impacting protein 
levels or localization. (A) Line plots showing the average GF HNF4A (light-colored line) and CV 
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HNF4A (dark-colored line) -seq signal at the 500 bp flanking HNF4A sites found in CV. We chose to 
forgo DESeq2 analysis with the HNF4 ChIP samples because of the obvious signal bias toward GF 
conditions would skew the results and fail to provide useful statistical significances. We therefore 
performed all subsequent downstream analyses using average signal surrounding ChIP peaks. (B) 
Top 10 GO terms and top 10 KEGG pathways for genes associated with CV HNF4A sites.  These 
enrichments indicate CV retains HNF4A binding near genes that are associated with canonical 
HNF4A and intestinal function. (C) Line plots showing the average GF HNF4A (light-colored line) and 
CV HNF4A (dark-colored line) -seq signal at the 500 bp flanking “Unique” HNF4A sites found in CV 
based on MACS2 peaks and peak coordinate intersections. (D) Bar graph of CTCF ChIP-PCR results 
at different loci (n = 2 per condition).  Loci were chosen based on publically available mouse intestinal 
CTCF tracks on the UCSC genome browser.  The relative CTCF enrichment at Agrp, Inf2, Rilp, 
Slc44a3, and Cyp3a11 loci was normalized to CTCF signal at the Neurog1 locus (negative control). 
Loci were chosen based on publically available intestinal CTCF ChIP-seq tracks on the UCSC 
genome browser These ChIP-seq tracks show CTCF binding at Agrp, Inf2, Rilp, and Slc44a3 loci but 
not at Cyp3a11 nor Neurog1 loci. (E) Two-sided Kolmogorov-Smirnov goodness-of-fit test shows no 
relationship between the presence of an HNF4A site in GF (blue) or CV (orange) and increased 
transcript abundance in that same colonization state.  Our zebrafish RNA-seq data predict that 
HNF4A directly or indirectly regulates both microbiota suppressed and induced genes. In accord, we 
did not find an overt association with HNF4A binding sites and microbiota suppressed or induced 
genes. (F) Line plots showing the average signal of GF (blue) and CV (orange) HNF4A ChIP-seq 
RPKM-normalized signal at the 500 bp flanking HNF4A peaks associated with microbiota-suppressed 
genes (solid) and microbiota-induced genes (dotted). Statistical measurements were performed using 
a two-tailed Mann-Whitney test. (G) Deming linear regression of the average GF and CV ChIP/DHS 
signals at HNF4A sites and DHS sites. To determine if histone marks correlate with the loss of 
HNF4A signal in CV conditions, we aligned the average histone ChIP signals and DHS signals to the 
28,901 GF HNF4A sites. As expected, we found both GF and CV H3K27ac and H3K4me1 signals 
were enriched on the flanks of the HNF4A peaks while DHS signal was enriched near the center of 
the HNF4A peaks (Figure 3.4A,B). Interestingly, we observed that colonization resulted in a reduction 
in H3K4me1 signal at HNF4A sites, a trend we did not see when comparing signals at all DHS sites 
(Fig.4B and Supplemental Figure 3.S4H). Active CV enhancer signals and CV DHS signals were also 
reduced at HNF4A sites (Fig.4B). However, the average signals of these genomic marks were 
already reduced upon colonization at DHS sites (Supplemental Figure 3.S4H). Therefore, to 
determine if the presence of an HNF4A site corresponded to a reduction in enhancer activity or 
chromatin accessibility upon microbiota colonization, we performed Deming linear regression.  If the 
slopes of the Deming linear regression are significantly different, we can conclude that the relative 
signal at the two different sets of genomic locations is significantly different. We found that HNF4A 
sites correspond with increased H3K27ac, H3K4me1 and DHS signal in GF compared to these same 
chromatin marks in CV. (H) Western blots of HNF4A and HNF4G from GF and CV mouse jejunal 
IECs. B-actin was used as a loading control. (I) Representative confocal immunofluorescence (n = 2 
per condition) optical section of wholemount GF and CV mouse jejunal villi stained for phalloidin (red), 
HNF4A/HNF4G (green) and DAPI (blue). (J) Heat maps and line plots of showing the average GF 
and CV HNF4A ChIP-signal from primary mouse jejunal IECs (blue) and the single replicates of 
control and DSS-treated HNF4A ChIP-signal from primary colonocytes. When we assessed the 
average GF and CV jejunal HNF4A signals at the colonic HNF4A peaks from this previous study, we 
observed jejunal HNF4A signal at the majority of colonic peaks and reduced CV HNF4A averaged 
signal compared to GF. This finding reveals that the HNF4A cistrome in the small and large intestine 
is remarkably similar, and that HNF4A occupancy at many of these sites is similarly reduced by 
microbiota and inflammation.  
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Figure 3.S7: Model of microbiota regulation of host gene transcription through modification of 
enhancer activity and suppression of HNF4A DNA binding. A model depicting the key findings 
from the manuscript. Microbiota-suppressed H3K27ac and H3K4me1 marks (microbiota-suppressed 
enhancers) are significantly enriched near genes that are downregulated by the microbiota. 
Microbiota-induced H3K27ac and H3K4me1 marks (microbiota-induced enhancers) are significantly 
enriched near genes that are upregulated upon microbiota colonization. Also, following microbiota 
colonization, HNF4A DNA binding is reduced across the genome. This reduced occupancy occurs 
near genes that are both microbiota-induced and microbiota-suppressed genes. GATA factor binding 
sites are located near HNF4A binding sites that associate with microbiota-suppressed genes and 
microbiota-suppressed enhancers. ETS factor binding sites are located near HNF4A binding sites 
that associate with microbiota-induced genes and microbiota-induced enhancers. 
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Supplemental Table 1: Primers and 
Oligos 
   
Primer name Sequence 
   
ChIP-PCR Primers 
    
Genomic 
Location 
Agrp_CTCF_F CAAGGAGTACGCCGCAAGAAGTG 8:105622531-
105622553 
Agrp_CTCF_R CCACAACCTAAAGTTGCTTCTTGAG 8:105622650-
105622674  
Slc44a3_CTCF_F CTCAAAGGATCAAGGACTGCAG 3:121500329-
121500350  
Slc44a3_CTCF_R GATCTTGCCTGCACCAACACAG 3:121500449-
121500470  
Rilp_CTCF_F GAAGCCAAGAGACCGAAGCGGTGAG 11:75510719-
75510743 
Rilp_CTCF_R GATCAGCAGGAGGCGCTGTAGCTG 11:75510831-
75510854 
Inf2_CTCF_F GTAGCTACCATAGTCTTATCTAAG 12:112605998-
112606021  
Inf2_CTCF_R GCTGTCTTCCCTTGACTTGG 
 
12:112606087-
112606106 
Mm_Neurog1_F GGCTACATTTGGTCTTTATCC 13:56247085-
56247105 
Mm_Neurog1_R GTGGAGCCAAGCTAACAATTTGC 13:56247171-
56247193 
Mm_Apoa1_F CTAGGGAGTTGGGGAGTTTCCT 9:46227267-
46227288 
Mm_Apoa1_R TCTCTCAGCCTTAGAGGCAAGG 9:46227355-
46227376 
Mm_Angptl4_F ATCTAATCTACAGTCCATATTCCAC 17:33788903-
33788927 
Mm_Angptl4_R AGGGCATCAATGCAAAGTGCAGTG 17:33788988-
33789011 
Mm_Pck1_F CCAGGTTGCAGAAAGGAGTGTC 2:173138399-
173138420  
Mm_Pck1_R AGAATGTGGTAAACAGGACTCAAG 2:173138479-
173138502  
qRT-PCR Primers 
     
hnf4a2.1 F CAGTGTCGGTACTGCAGACTAAAG 
 
hnf4a2.1 R GTGAGCTCGCAGTAAAGCCACCTG 
 
hnf4b1.1 F AGACCGAGCCACTGGAAAAC 
 
hnf4b1.1 R CATGTGTAGGCATGGTTCTTG 
 
hnf4g2.1 F ATGAAGTTTTCTCCAACTCCTCTCC 
 
hnf4g2.1 R CTGCTGTGAAAGTGCTTCAGCGTGAGC 
saa F CGCAGAGGCAATTCAGAT 
  
saa R CAGGCCTTTAAGTCTGTATTTGTTG 
 
gfp F GAAGAAGTCGTGCTGCTTCA 
 
gfp R CCTGAAGTTCATCTGCACCA 
  
angptl4 F CGAGCGCATCAAGCAACA 
  
85 
 
angptl4 R TCGCTCGTTTTTCATCGTAATCT 
 
ifabp F TGCCCATGACAACCTGAAGA 
 
ifabp R GTTAATTTCCAGTGTGCGGAAAG 
 
18S F CACTTGTCCCTCTAAGAAGTTGCA 
 
18S R GGTTGATTCCGATAACGAACGA 
 
elf1a F CTTCTCAGGCTGACTGTGC 
  
elf1a R CCGCTAGGATTACCCTCC 
  
Primers for Yeast-1-Hybrid 
Screen 
    
in3.4 F AAAAGAGCTCCCTTGTAGGCTGTTGGAAATAC 
in3.4 R AAAACTCGAGACTGAAAGACACAAACACA 
hnf4a_pENTR F CCGCCCCCTTCACCATGGAGATGGCAGACTATAGCGAG 
hnf4a R TCGGCGCGCCCACCCTTTCAGATGGCCTCTTGTTTAGT
G 
hnf4g F CCGCCCCCTTCACCATGGATGTAGCCAATTACTGCGA 
hnf4g R TCGGCGCGCCCACCCTTTCATAGCGGGGGCTCCGGAG
A 
Oligos for guide RNAs 
     
hnf4a_gRNA F 1 TAGGGCACCAGAAGATCCAGCTATG 
 
hnf4a_gRNA R 1 AAACCATAGCTGGATCTTCTGGTGC 
 
hnf4a_gRNA F 3  TAGGGTAAGCTGCTGTCCTCATAGC 
 
hnf4a_gRNA R 3 AAACGCTATGAGGACAGCAGCTTAC 
 
hnf4a_gRNA F 4 TAGGGTCCTCATAGCTGGATCTTC 
 
hnf4a_gRNA R 4 AAACGAAGATCCAGCTATGAGGAC 
 
Primers for Hnf4a mutation screening 
   
hnf4a_Cris_checkF TGATTCACACTACTTACTTGTCTAG 
 
hnf4a_Cris_checkR GATTAAAAGTAGTTATCTCATCCTCAG 
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Supplemental Table 2: Total number of MACS2 peak calls per ChIP per replicate  
 
Number of peaks indicated are raw results generated from MACS2 and peaks generated by 
background signal/noise have not been filtered out.  All peaks generated by background 
sequencing noise were removed manually for downstream analysis.  
 DHS H3K4me1 H3K27ac HNF4A HNF4G 
GF rep 1 89,507 132,275 82,935 36,850 12,465 
GF rep 2 61,355 131,876 83,336 27,016 35,302 
GF rep 3  137,770  29,070 15,934 
GF rep 4     27,816 
CV rep 1 70,794 139,559 83,661 1,889 101 
CV rep 2 52,431 144,137 81,997 8,473 18 
CV rep 3 42,433 146,199  4,195 27 
CV rep 4     106 
GF Average 57,485 133,974 83,136 30,979 22,879 
CV Average 55,219 143,298 82,829 4,852 63 
GF Median 57,485 132,275 83,136 29,070 21,875 
CV Median 52,431 144,137 82,829 4,195 64 
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CHAPTER 4: PROSPECTUS
 
4.1 Introduction 
The microbiota contribute to human physiology by facilitating energy harvest, tuning 
metabolic programs, and promoting immune system development. In addition to these 
important roles in health, intestinal microbiota have been implicated in a growing number of 
human diseases associated with loss of intestinal epithelial identity, like cancers and 
inflammatory bowel diseases [221, 284]. However, these diseases represent extreme 
circumstances and do not reflect the normal symbiotic relationships that have been 
maintained between animals and their microorganisms for over 650 million years. From an 
evolutionary perspective, the presence of microbiota is a normal part of the animal’s life 
cycle, and physiological states have evolved to assume the presence of microbes. 
Extensive research has identified microbial factors and aberrant host responses that impair 
intestinal epithelial function. Similarly, thought the impact of the microbiota on host IEC 
transcriptomes and their downstream consequences have been extensively documented, 
the upstream transcriptional regulatory mechanisms remain poorly understood. Recently, 
this gap in knowledge has started to be filled with both my work and others that have 
identified differences in histone modifications following microbiota colonization [141, 142, 
334]. However, my work is the first to show the impact of microbiota colonization on the 
binding activities of a transcription factor. This finding has provided a novel genomic 
mechanism for understanding how the microbiota tune intestinal epithelial cell transcription 
programs and provides a potential model for how dysregulation of these same transcription 
programs may lead to human disease.  
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The identification of HNF4A as a novel transcription factor that mediates the 
epithelia’s response to the microbiota provides new insight into nuclear receptor biology, 
host-microbiota interactions and intestinal pathophysiology. However, my work only provides 
a genomic mechanism for the host response. That is, I only show that genome wide, HNF4A 
activity is suppressed. We still do not understand the signaling mechanisms that mediate 
HNF4A activity. Since HNF4A is a nuclear receptor, does microbial colonization result in 
changes in ligand availability? Does PRR signaling regulate HNF4A DNA binding? These 
are questions we are now poised to address, but due to complexity of nuclear receptor 
regulation, they were beyond the scope of my initial effort in characterizing mechanisms of 
transcriptional control. We first needed to identify a candidate transcription factor that 
mediates epithelial response. The identification of HNF4A as a regulator of the host 
response is profound. Loss of HNF4A function and the microbiota are both linked to human 
diseases like metabolic syndrome and IBDs. Further, HNF4A is the most ancient of the 
nuclear receptor transcription factors, so framing this transcription factor in a new role could 
provide insight into the evolution of nuclear receptor biology and host-microbiota 
interactions. 
 In this last chapter of my dissertation, I discuss several possible mechanisms that 
may mediate HNF4A activity. I speculate how suppression of HNF4A is advantageous to the 
host and to some extent the microbiota. I speculate how human disease pathology may be 
determined by microbial suppression of HNF4A. Finally, I speculate on the evolution of the 
nuclear receptor superfamily as novel mediators in the host response to the microbiota. 
 
4.2 Models of microbiota suppression of HNF4A activity: 
Previous in vivo and cell culture studies indicate HNF4A serves as both an activator 
and repressor of target gene transcription. In the third chapter of this dissertation, we 
learned that HNF4A binds at loci of both microbiota-suppressed and microbiota-induced 
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genes. And we learned that microbiota colonization is associated with loss of HNF4A 
occupancy on the genome. Therefore, HNF4A may activate microbiota-suppressed genes 
and may repress microbiota-induced genes. Transcription factors commonly have bimodal 
functions, like HNF4A, where they both activate and repress transcription [335]. These 
different modes are sometimes governed by cofactor binding that designate the transcription 
factor as a repressor or activator at a locus [336]. However, the kinetics of transcription 
factor binding can also mediate repressor or activator assignment. For instance, RAP1, a 
well-studied yeast transcription factor, occupies several different loci on the yeast genome. 
However, the kinetics of RAP1 binding differ at these loci. These kinetic properties of RAP1 
binding are associated with repressor or activator assignments. RAP1 may “treadmill” at 
genes it represses, meaning it has short residency time on the DNA [337]. However, RAP1 
has long residency at genes it activates. By conventional ChIP, these two modes of function 
are associated with approximately the same occupancy signal. A technique called 
“competition-ChIP” reveals kinetics of DNA binding and the kinetic associations with 
repressor vs activator assignments [338].  
Perhaps, HNF4A adopts a “treadmilling” mode of function at microbiota-induced 
genes and maintains a long DNA residency at microbiota-suppressed genes (further 
discussed below under 4.2.2). Whatever mode of function HNF4A initiates across the 
genome, microbiota colonization is associated with loss of HNF4A genome occupancy and 
thus trans-activity (either repressor or activator). However, the mechanism that mediates this 
loss of HNF4A occupancy remains unknown. Do microbes affect HNF4A activity through a 
microbial-derived metabolite/molecule that directly binds and blocks HNF4A function? Or 
does the upregulation of TLR signaling following microbiota colonization result in loss of 
HNF4A function? Perhaps HNF4A activity is suppressed by the microbiota indirectly through 
a reshaping of the metabolic programs. Below I explore several models that describe how 
the microbiota may suppress HNF4A.  
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4.2.1 Ligand binding: 
The HNF4A ligand binding domain contains a single fatty acid (although other papers 
have demonstrated it may also bind flavonoids [339]). Originally labeled as an orphan 
receptor, in non-physiological conditions, researchers have found HNF4A can bind several 
different species of long chain fatty acids [308]. Although these putative ligands may be valid 
HNF4A ligands, their role in controlling and mediating HNF4A activity in physiological 
conditions remains unknown. In the mouse liver, HNF4A binds linoleic acid (C18:2) almost 
exclusively [316]. Some papers have suggested linoleic acid may suppresses HNF4A 
activity in cell culture lines [316, 340]. However, linoleic acid does not suppress transcription 
of HNF4A target genes, like fabp2, in the Germ free (GF) zebrafish intestine (data not 
shown), suggesting dietary linoleic acid does not suppress HNF4A activity. However, similar 
to how cofactors regulate transcriptional activity, ligand binding may provide a mechanism 
for controlling HNF4A. Perhaps different fatty acid ligands tune HNF4A activity so that small 
conformational adjustments on the protein modify the affinity for the same binding site. 
Perhaps conformational changes impact HNF4A’s ability to bind DNA altogether or inhibit its 
ability to form homodimers, a necessary step for trans-activity. Specific taxa within the 
microbiota express proteins called linoleic acid isomerases. This family of enzymes edits the 
location of the double bond in linoleic acid, generating a new isomer of LA (18:2; 9-cis, 12-
cis) called conjugated linoleic acid (CLA – 18:2; 9-cis, 11-trans and 18:2,10-tras, 12-cis). 
Importantly, even though this fatty acid has the same atomic makeup, the location of the 
double bonds and the double bond isomer (i.e. cis vs trans) greatly impact the structure of 
the fatty acid. It remains to be determined if HNF4A binds CLA. However, if HNF4A can bind 
both CLA and LA independently, these fatty acids will likely fill the ligand binding pocket 
differently due to their differences in chemical structure. Thus, HNF4A may need to change 
confirmation to bind CLA versus LA which may modify its activity (Figure 4.1A). It is also 
certainly possible that the microbiota regulate HNF4A activity through the modification of 
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other putative ligands like flavonoids which are known to modulate microbiota composition 
[341]. 
For an unbiased approach to identify if the microbiota impact the FA species bound 
by HNF4A, I recommend performing GC/MS on organic compounds isolated from 
immunoprecipitated HNF4A from gnotobiotic mouse IECs. My initial attempts at performing 
these experiments failed but similar experiments from mouse liver provide a blueprint for 
success [316]. The major limiting factor for performing these experiments is the starting 
material. To detect the ligand, the fatty acid should ideally be at a concentration of 50 ng/mL 
(personal correspondence with George Dubay at Duke University). Assuming a 1:1 
stoichiometry between HNF4A and the fatty acid (meaning HNF4A binds only one ligand at 
a time), pulled down HNF4A concentration must be 9.4 ug/mL (based on the molecular 
weight of HNF4A and LA: 52,785 g/mol and 280 g/mol respectively). Previous published 
experiments used 3 mouse livers for each pull down to concentrate HNF4A to a sufficient 
level [316]. Therefore, based on the number of cells isolated during an IEC extraction, I 
predict we would need approximately 3 – 4 gnotobiotic mice for a single replicate to perform 
the equivalent experiment from isolated jejunal IECs. Pilots of this experiment could be 
performed with thin-layer chromatography (TLC). If HNF4A binds different ligands in germ 
free and colonized conditions, these fatty acids may migrate at different speeds with the 
correct organic solutions. However, due to the similar chemical structures, TLC is not an 
appropriate assay to address the LA and CLA hypothesis). Another key aspect for success 
with these experiments is the efficacy of the antibody used for the immunoprecipitation. 
Antibody choices will be discussed in a future section under post-translation modifications. 
I also propose three experimental models that test if different fatty acids have the 
capacity to suppress or modify HNF4A activity: 1) Perform qPCR from zebrafish that have 
been fed a single fatty acid species, like oleic acid (18:1), LA (18:2) or CLA (18:2). This 
experiment may identify if HNF4A target genes are differentially transcribed during feeding 
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with these various fatty acids. 2) Perform ChIP-PCR or ChIP-seq from gnotobiotic mice that 
have received an oral gavage of CLA or another fatty acid species. This experiment may 
identify if HNF4A binding at specific locations on the genome is impacted by specific fatty 
acids. 3) Test the HNF4A activity in the presence of different fatty acids in a quantitative 
Yeast-1-Hybrid (Y1H) assay. I have piloted this experiment in the original Y1H system that 
identified HNF4A as a potential microbiota-regulated host transcription factor. However, 
incubating yeast with LA, OA, or CLA conferred resistance to the antibiotic and increased 
the noise of the assay. Instead, I recommend an assay that utilizes a luciferase reporter 
instead of antibiotic resistance. The luciferase reporter will provide more quantitative 
measurement of HNF4A activity in the presence of different fatty acids. All three of these 
experiments may provide new insight into how HNF4A responds to specific putative fatty 
acid ligands. Unlike the proposed GC/MS experiment, these fatty acid feeding experiments 
are biased and will not inform us if the microbiota impact HNF4A ligand binding. Rather, 
these experiments provide a potential model for how the microbiota mediate HNF4A activity. 
 
4.2.2 Splice form abundances:  
In humans, the HNF4A gene encodes 9 different splice forms [342]. Expression of 
these different splice forms is driven by two promoters (P1 and P2). HNF4A splice form 
variation and the mutations within the possible splice forms contributes to human disease 
pathology including Crohn’s disease and diabetic phenotypes [290, 343]. The different splice 
forms differ in transcriptional activity and modes of coactivation. For instance, splice forms 
transcribed from the P1 promoter include the “AF-1 domain”, a conserved n-terminal domain 
found in several members of the nuclear receptor super family. This domain regulates 
cofactor binding and increases trans-activation potential [344]. Therefore, HNF4A splice 
forms transcribed from the P1 promoter may interact with different coactivators than splice 
forms transcribed from the P2 promoter [345].  
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The antibody that I used in my studies for ChIP only detects HNF4A splice forms 
transcribed from the P1 promoter. However, the antibody I used in the western and 
immunofluorescence data detects all possible splice forms. Therefore, the ChIP data only 
represent a subpopulation of HNF4A and the western and immunofluorescence data 
includes all possible HNF4A splice forms. Perhaps the microbiota suppress transcription of 
Hnf4A at P1 by activating a known repressor of the P1 promoter, SREBP2 [346]. Or, 
perhaps the microbiota induce HNF1A activity, a known activator of transcription at the P2 
promoter [347] (Figure 4.1F). However, my current data do not support these hypotheses. 
DEX-seq analysis of RNA-seq data from GF and CV mouse IECs indicate there in no 
difference in exon bias between GF and CV mice at the HNF4A gene locus. Perhaps the 
downregulation happens at a protein level. However, the western and immunofluorescence I 
performed in chapter 3 do not indicate reduced protein levels upon colonization. Perhaps 
different transcriptional cofactors become available upon colonization and preferentially 
activate P2 isoforms. To test if P2 isoforms preferentially occupy HNF4A binding sites on the 
genome upon microbiota colonization, I recommend performing ChIP-seq using an antibody 
that recognizes all possible isoforms. The initial polyclonal antibody I tested for the ChIP-seq 
experiments detects all isoforms, however this antibody failed to immunoprecipitate HNFA. I 
therefore chose a monoclonal antibody that only detects 6 HNF4A isoforms, but had been 
previously shown to successfully immunoprecipitate HNF4A from intestinal epithelia. 
Finally, microbiota colonization may promote “treadmilling” activity of HNF4A splice 
forms. If HNF4As transcribed from promoters 1 and 2 begin to compete for the same binding 
site, the conventional ChIP I performed would only detect P1-splice-form DNA-binding and 
therefore HNF4A occupancy would appear reduced. It would be interesting to perform true 
competition ChIP by using a ChIP antibody for P1 splice forms and a second antibody for P2 
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splice forms. These data would provide a new level of insight on HNF4A DNA binding 
kinetics that have never been attempted, let alone in a gnotobiotic setting.  
 
Figure 4.1: Six possible mechanisms that regulate suppression of HNF4A activity associated 
with microbiota colonization. (A) The first model predicts that the microbiota modify the 
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endogenous ligand of HNF4A from linoleic acid (LA) to conjugated linoleic acid (CLA). Because CLA 
is structurally unique from LA, HNF4A may need to change protein confirmation to bind it and as a 
result be incapable of binding DNA. (B) The second model predicts HNF4A might be phosphorylated 
by PKA, PKC or the MAPK pathway following activation of transmembrane receptors that activate 
these kinases. For instance, TLR4 signaling may initiated a MAPK signal transduction, or TNFa or 
IFNg might activate their corresponding receptors to which may activate these kinases. 
Phosphorylation of HNF4A reduces its potential to activate transcription. (C) The third model predicts 
microbiota colonization results in a rewiring of fatty acid handling within the intestinal epithelial. 
Instead of being consumed by the cell for energy via beta-oxidation, the cell may preferentially 
package dietary fatty acids in triglycerides and store them. Therefore, the fatty acids are unavailable 
to serve as ligands for HNF4A. Active beta-oxidation may increase the availability of fatty acids for 
HNF4A to bind and thus increase its potential for transcriptional activation. (D) The liver and skeletal 
muscle of GF mice have increased activated-AMPK compared to CV mice. The fourth model 
assumes that IECs also have increased activated-AMPK levels in GF mice. This increase in AMPK 
activity may result in increased PGC-1A activity, a known target of AMPK. PGC-1A is a known 
coactivator of HNF4A. Therefore, upon microbiota colonization, HNF4A-mediated transcriptional 
activation might be reduced due to reduced AMPK and thus PGC-1A activity. (E) The fifth model 
predicts that HNF4A is replaced by other transcription factors on the genome in complex with known 
corepressors, like NCORs.  It similarly suggests that HNF4A complexes with NCORs at microbiota 
induced-genes, which might indicate why these genes are suppressed in GF conditions. (F) The last 
model predicts that HNF4A activity is reduced because of a change in splice form/exon usage. 
Perhaps microbiota colonization results in increased usage of the HNF4A promoter 2. My ChIP 
antibody did not detect splice forms generated from this promoter. Therefore, my ChIP HFN4A 
occupancy may be reduced because of less frequent binding of HNF4A from promoter P1. 
 
4.2.3 Energy Balance: Fatty acid availability: 
Microbiota colonization induces significant shifts in metabolic programs in several 
tissues in the mice. These metabolic shifts occur at both the transcriptional level and protein 
level. Following colonization, intestinal tissue and liver transcriptomes shifts from 
gluconeogenesis and fatty acid lipolysis programs to glycolysis, lipogenic, amino acid and 
nucleotide metabolic program [119, 120, 169]. This shift in metabolic programs occurs 
concurrently with increased serum glucose levels and glycogen production following 
colonization [169]. Compared to GF mice, Livers and skeletal muscle of colonized (CV) mice 
have reduced active-AMPK levels, and reduced Cpt1a expression and activity, an enzyme 
involved in the rate limiting step of beta-oxidation. These data indicate that beta-oxidation 
may be the primary metabolic program in GF mice. Because of increased beta-oxidation in 
GF mice, fatty acids will preferentially be consumed for energy production rather than 
packaged and stored. In support, previous work in zebrafish and mice shows microbiota 
promote lipid droplet accumulation in enterocytes and in extra intestinal tissue [168] [and 
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data not shown]. Perhaps GF animals accumulate fewer lipid droplets upon lipid feeding 
because the lipid is preferentially directed toward beta-oxidation and not toward storage. 
Given all of the data and previous studies that show the shift in metabolic activities following 
colonization, this is the model I favor for HNF4A regulation.  
Since lipids enter the beta-oxidation cycle as individual fatty acids, more free-fatty 
acids may be available within cells of GF animals compared to CV animals. As a results, 
HNF4A may bind one of these free fatty acids as a ligand and become active. Therefore, 
HNF4A activity may be higher in GF animals because of increased free-fatty acids (Figure 
4.1C). This hypothesis is in accord with previous models of HNF4 activity [308]. To test this 
hypothesis, we can try to capture and detect the total free-fatty acids within IECs from GF 
and CV mice. I also recommend performing GC/MS and TLC experiments (discussed in 
4.2.1) which may elucidate if HNF4A protein from GF mice binds more fatty acid compared 
to CV mice. Finally, chemical screens of agonists or antagonists for enzymes involved in 
lipolysis, gluconeogenesis and lipogenesis in GF zebrafish may provide some insight into 
the mechanism controlling HNF4A.  
 
4.2.4 Energy Balance: AMPK activity and PGC-1A: 
As mentioned in the previous section, phosphorylated AMPK (activated-AMPK) 
levels are reduced in skeletal muscle and liver in CV mice compared to GF mice. AMPK 
functions as a metabolic rheostat which regulates several metabolic pathways based on 
AMP levels. AMPK activity suppresses cellular proliferation and lipolysis and activates 
mitochondrial biogenesis and fatty acid oxidation. It performs these functions through 
phosphorylation and inhibition of Acetyl-CoA Carboxylase (ACC), which directs Acetyle-
CoAs to lipogenesis, and phosphorylation and activation of PGC-1A, which functions as a 
transcriptional coactivator [348]. PGC-1A binds the HNF4A homodimer at multiple locations 
and promotes stability on DNA and induces transcriptional activity [312]. I recommend 
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performing phospho-PGC-1A westerns to confirm microbiota suppress PGC-1A in this tissue 
as well. If PGC-1A is more active in GF IECs, like it is in the liver, perhaps microbiota 
colonization suppresses HNF4A DNA binding by reducing activity of PGC-1A (Figure 4.1D).  
When bound to a transcription factor, the cofactor PGC-1A can also recruit CREB 
Binding protein (CBP/P300) to genomic locations. CBP/P300 is a histone acetyltransferase 
enzyme that modifies lysine 27 of Histone 3 to generate H3K27ac. CBP/P300 also 
acetylates HNF4A at lysines 97 and/or 99 [310]. Therefore, a model in which the microbiota 
suppress PGC-1A activity provides mechanisms for two genomic observations from Chapter 
3: 1) Perhaps microbial colonization inactivates PGC-1A in IECs and thus reduces HNF4A 
stability on DNA. 2) Locations bound by HNF4A had statistically higher H3K27ac signal 
compared to open chromatin regions that were not bound by HNF4A. Perhaps PGC-1A 
recruited CBP/P300 to regions bound by HNF4A. Once recruited to these regions, 
CBP/P300 could acetylate nearby H3K27 and thus increase H3K27ac signal around HNF4A 
bound enhancers. Other cofactors and other transcription factors are perhaps more 
“permitted” to bind and coactivate these enhancer elements following H3K27ac modification.    
To test if reduced PGC-1A activity mediates microbial suppression of HNF4A, I 
recommend performing co-immunoprecipitations from IEC nuclear extracts from GF and CV 
mice. Perhaps PGC-1A only co-immunoprecipitates with HNF4A in GF conditions. This 
experiment could also be scaled up to perform mass spectrometry which would provide an 
unbiased approach for testing cofactor binding. Mass spectrometry also permits detection of 
post-translation modifications therefore allows testing of the impact of microbiota 
colonization on HNF4A PTMs.  
Co-immunopreciptation experiments, particularly from in vivo tissue, can be 
technically challenging, especially if the starting material is limiting. Therefore, these 
experiments could also be tested in vivo using the zebrafish model. Transgenesis of 
zebrafish coupled with genetic mutation provides an opportunity to quickly test the function 
98 
 
of multiple genes and mutant proteins. For these experiments, I recommend generating a 
transgenesis construct that will encode and induce expression of wild-type hnf4a and 
rescues the hnf4a-/- zebrafish line (Figure 4.2). With this construct and with the power of site-
directed mutagenesis, we can test if Hnf4a with a single amino acid mutations maintain the 
capacity to rescue the hnf4a-/- phenotype. The simplest assay to test for function of the 
transgenic and mutant Hnf4a is qRT-PCR, specifically assaying genes that are known Hnf4a 
targets. Mutations at amino acids that interact with PGC-1A recognizes will inform us of the 
importance of PGC-1A in regulating HNF4A activity [312]. Phospho-mimetic mutations or 
another amino acid substitution at locations of post-translational modifications will provide 
insight into which kinases or other protein modifying enzymes are regulating Hnf4a activity 
(see 4.2.6). Finally, these experiments can be moved into a gnotobiotic system to test if the 
microbiota impact the activity of these transgenic and mutant hnf4a zebrafish.  
 
Figure 4.2:Transgenic screening strategy to test for the influence of PTMs and PGC-1A 
binding on Hnf4a activity in zebrafish. (A) A simple plasmid that includes an intestine specific 
promotor driving expression of hnf4a. This plasmid can be injected into hnf4a-/- zebrafish embryos w/ 
transposase to generate transgenic animals and to test if intestinal expression of hnf4a is sufficient to 
rescue hnf4a-/- mutant zebrafish from the IBD-like gene expression signatures. The hnf4a gene within 
the plasmid can be modified via SDM to introduce amino acids that mimic or inhibit PTMs or inhibit 
PGC-1A from binding. (B) An Hnf4a protein schematic with functional domains annotated. Amino 
acids with pink lines have been shown to be phosphorylated [349-352]; all annotated residues are 
conserved between mammals and zebrafish except for S313, which is Y313 in zebrafish (annotated 
as y313 in the diagram). The K77 and K79 (blue line) have been shown to be acetylated by CBP 
[310] and K365 and D367 (brown line) have been shown to be SUMOylated [353], which promotes 
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protein degradation via a ubiquitination pathway. The 12 amino acids below the protein schematic 
have been shown to directly interaction with PGC-1A via protein crystallography [312]. 
   
4.2.5 Nuclear receptor repressors and HDACs: 
Nuclear receptors function as both transcriptional activators and repressors [354, 
355]. Repression of genes is facilitated by a class of proteins called corepressors which bind 
to the transcription factors and form a repressor complex. This repressor complex occupies 
cis-regulatory regions, and blocks the transcription of a target gene. A family of 
transcriptional repressors called Nuclear receptor Corepressors (NCOR1 and NCOR2) bind 
transcription factors (not just nuclear receptors, as suggested by their name) and repress 
transcription of a target gene. NCORs function together or individually with several different 
transcription factors at many loci with varying degrees of repressor activities [356]. NCOR2 
interacts directly with HNF4A and recruits histone deacetylases to repress transcription of 
genes [357]. No studies show a direct interaction between NCOR1 and HNF4A, but NCOR1 
does repress several genes in the HNF4A regulon through VDR-mediated repression [358].   
Microbiota colonization results in significant induction of NCOR1 and VDR 
expression in the small intestine [119]. Perhaps these factors form a repressor complex and 
replace HNF4A on the genome, thereby suppressing HNF4A activity and repressing HNF4A 
target genes. This model may be unlikely since VDR, like HNF4A, has been shown to 
promote transcription of fatty acid oxidation genes, which are suppressed upon microbiota 
colonization. However, members of the PPAR and RAR family of nuclear receptors also 
interact with NCORs [359]. Like HNF4A, PPARs and RARs recognize “DR2” (see figure 
3.3E) DNA sequence motifs, indicating these transcription factors have the capacity to 
replace HNF4A at the same genomic location and perhaps recruit the NCOR corepressor. In 
support, the microbiota stimulate PPARG-mediated transcription in the colon [360]. Perhaps 
microbes similarly promote PPARG-repressor activity which could then replace HNF4A on 
the genome. Regardless of the specific transcription factors, I propose a model in which a 
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repressor complex replaces HNF4A on the genome and represses transcription of HNF4A 
target genes (Figure 4.1E). In this model and others, it is important to note that HNF4A 
target genes are not completely repressed; and similarly, HNF4A activity is not completely 
inhibited. Instead, these models provide a mechanism that may attenuate HNF4A activity 
and its target gene transcription. 
NCORs also recruit histone deacetylases (HDACs) to chromatin which then 
deacetylate H3K27ac, making the chromatin less “permissive” for transcription factor binding 
and thus reducing enhancer activity. Therefore, if the NCOR models above are correct, 
following replacement of HNF4A by a repressor complex, HNF4A bound regions will have 
reduced H3K27ac signal. Indeed, microbiota-suppressed enhancers are significantly 
enriched for HNF4A binding sites, indicating these may be sites where HNF4A was actively 
promoting transcription prior to colonization (see Figure 3.3F). However, following 
transcription, a repressor complex replaced HNF4A and reduced enhancer activity. 
Similarly, HNF4A also functions as a transcription repressor with NCOR2; perhaps 
microbiota-induced genes are repressed by HNF4A [357]. Following microbiota colonization, 
perhaps the HNF4A-NCOR2 repressor complex is replaced by transcription factors that 
activate the gene and recruit histone acetyltransferases. This model explains why 
microbiota-activated enhancers contain HNF4A sites (see Figure 3 in Chapter 2).  
 
4.2.6 Post-translational Modifications: 
Post-translational modifications on HNF4A can both activate and suppress its activity 
by either impacting its ability to bind DNA or by destabilizing homodimer formation. CREB 
binding protein (discussed in 4.2.4) acetylates HNF4A and promotes HNF4A binding affinity 
for DNA [310]. In a human embryonic stem cell based model of hepatocyte differentiation, 
HNF4a becomes modified by SUMOylation on the c-terminus. Following SUMOylation, 
HNF4A becomes targeted for degradation by RNF4-mediated ubiquitination [353]. Four 
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kinases have been shown to phosphorylate HNF4A in either in vitro and cell culture 
conditions. AMP-activated kinases (AMPK) phosphorylates HNF4A and destabilize 
homodimerization and DNA binding affinity [311]. Phosphorylation of HNF4A by Protein 
Kinase A (PKA) inhibits recruitment to its target genes and blocks nuclear localization [349]. 
Protein Kinase C (PKC) phosphorylation similarly blocks HNF4A nuclear localization and 
targets it for degradation via the proteasome pathway [350]. The Mitogen Activated Protein 
Kinase (MAPK) pathway also inhibits HNF4A activity [352]. A recent paper suggests the 
ERK1/2 may be the kinases that suppress HNF4A activity following MAPK signaling [351]. 
Excitingly, the microbiota stimulate the transcriptional activity of the nuclear receptor PPARG 
through phosphorylation by ERK1/2 [360]. Perhaps the microbiota suppress HNF4A through 
the same signaling pathway. 
Microbiota colonization may activate the MAPK pathway through TLR4, which binds 
microbe associated molecular patterns like LPS. Similarly, cytokine receptors, like TNFSFR 
and IFNGR, and growth factor receptors may also activate MAPK signaling; however, these 
receptors may also activate PKC and PKA. The activation of these signaling cascades may 
result in phosphorylation of HNF4A and thus reduce HNF4A activity (Figure 4.1B). However, 
I predict neither PKA nor PKC are involved in HNF4A suppression upon colonization since 
phosphorylation by these kinases causes HNF4A to localize to the cytoplasm. 
Immunofluorescence from jejunal villi indicate HNF4A remains in the nucleus of IECs 
following colonization (See Supplemental Information in Chapter 3). The mode of inhibition 
by MAPK activity on HNF4A remains unknown, but perhaps ERK1/2-mediated inhibition 
does not alter nuclear localization and only impacts HNF4A DNA binding affinity. Excitingly, 
LPS treatment does suppress transcription of HNF4A target genes [361]. LPS activates 
TLR4 which signals through both a MYD88 independent and MYD88 dependent pathways 
(See 2.4.2). MAPK activation by TLR4 is dependent on MYD88 function. Loss of MYD88 in 
mice does not impact the suppression of most HNF4A target genes following microbiota 
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colonization [119], indicating TLR4 signaling through the MAPK pathway is not necessary 
for the microbiota to suppress HNF4A. However, MAPK pathways may become active 
through other receptors following microbiota colonization. 
Microbiota colonization also induces activation of other receptor signaling cascades, 
like TNFSFR. TNFA, which binds TNFSFR, signaling also activates MAPK pathways, along 
with PKC [362]. Perhaps activation of these membrane receptors results in suppression of 
HNF4A by a post-translational modification. To test if the microbiota induce post-
translational modifications on HNF4A, I recommend proteomic analysis both from mouse 
tissue and using transgenic zebrafish. Please see Section 4.2.4 for details regarding 
experimental design. We similarly do not know if these kinases are more active in a 
colonized state. So I recommended performing western blots for phosphorylated (activated) 
forms PKA, PKC, ERK1/2 from IECs from gnotobiotic mice. If one of these kinases are more 
active following colonization, I recommend treating GF zebrafish with kinase agonists like 8-
bromo-cAMP [363], which selectively activates PKA. GF fish treated with this chemical may 
have reduced expression of HNF4A target genes compared to untreated germ free controls 
if PKA suppresses HNF4A activity. Similar experiments can be performed for the other 
kinases using both agonists and antagonists. These experiments could also be coupled with 
the transgenic zebrafish experiments detailed in Section 4.2.4 to provide specific information 
about where the PTMs are located on HNF4A.  
 
4.2.7 Combination of several of the models 
 Gene expression is a nuanced biological process with several layers of regulation 
that include nucleosome location, transcription factor binding, cofactor binding, RNA 
polymerase binding, and microRNA silencing. Several competing and compensatory 
mechanisms orchestrate these layers of regulation. Maintaining the appropriate level of 
regulation remains a vital process for all cellular life. The models above describe six 
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strategies cells may use to regulate HNF4A. Each model was described independently of 
the others; but these models may blend together to regulate HNF4A activity. For instance, 
HNF4A may bind PGC-1A only in the presence of microbiota-generated CLA. Furthermore, 
although microbiota colonization suppresses HNF4A activity, these models similarly provide 
competing pathways that function to maintain or increase HNF4A activity. 
The paradigm of science is that all answers leads to new questions. My work has 
answered a few important questions about the nature of host-microbiota interactions, 
however it has led to several new questions that the field is poised to address. I foresee 
future progress requiring more biochemical approaches to identify the molecular processes 
that control intestinal epithelial transcription. Transcriptional assays, like those I have 
discussed extensively, do not necessarily translate to function and therefore more 
functional/biochemical assays must be performed to gain a deeper understanding of this 
intimate relationship.  
 
4.3 Why suppress HNF4A activity? 
I have now established that microbiota colonization is associated with a suppression 
of HNF4A activity, and I have proposed 6 possible methods that may coordinate this 
suppression. However, what are the downstream effects of microbial suppression of 
HNF4A? What are the possible consequences and the advantages to the microbiota for the 
suppression of HNF4A activity? What are the possible consequences and the advantages to 
the intestinal epithelia and host for this interaction? In the following section, I discuss the 
possible roles HNF4A may play in regulating metabolic, proinflammatory, and innate 
immune responses and how these processes are advantageous to the intestinal epithelia 
and the host. I then explore the concept of commensalism. Does a true mutualistic 
relationship exists between the microbiota and the host? Or, are host-microbiota interactions 
a constant tug-of-war for the available resources within the intestinal lumen?  
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4.3.1 Suppressing HNF4A may provide a significant advantage to the host 
 Both proinflammatory and metabolic genes are directly and indirectly regulated by 
HNF4A [248, 249, 308, 309]. In the mutant hnf4a zebrafish model, Hnf4a activity appears to 
repress expression of tnfa, duox2, and il-1b (proinflammatory and innate immune genes) 
and activate expression of fabp2, elovl2, and apoa1a (metabolism or mobilization of fatty 
acid genes). My data indicate the microbiota regulate these same genes in gnotobiotic 
zebrafish. Similarly, in mice, HNF4A binding sites are located at loci of innate immune or 
redox genes and fatty acid metabolism and mobilization genes. The exact role of HNF4A 
activity in regulating some of these genes, particularly the proinflammatory genes, remains 
unknown. However, the coincidences between the expression patterns in mutant zebrafish 
and the occurrence of HNF4A bindings sites at the same gene in mice suggest a conserved 
role of HN4A in regulating proinflammatory and metabolic transcription networks.  
An obvious disadvantage to my data is that the mouse ChIP-seq, RNA-seq and 
DNAseq were performed from all villi-epithelial cells types. Therefore, most of my data is 
derived from enterocytes since this is the most prevalent cell type on villi; however, goblet 
cells and EECs may have some impact on my datasets since they make up a small 
percentage of cells on villi. My -omics datasets likely exclude Paneth cells, progenitor cells 
and stem cells, however they may make up a very small percentage of cells in the extracts. 
Therefore, the induction of Reg3b and Reg3g, classically thought be markers of Paneth cell 
which reside in the intestinal crypts, following microbiota colonization is likely be derived 
from villus cells. 
Based on my datasets, HNF4A binds to the loci of Muc13 and Muc4 genes. Upon 
microbiota colonization, HNF4A occupancy at these loci is reduced and these genes 
become highly expressed. These data suggest that HNF4A may be repressing their 
transcription (or HNF4A binding near these loci is coincidence). Upon microbial stimuli, it is 
advantageous for the epithelium to upregulate its mucus production to maintain a barrier 
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between itself and the microbiota. A similar logic may exist for the gene Reg3b which 
functions as an antimicrobial peptide. Upon microbial colonization, HNF4A occupancy at the 
Reg3b loci is lost and its expression increases. The protein product of the Duox2 gene 
generates reactive oxygen species that can kill bacteria. HNF4A also binds at the Duox2 
locus in the intestinal epithelium and this binding is reduced following colonization. Like the 
mucins and Reg3b, microbiota colonization induces Duox2 expression, again suggesting 
HNF4A suppresses these epithelial defense mechanisms. Therefore, if the binding of 
HNF4A near these downregulated genes is not just coincidence, reduced HNF4A-repressive 
activity following microbiota colonization offers significant advantages to the intestinal 
epithelium because it provides a mechanism for the host to adapt to life with a microbiota by 
initiating anti-microbial defenses. 
Activation of defense mechanisms upon microbiota colonization; is a logical 
response; however, what are the possible advantages to downregulating metabolic genes, 
particularly those involved in lipolysis, lipid mobilization, gluconeogenesis and beta-
oxidation? As mentioned several times in my dissertation, microbiota colonization results in 
a rapid and prolonged shift in metabolic programs that results in downregulation of 
ketogenetic, beta-oxidative and gluconeogenic programs and an increase in glycolysis, 
amino acid metabolism, nucleic acid metabolism, and lipogenesis [364, 365]. This 
reorientation in metabolic programs may be a result of increased energy availability since 
the microbiota facilitate nutrient absorption and storage by the epithelium [156, 167, 168, 
366]. I speculate the response to microbiota colonization is the host attempting to store all 
available energy. The epithelium shuts down its lipolysis and beta-oxidation programs so 
those fatty acids can be stored and later consumed during times of fasting. Meanwhile the 
host uses other sources of energy that may have just become available. Since time between 
meals could be an indefinite wait over the course of animal evolution, storage of energy 
would have been critical for survival. Since HNF4A activates the transcription of several 
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genes involved in the beta-oxidation pathway, suppression of HNF4A in the intestinal 
epithelium upon microbiota colonization may provide the host an advantage by enabling 
storage of energy in preparation for fasting. Furthermore, HNF4A appears to play a central 
role in the epithelium’s adaptation to life with a microbiota, since loss of HNF4A activity 
results in severe metabolic derangements in response to microbiota colonization.  
 
4.3.2 Mutualism or antagonism? 
 The microbiota field often refers to the relationship between the microbiota and the 
host as commensal. These paradigms suggest that the microbiota provide a benefit to the 
host while the host similarly provides a benefit to the microbial communities. For example, 
the host provides the microbiota a niche within the intestinal epithelium. Within this niche, 
the microbiota collect the resources and energy they need to survive and in return facilitate 
energy harvest for the host. However, even if majority of these interactions appear 
symbiotic, they may stem from a cellular struggle for control of the environment. An analogy 
of this relationship may be the relationship between two parties in a bipartisan political 
system. Both parties require each other to maintain political homeostasis and suppress new 
forms of government. That is, both parties will protect the bipartisan system to the mutual 
benefit of both parties. However, both parties similarly adopt strategies to undermined and 
attack the opposing party to gain independent power within the system. They fight over the 
same resources (voters) to gain and maintain political power. The microbiota and the 
intestinal epithelium appear to function similarly. Both the host and microbiota support 
homeostasis by killing invading pathogens; however, both the host and the microbiota fight 
over the same resources (dietary nutrients) and both have adopted strategies to impede the 
other’s progress (Figure 4.2B).  
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Figure 4.3: The advantages to the host and the microbiota following suppression of HNF4A 
activity. (A) Suppression of HN4A activity associated with microbiota colonization provides two 
potential advantages to the host. 1) Suppression of HNF4A relieves a possible repressive activity by 
HNF4A on proinflammator9y, innate immune, and redox genes. Upregulation of these genes protects 
the intestinal epithelia from the microbiota. 2) Suppression of HFN4A reduces the transcription of 
genes involved in beta-oxidation, lipolysis, and lipid transport, enabling FAs to be stored for 
consumption during fasting. (B) Microbiota colonization increases the energy availability to the host. 
Indeed, fecal samples from GF mice fed a high-fat diet have increased TG levels compared to fecal 
samples from CV mice [167]. The intestinal epithelial may begin rapid transport of FAs because of a 
new competition for the energy sources, i.e. a “Tug-of-War” for FAs and other nutrients. 
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Both the microbiota and the host utilize fatty acids as energy. Microbiota colonization 
results in repressed expression of fatty acid transporter genes in the intestinal epithelium; 
strategy used by both the epithelia and the microbiota to control energy availability. This 
suppression provides each an advantage in this tug-of-war for resources. Upon colonization, 
the host begins to utilize other energy sources and preferentially stores dietary fatty acids 
and retains them from the colonizing microbiota. Some microbial taxa similarly consume 
dietary fatty acids for metabolic processes [367]. Microbiota-suppression of HNF4A reduces 
transcription of fatty acid transport genes. This may result in a retention of fatty acids in the 
intestinal lumen where the microbiota can maintain access to these dietary nutrients. 
Similarly, the downregulation of fatty acid absorption genes may be a secondary effect 
following an initial burst in fatty acid absorption and storage following colonization. 
Therefore, suppression of HNF4A activity provides advantages to both the microbiota and 
the host, which may sound mutualistic, but the mechanisms that drive this process may be 
antagonistic.  
 
4.4 The overlap of HNF4A activity and the microbiota in human diseases:  
Both the microbiota and HNF4A are implicated in a variety of intestinal and metabolic 
diseases. Loss of HNF4A activity and HNF4A variants are associated with Crohn’s disease, 
ulcerative colitis, maturity onset diabetes of the young (MODY1), and metabolic syndrome 
[233, 256, 303, 368]. Similarly, the microbiota are associated with obesity, insulin resistance, 
type 2 diabetes, Crohn’s disease and ulcerative colitis [221, 364, 369]. Given that microbiota 
colonization results in reduced HNF4A activity, what role does this suppression play in these 
diseases? Is HNF4A a viable therapeutic target for treating these human diseases? As 
discussed in the previous section, how does this antagonistic relationship, which typically 
maintains homeostasis, become detrimental to the host? What role does HNF4A play in 
maintaining the balance in this relationship and what are the consequences of improper 
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HNF4A regulation? In this next section, I will discuss how both HNF4A and the microbiota 
contribute to metabolic syndrome and inflammatory bowel diseases. I will discuss models 
how suppression of HNF4A may mediate the pathology of these diseases.  
 
4.4.1 Metabolic syndrome 
Metabolic Syndrome is defined as a cluster of risk factors that indicate increased risk 
of diabetes, cardiovascular disease and premature mortality [370]. These risk factors include 
but are not limited to insulin resistance, increased ratio of visceral to subcutaneous 
adiposity, dyslipidemia and arterial hypertension [370-372]. The composition of the gut 
microbiota is linked to several of these risk factors including obesity and insulin resistance 
[373, 374]. Based on the microbial alterations of host metabolic programs, it is not surprising 
that the microbiota contribute to these risk factors. Indeed, microbiota colonization in mice is 
associated with increased serum glucose levels, increased adipose tissue size, and 
decreased activity [156, 169]. Furthermore, the transcriptional changes associated with 
microbiota colonization indicate a shift from a “starved” state to a “fed” state. This 
transcriptional shift is logical because of enhanced nutrient availability including fatty acids 
[168]. However, impaired adipose tissue handling of dietary fats may result in increased 
circulating triglycerides [375]. If the body fails to compensate for these circulating 
triglycerides by increasing fatty acid oxidation within cells, these triglycerides may be stored 
in non-adipose tissue, such as skeletal muscle, or continue to circulate. Both the increase of 
fat stores in non-adipose tissue and increased circulating triglycerides can contribute to the 
development of insulin resistance [376]. Therefore, maintaining a sensitivity to circulating 
triglycerides is essential for proper clearance of circulating triglycerides and maintaining 
insulin sensitivity. 
HNF4A serves as a master regulator of metabolism. Aberrant suppression of its 
activity impairs cellular fatty acid-oxidation [308] and increases risk of diabetes [309]. 
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Furthermore, gene variants have been associated with both type 2 diabetes and metabolic 
syndrome [303, 304]. Genetic factors, diet, activity level, and microbiota collectively 
contribute to metabolic syndrome. These factors control the function of several tissues and 
cellular processes that become impaired during the progression of insulin resistance and 
obesity. Therefore, I speculate that microbial suppression of HNF4A may only play a small 
contribution to insulin resistance but is not the only element mediating the risk factor.  
The Hnf4a intestine-specific knockout mouse has impaired fatty acid uptake and 
does not develop insulin resistance. These data suggest aberrant suppression of HNF4A 
activity in the gut may not be sufficient to drive insulin resistance. Instead, these results 
address an important aspect of HNF4A activity and microbiota impact on epithelial function: 
fatty acid uptake. Aside from beta-oxidation genes, the microbiota also suppress several 
fatty acid transport and mobilization genes, including Slc27a2, ApoA1, and Fabp2. Based on 
my zebrafish RNA-seq and my mouse RNA-seq and ChIP-seq datasets, these genes also 
appear to be regulated by HNF4A. So, aberrant suppression of HNF4A activity in the 
intestine should, in part, be protective of obesity and insulin resistance due to an impairment 
of fatty acid uptake. So microbial suppression of HNF4A activity in the intestine may not 
contribute to metabolic syndrome. However, loss of HNF4A activity in the liver may 
contribute to insulin resistance. Indeed, the liver-specific HNF4A knockout mouse has 
increased fat deposition in the liver likely due to lipid transport failure [377]. Liver fat is highly 
correlative to metabolic syndrome and insulin resistance [378, 379]. Therefore, I speculate 
that microbial suppression of intestinal HNF4A does not contribute to metabolic syndrome. 
Instead, since the microbiota are known to mediate transcription and metabolic responses in 
the liver [169, 380], perhaps microbial regulation of liver HNF4A contributes to metabolic 
syndrome. This regulation may occur through any of the mechanisms detailed in section 4.2. 
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4.4.2 Inflammatory Bowel Disease 
 Both the microbiota and HNF4A have been independently implicated in inflammatory 
bowel diseases (IBD). Indeed, HNF4A variants are associated with both CD and UC [232, 
233]. Similarly, HNF4A expression has been shown to be decreased in UC as well as in 
mouse models of colitis [256, 260]. Finally, transient knockdown of Hnf4a in liver cell culture 
induces an inflammatory response that continues to repress HNF4A expression [250]. 
Microbiota composition is also associated with onset of inflammation in CD and UC [221, 
381]. Antibiotics have been shown to provide relief to some CD and UC patients, indicating 
episodes of inflammation are associated to microbiota composition [382]. And many/most 
mouse models of IBD are asymptomatic when raised GF, underscoring the central 
importance of microbial stimulation in IBD pathogenesis. The multi-species meta-analysis 
performed in chapter 3 (Figure 3.5) is the first to draw a link between the microbiota and 
HNF4A in the context of IBD. My data indicate that HNF4A may protect from intestinal 
inflammation and disease pathology. Deletion of hnf4a activity in the presence of a 
microbiota in gnotobiotic zebrafish results in a transcription program that resembles the 
transcriptome of CD and UC patients. This IBD transcription program generates high 
expression of inflammatory genes and low expression of metabolic genes. Together, these 
studies indicate HNF4A may play a significant role in UC and CD pathologies. However, 
several questions remain to be answered: Does microbial suppression of HNF4A contribute 
to IBD progression? Or, does loss of HNF4A activity through other mechanisms contribute to 
IBD pathologies? How does HNFA protect against IBD? Is HNF4A a viable target for 
therapies in IBD research?  
 We do not know if microbial suppression of HNF4A contributes to disease pathology. 
The data collected only indicate the microbiota have the capacity to suppress HNF4A 
activity, but we do not know if this suppression causes IBDs. Perhaps the microbiota only 
induce IBD after a microbiota-independent loss of HNF4A activity. Perhaps, genetic variants 
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of HNF4A are more susceptible to suppression by the microbiota and thus predispose 
patients to IBDs. We also do not know if the mechanisms that control HNF4A activity upon 
microbiota colonization are the same mechanisms that suppress it in IBD.  
How does the suppression of HNF4A, a master regulator of metabolic gene 
expression suppress inflammation and epithelial function? And similarly, why does HNF4A 
appear to activate metabolic genes and repress proinflammatory and innate immune genes 
(as discussed in the previous section)? A common theme in inflammation studies is that the 
activation of innate immune genes coincides with a suppression of metabolic gene programs 
[132]. However, we do not have a strong understanding as to why the activation of these 
programs are mutually exclusive. 
Poly-unsaturated fatty acids have also been shown to reduce inflammation in 
patients; however, the mechanisms for this relief are largely unknown. Some studies have 
shown that poly unsaturated fatty acid reduces NF-κB activity thereby suppressing the 
immune response [319, 383, 384]. The putative endogen ligand of HNF4A, linoleic acid, 
protects zebrafish from chemical-induced inflammation [385]. Perhaps this fatty acid, and 
other poly unsaturated fatty acids promote HNF4A activity and suppresses the inflammation.  
 HNF4A activity may protect the intestine from chronic inflammation through several 
mechanisms: 1) HNF4A promotes general IEC homeostasis, including barrier function. 2) 
HNF4A activates transcription of specific anti-inflammatory genes like APOA1 and miR-124, 
a gene that is commonly suppressed in both UC and CD [2, 237]. Injection of APOA1 
mimetic peptide rescues experimental colitis [262]. 2) HNF4a activates the transcription of 
miR-124 in liver cells [250]. STAT3 expression is silenced by miR-124 [261]. Since miR-124 
has reduced expression in biopsies from pediatric CD patients compared to healthy patients 
[261], perhaps HNF4A regulates miR-124 in the intestine as well. 3) My ChIP-seq and RNA-
seq data suggest HNF4A may repress several proinflammatory and innate immune genes, 
including DUOX2, which is commonly upregulated in UC and CD [237]. Increased DUOX2 
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expression is only correlative with the onset of disease and inflammation and has yet to be 
shown as a causative factor in IBD; however, its activity does increase the potential for DNA 
damage and epithelial cell death [386]. 4) Four HNF4A binding sites are found at Il10rb 
gene locus, an important anti-inflammatory cytokine receptor. Loss of IL10 signaling can 
similarly result in spontaneous colitis [387], so perhaps HNF4A activates transcription of this 
receptor. Loss of HNF4A respective activities at these genes may lead to aberrant 
inflammation. 
 
4.5 Concluding Remarks: HNF4 and the expansion of the nuclear receptor 
superfamily 
The genome of the demosponge, the most ancient member of the metazoan, 
encodes a single nuclear receptor that resembles HNF4A [148]. Because HNF4A resembles 
the most ancient of the nuclear receptors, the discovery that HNF4A mediates microbial 
suppression of host genes is exciting because it suggests a possible model that an HNF4-
like nuclear receptor has been interpreting and protecting the host from microorganisms 
since the dawn of the metazoa. It also permits a possible theory for the evolution of other 
metabolically regulated nuclear receptors: as animal evolution progressed and as animal 
tissues and cell-types became more diverse and their microbial communities that interface 
with these host cells became more diverse, the need for molecules and signaling pathways 
that can interpret and respond to these new microbiota-derived cues arose. Since nuclear 
receptors provide a simple mechanism that can fulfill this need, it makes sense that these 
evolutionary pressures resulted in radial expansion of the nuclear receptor superfamily. 
Over the course of metazoan evolution, molecular tinkering [388] drove the 
expansion of the nuclear receptors superfamily to over 50 members family found in humans 
[147]. Even If HNF4A resembles the most ancient of the nuclear receptors, it certainly is not 
nature’s most malleable nuclear receptor. That role belongs to the RXR family of nuclear 
114 
 
receptors. The RXR family of nuclear receptors arose shortly after HNF4-like nuclear 
receptors evolved [148]. Evolution has tinkered with RXR activity repeatedly as new 
metabolite-binding nuclear receptors evolved. Indeed, almost every non-steroid binding 
nuclear receptor, with the notable exception of the HNF4A, heterodimerizes with RXR [147]. 
Examples of these nuclear receptors that heterodimerize with RXR are: PPARs, FXRs, 
RARs and VDRs, all of which are activated by metabolites that are either generated or 
modified by the microbiota [147, 152, 155, 389, 390]. So even if HNF4A represents the first 
of the putative-microbiota-sensing nuclear receptors, the evolution of RXRs, along with the 
evolution of their dimerization partners, has vastly increased the sensitivities of host cells, 
enabling new responses to the environment which may include responses to the microbiota. 
An obvious question regarding nuclear receptor evolution is: what drove the 
expansion of the family? Did the complexities of host-microbiota relationships and the 
environment drive the expansion of the nuclear receptors? Or have the microbiota and the 
environment only tapped into developmental programs that were established before 
exogenous interventions? Several nuclear receptors are required for mouse embryonic 
development, including HNF4A [391, 392], RXR [393], and PPARG [394, 395]. These 
developmental failures suggest, at the very least, that these transcription factors became 
essential for development after they evolved. Unfortunately, we do not know if 
demosponges require their HNF4-like nuclear receptors for development, which may provide 
insight into what drove HNF4 evolution. However, the hnf4a mutant zebrafish is viable. 
Hnf4a knockout mouse embryos do not initiate the gastrula stage and stall during visceral 
endoderm differentiation [391], indicating Hnf4a plays a critical role in the development of 
this essential extra-embryonic tissue. We believe the hnf4a mutant zebrafish is viable 
because zebrafish and other fishes do not have a visceral endoderm and therefore hnf4a is 
less critical during embryogenesis. The visceral endoderm, which develops from the 
hypoblast, appears to be a mammalian-specific extra-embryonic tissue, suggesting that 
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Hnf4a may have only become essential for embryonic development since the evolution of 
mammals. These studies permit the theory that HNF4A, and perhaps other nuclear 
receptors required for development of mammalian-specific tissues (PPARG [394]), may 
have originally evolved to establish cellular sensitivities to the environment and the 
microorganisms within it. 
 My work represents one of the first studies to demonstrate how the microbiota 
regulate transcription factor binding genome wide. My data place a focus on HNF4A a as 
key determinant in the host response to the microbiota. However, recent work has indicated 
that other nuclear receptors play important roles in the host response along the entire length 
of the intestine as well as along the villus-crypt axis [152, 360, 389]. Together with my work, 
these studies suggest that nuclear receptors maintain homeostasis between the intestinal 
epithelia and the microbiota. Because nuclear receptors bind directly to exogenous 
molecules that impact their activities, this superfamily of transcription factors may provide 
sensitivity to the environment that tunes intestinal epithelial function and identity.  
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APPENDIX 1: A NOTE ON MODEL SYSTEMS 
 
The epithelia must respond to fluctuations of two primary components within the 
luminal environment: microbiota and dietary nutrients. However, distinguishing the individual 
effects of these components on epithelial response and gene regulation is confounded by 
dietary impact on microbial community compositions and the microbial modifications of 
dietary molecules  (Figure 2.2. Indeed, some bacterial taxa including Rosburia intestinalis 
encode genes that generate non-native isomers of poly-unsaturated fatty acids which have 
been shown to affect host physiology [129] and the large cohort of anaerobic bacteria in the 
colon have the capacity to catabolize dietary fibers that generate short-chain fatty acids 
[130]. Furthermore, diets with high lipid composition promote the growth of specific bacterial 
taxa, which can induce proinflammatory transcriptional responses from the intestinal 
epithelial cells, and diets with high-protein and low-carbohydrate intake promote growth of 
other bacterial taxa [124, 396, 397]. These studies indicate there is an intimate relationship 
between microbiota composition and the availability of specific dietary molecules and vice 
versa. Therefore, because the addition of one component to the luminal environment can 
have a rippling effect that impacts whole microbial communities and subsequent dietary 
molecules, establishing controlled and high throughput in vivo model systems remains 
paramount to understanding clear mechanisms that mediate the epithelial response to the 
microbiota and diet. To study these complex relationships, the microbiota field has taken 
advantage of several model systems, each with their own advantageous tools that permit 
the dissection of these multidimensional interactions. 
The zebrafish and Drosophila model systems have provided important 
understandings to intestinal epithelial development and transcriptional regulatory programs. 
Non-mammalian host systems are equipped with the powerful genetic and amenable tools 
and screening platforms for determining the molecular mechanisms that mediate 
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transcriptional responses. A forward genetic screen in zebrafish demonstrated that the loss 
of function of a DNA-methylation protein (uhrf1) results in hypomethylation of the tnfa locus. 
This hypomethylation results in high expression of the proinflammatory marker and an 
intestinal epithelial phenotype that resembles IBD [285]. Knocking down tnfa expression by 
morpholino injection rescues this IBD-like phenotype. Although Human GWAS studies have 
suggested similar mechanisms, this forward genetic screen provided mechanistic 
understanding to how loss of epigenetic repression of a proinflammatory marker can lead to 
IBD onset. Furthermore, compared to the mammalian model systems, the relatively simple 
microbiome of the Drosophila makes the fruitfly an ideal model organism to study host-
microbiota interactions [398]. Taking advantage of these smaller microbial communities, 
researchers could identify that microbiota regulate insulin signaling and are required for 
pupal survival [399]. Further studies indicated that this interaction was diet dependent and 
that supplementing a glucose only diet with a vitamin B source rescued the requirement for 
a microbiota [400]. These drosophila studies demonstrate the power of the fast, low-cost 
and high throughput system; this system enables researchers to perform gnotobiotic 
experiments with multiple diet manipulations to determine nutritional requirements for 
development and how the microbiota can and cannot satisfy those requirements. 
The ability for high-throughput transgene screening of an in vivo system is a unique 
attribute of non-mammalian models. The high throughput transgenic tools available in 
Drosophila facilitated a study addressing how each epithelial cell type along the intestinal 
tract rewires its transcriptional program in response to infection [401]. Furthermore, 
transgenic tools available in these non-mammalian systems permits functional testing of 
non-coding genomic regulatory elements. Indeed, zebrafish have provided the first example 
of a microbiota controlled cis-regulatory region [145], indicating that the microbiota may also 
regulate the transcription factors that bind within the region. Studies such as these provide 
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the necessary context to determine which transcription factors are regulated by the 
microbiota. 
Most of what we know from host-microbiota interactions comes from data collected 
from mammalian model organisms.  An obvious reason why mammalian systems have an 
advantage over non-mammalian systems is their homology to human physiology and health. 
However, they also provide other unique opportunities that are simply not available or are 
limited in zebrafish or fruitfly. For instance, functional genomic studies, particularly 
Chromatin Immunoprecipitation, are more easily performed in mammalian systems because 
these techniques require a lot of starting material and good antibodies. Furthermore, the 
large tissue sizes enable pairwise comparisons for different functional genomic datasets 
from the same animal, strengthening statistical power from these datasets. Although 
becoming more common in zebrafish systems [402], tissue specific knockout mutations in 
murine models represents a commonly used technique in mammalian studies and have 
been used to show how the transcription factor CDX2 or HNF4A both maintain homeostasis 
in the intestinal epithelia [29, 89] as well as showing how HDAC3 is necessary for the host 
response to microbiota colonization [236]. The mammalian system also provides the primary 
platform longterm gnotobiotic studies. Gnotobiot zebrafish studies end during early larval 
stages, providing insight into the how the microbiota control developmental programs, such 
as the edification of the immune system [146, 194]. However, murine gnotobiotic studies 
maintain GF and conventionalized status for several weeks, providing important information 
regarding the length of time it takes to reach mucosal and transcriptional homeostasis in the 
intestinal epithelia following microbiota colonization. Only recently, have there been 
advances toward longterm zebrafish gnotobiotic zebrafish husbandry [403]. 
Enteroid culture has also provided unique opportunities to study intestinal epithelium 
biology. Enteroids are small cultured epithelial colonies that are commonly generated from a 
single small intestinal epithelial crypt. The stem cells in these crypts asymmetrically divide 
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as they would in the intestine and generate a small luminal organ differentiated daughter 
cells [404]. These cultured organoids have provided key understandings in:1) how the 
enteric nervous system participates in microbiota stimulated inflammatory responses [405]; 
2) cytokine maintenance of the stem cell niche [406]; 3) signaling pathways that mediate 
cellular differentiation [407]. However, the obvious limitations to cultured organoids are the 
lack of a true basolateral membrane as well as a lack of extra-intestinal systems, like an 
enteric nervous system or a liver which are both known to communicate with the intestine 
and regulate digestive processes. A current cell culture technology that would be fascinating 
to apply to any model system would line scan photo-activatable Fluorescence Correlation 
Spectroscopy, in which the activity of individual transcription factors is monitored within a 
single nucleus [408]. Establishing this microscopy system in enteroid culture or in zebrafish 
model would provide novel insight into how transcription factors are responding within a 
given epithelial cell that is exposed to different luminal environments.  
Higher throughput transgenic technologies in mammalian model systems have 
recently become to rival those in non-mammalian systems. Although incapable of the same 
offspring sizes as zebrafish and fruitfly, and therefore limited by its throughput, shotgun 
delivery of transgenic reporters for functional genomic studies [409] as well as CRISPR 
targeting for genetic mutation [410] and transcriptional trans-activation/repression [411] have 
become powerful techniques in the mammalian and cell culture toolsheds. Although these 
techniques have not been applied to understanding intestinal biology or host-microbiota 
interactions, they hold great potential to unlock new knowledge in intestinal homeostasis. 
For instance, previous studies have identified differentially regulated enhancers in IBD 
patients and some of these enhancers also harbor known SNPs in IBD. Using a viral 
transgenic shotgun approach, the activity of these enhancers can be tested in the intestinal 
epithelia in a gnotobiotic setting, providing insight into the function of these mutations and if 
the microbiota, known contributors to IBD, mediate the activity of these mutant enhancers. 
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APPENDIX 2: MICROBIOTA COLONIZATION METHODS AND “THE WINDOW 
OF OPPURTUNITY”  
 
Various methods of colonization or depletion may elicit different host responses 
Microbiota colonization of germ free mice elicits a strong transcriptional response in the 
intestinal epithelia that is most robust in the first 1 – 2 weeks following colonization and 
persists for several weeks before reaching equilibrium [120, 121]. This sustained 
transcriptional response may be driven in part by the fact that the mucus layer within the 
small and large intestine does not achieve conventionally-reared (animals that were 
colonized by the microbiota from birth) viscosity and thickness until 8 weeks post 
colonization [412]. Surprisingly, the mucus layer of GF animals is highly viscous and difficult 
to remove from the epithelial layer because the mucin is still attached to the goblet cells [69]. 
Following microbial colonization, bacteria begin to modify the mucus layer, which begins to 
expand and develop a gradient of viscosity, where the most difficult to penetrate mucus 
resides closest to the epithelia. Following colonization, bacterial communities residing in the 
intestine show dramatic fluctuations and the most abundant phyla switches between 
Firmicutes and Bacteroidetes [412]. Perhaps, induction of antimicrobial peptides, derived 
from the host epithelium, sustains this long-term battle for most abundant bacteria.  
These mucosal and transcriptome data provide the basis for a debate about when to 
assay the host response. Although not necessarily physiologically relevant in healthy 
animals, assaying during the most robust response (2 weeks post colonization) provides 
important information that indicate which cellular processes the microbiota do mediate, 
particularly in non-homeostatic settings like in human disease. One final frequently used 
method to investigate microbiota control of host physiology is to evaluate the impact of 
treating conventionally-reared animals with antibiotics. However, it has been established 
that the majority of host transcriptional changes induced by antibiotic treatment can be 
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explained by direct effects of the antibiotic on host cells or by the effects of remaining 
antibiotic-resistant microbes [287]. 
Both the method of colonization and the age of the host impact the epithelial 
responses. Some colonization methods fail to preserve the anaerobic bacteria, which are 
known to generate short chain fatty acids in the colon which can prevent human diseases 
[130]. Other colonization methods fail to control for differences between inoculums, 
indicating the host responses may differ between experiments due to differences in 
microbial communities. Studies involving cesarean-born mouse neonates vs vaginally-born 
neonates show that microbiota colonization from vaginal births mediates down-regulation of 
TLR signaling and downstream transcriptional programs in IECs. This suppression reduces 
sensitivities to gram negative bacteria during the first few weeks of life and protects against 
epithelial damage and epithelial tolerance later in life [413, 414].  
Regardless of the method of colonization or the age of the animal at the time of 
colonization, studies have shown the microbiota have profound impacts on host gene 
expression. Therefore, we can continue to learn something regarding how the microbiota 
mediate these transcriptional changes. The debate of how to colonize and when to colonize 
will likely continue for as long as the microbiome field remains an intense area of study. 
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